Home Blog Page 176

Verghese reveals how drug production in Nigeria can be self-sufficient

2

In this interview with Yusuff Moshood, Mr Varkey Verghese, founder and managing director of the Jawa Group of companies, spoke on how Jawa overcame the challenges it faced at inception and rose to its present level as one of the top ten pharmaceutical manufacturing companies in Nigeria. Verghese, who received the prestigious Member of the Order of the Federal Republic (MFR) national merit award in 2001, also spoke on measures that can be taken to transform the pharmaceutical sub-sector and enable it contribute more to the Nigerian economy. Excerpts:


Pharmaceutical manufacturing business in this clime is a venture seriously hampered by a number of challenges. You could have chosen other businesses that are less problematic but still chose to invest in pharmaceutical manufacturing business, what prompted your decision?

 

Pharmaceutical business is indeed very challenging, particularly manufacturing. The reason we chose pharmaceutical manufacturing business is because of certain basic criteria. First, for human beings, the following are basic essentials – food, shelter, clothing and healthcare. Health care provision is essential and we require it as a basic requirement in all situations.

As a person, I have always been interested in helping to enhance the quality of life of people and I am happy doing this through healthcare delivery. We also know that Nigeria has a huge population and the potential for growth for healthcare business is very high compared to all other African countries.

 

Jawa started in the 90s with about five OTC products, but the company now has over 50 products covering diverse therapeutic range, how did you manage this remarkable growth?

 

Jawa started with five products and 50 staff members. Yes, we have achieved reasonably modest growth in our business despite the fact that we were hit badly by a serious challenge two years after we commenced production and faced a similar challenge again about three years after we had the first problem. Regardless of these challenges, God Almighty gave us the grace and wisdom to take every challenge as an opportunity to grow.

The challenges we faced had to do with the withdrawal of two of our shareholders at an interval of two years each, after the commencement of operations. It was a serious setback.

Apart from the pull out of our shareholders, we also inherited a bank loan at the time the partition was done. However, by God’s grace we were able to overcome the challenges and got to this stage. I would attribute our success to the support of our staff from the lowest to the highest. They all stood and supported the management at the most critical time, even when we could not meet salary obligations. Some expatriates managers left but my Nigerian colleagues, particularly the seniors, stood with us.

 

Two other factors also aided our growth as a company. The first is the goodwill of our customers and the quality of our products from inception; the second is the patronage of Jawa’s products by our valued distributors, wholesalers, retailers, government and hospitals both in the public and the private sectors. Currently, we have 425 staff working for the Jawa Group. We have three divisions, namely,OTC drugs, ethical drugs and veterinary drugs.

For our OTC Drugs division, we have haematonics, antacids, cough syrup, anti-diarrhoea, anti-malaria syrups and multivitamins. We also make external liquid preparation. Apart from this, we also make ointment and creams,including antiseptic, antifungal and muscular relief drugs.

For our Ethical Drugs division, we have antibiotics, antimalarials, anaesthetics and other injectables imported in our own brand name.However, for our Veterinary Drugs division, we manufacture anti-helmenthetics for deworming, as well as multivitamins and anti-septic ointments.In all, we have 117 registered products with NAFDAC and another 42 products under registration with NAFDAC.

The impressive support of Nigerians for our company and products informed our decision to also pay back to the society for every unit of product we sell in Nigeria. This is to ensure we contribute to the community in a positive way. Some of our Corporate Social Responsibility (CSR) activities include donation of drugs for ante-natal care, child health, and accident & emergency interventions in Osun, Oyo, Ondo, Ekiti, Katsina and Cross River States.

We also donated drugs and clothes to the Internally Displaced People (IDP)’s camp in Yola, Adamawa State, as well as a delivery van to the Kano State Drug Medical Agency and the Katsina State Ministry of Health.

Also, as part of our CSR and on humanitarian grounds, some patients known to us through our customers and friends were sponsored for treatment in India for ailments like heart surgeries, cancer, liver abscess, bone surgeries, etc. We equally partnered with the Tulsi Chanrai Eye Foundation and conducted free eye operations for 450 patients across the country.

We take CSR seriously and I can assure you that for every unit of Jawa product you patronise, a portion goes back to the community to touch lives.

 

Last year (2014), four pharmaceutical manufacturing companies in Nigeria attained the WHO prequalification status. How do you see this new trend of local pharmaceutical manufacturers going for the WHO prequalification and what can the government do to ensure these companies and the entire populace benefit from the prequalification status?

 

Getting the WHO prequalification by four companies is a very big achievement and Nigeria can be very proud of this. In the whole of Africa, Nigeria is the only country where four manufacturing plants are accredited. This has opened the eyes of many manufacturers in Nigeria. The WHO accreditation, which was considered not achievable in Nigeria is now achievable. This has encouraged many others to follow suit and we hope many more will get qualified.

To further improve the pharmaceutical sector, the federal government should consider having a pharmaceutical sector development fund as they have done for the textile and agricultural sectors. The Bank of Industry should also be adequately funded to enable it deliver on its mandate.

 

The pharmaceutical industry as a sub-sector of the Nigerian economy has been said to have the potential to contribute more to both national income and wellbeing. As a key player in this sector for years, how true is this and what factors are impeding the industry from realising its full potential?

 

The pharmaceutical industry as a sub-sector of the economy is worth three billion United States dollars (USD) which clearly shows that it has a potential to contribute more to the Nigeria economy and still there is room for growth. The main impediment is lack of patronage by government agencies and the political will not to accept funds from donor agencies that will always prefer to buy from foreign companies. Nigeria, while accepting donor funds, should insist on the sourcing of the products from local manufacturers.

 

How can we stop the huge dependence of Nigeria and Nigerians on external sources (importation) for local medicine needs?

 

There are 120 pharmaceutical manufacturers in Nigeria in the category of small, medium and large; and all the companies put together have the capacity to produce 70 per cent of the country’s requirements. This can be achieved over a period of five years, provided the federal and state governments can support the pharma sector through adequate long-term funding to expand and upgrade existing facilities, patronage of local manufacturers, and increase in the medicines on import prohibition list, especially those medicines that can be manufactured locally.

Also, importers should not be allowed to bring in products that can be made in Nigeria. This alone will help to improve the capacity utilisation of existing plants.

It may be equally worthwhile to see how other nations achieved self-sufficiency in local manufacturing. Take the examples of India and China. They were closed economies for a long time and this did not allow any importer to come in. During this period, companies operating in those two countries looked inwards and developed local industries which have matured to great heights. They have now opened their countries to importation from outside; but other countries are not able to compete with them because of the economy of scale they have achieved.

It is worth emulating such countries so that Nigeria can become self-sufficient not only to meet local demands but to also export products to other countries.

 

In our quest to rid the nation of the menace of fake drugs, are there things we should be doing that we are not doing? How can we further strengthen the fight against drug counterfeiting?

 

I commend the NAFDAC for the war against fake drugs. The introduction of the Mobile Authentication Service (MAS) sticker for selected products by NAFDAC is a welcome development and, in due course, it should be expanded to other products also.

However, it is important to state that fake drugs usually enter the country basically through three avenues- seaports, airports and land borders. Therefore, if the federal government and NAFDAC can properly police the loopholes at these entry points, it will go a long way to minimise the problem of fake drugs. NAFDAC should equally be adequately funded and equipped to consistently deliver on its mandate.

UNILAG Pharmacy Faculty marks 2nd ‘White Coat ‘ceremony

0

The second annual ‘White Coat’ ceremony was recently held by the Faculty of Pharmacy, University of Lagos (UNILAG), Idi-Araba, with a massive turnout of students and academic staff.

UNILAG2

L-R: Dr Rebecca Soremekun, lecturer, Clinical Pharmacy and Biopharmacy, University of Lagos; Pharm. Joseph Oiseoghaede, secretary, National Association of Pharmacists in Academia (NAPA); Prof. Bola Silva, head of department, Pharmaceutics and Pharmaceutical Technology; Prof. Olukemi Odukoya, dean of the faculty; Dr Bola Aina, lecturer, Clinical Pharmacy and Biopharmacy; Pharm (Mrs) Ogochukwu Amaeze, NAPA financial secretary; Pharm. Amina Oyawaluja, lecturer, department of Pharmacognosy; Pharm. (Mrs) Fatima Ikolaba, NAPA treasurer during the White Coat ceremony.
Addressing the 175 pharmacy undergraduates at the ceremony which took place at the school auditorium on 13 March, 2015,Kayode Olatunji, one of the four 300 level students with distinction brought to educate the 2014/2015 intakes on achieving excellence in pharmacy education, charged them to brace up for the challenges ahead.
Olatunji, in his keynote address,counselled the students on the need to define what they aimed to achieve the moment they gained admission to study Pharmacy.
“By now, you should have decided what you want to become the moment you graduate. Whether you hope to sell drugs, go into academia, work in hospitals and so on,” Olatunji said, adding that “studying pharmacy is very stressful; but you shouldn’t allow the stress to get to you. You must remain focused, read to understand and avoid cramming.”
According to the young sch

International workshop on health care leadership, financing and innovation (DUBAI)

0

In every health care delivery system, there is need for productive leadership to ensure the provision of optimum health care service. All over the world, governments and private institutions are developing and implementing unique models for meeting present and emerging challenges in health care delivery. For the past 21 years, it has been our task at Pharmanews to help deliver the requisite capacity development required to proactively champion sustainable models of service delivery among health care and pharmaceutical industry players.

We wish to invite you to participate in our international workshop on “Health Care Leadership, Financing and Innovation”, taking place in Dubai, The United Arab Emirates.

Date:            Sunday 17 – Friday 22 May, 2015

Time:            9.00a.m – 5.00p.m (daily)

Venue:         Aster DM Health Care, 33rd Floor,

                     Tower D – Aspect Towers, Executive Towers at Bay

                     Avenue, Business Bay, Dubai, United Arab Emirates

 Target Participants

Doctors, Pharmacists, Nurses, Medical Laboratory Scientists and other clinical, administrative, management and technical personnel in the public and private health care system.

 Course Contents:

  • Developing and Managing Strategic Change
  • Quality Management
  • Health Care Financing Models and Structure
  • Investment Models in Health Care Facility Development
  • Comparative Study of Global Health Care Entrepreneurship Models
  • ICT in Health Care Systems
  • Essentials of Clinical Leadership

 Learning Objectives:

At the end of the workshop, participants will be able to:

  • Lead effectively, communicate clearly and deliver optimal health care service within the health care delivery system.
  • Understand basic concept in managing and developing strategies for effective change.
  • Understand globally accepted and sustainable techniques in quality management protocols.
  • Understand global health care financing models, challenges and it’s opportunities for Innovation in Africa.
  • Comprehend best investment models and current management approaches and strategies for achieving effective facility development.
  • Learn global best-case models for driving health care entrepreneurship ventures.
  • Effectively initiate and supervise ICT integration with operational processes of health care service

Registration Fee

  • $1,950 (or Naira equivalent) per participant on or before 30th April, 20
  • $2,050 (or Naira equivalent) per participant after 30th April, 2015.

 Group discounts: 3 – 5 participants: 10%,    6 participants and above: 15%

Registration fee covers: Tour, workshop materials, tea/coffee break, lunch, certificates, and visa processing ONLY.

Participants are to take care of their travel expenses, dinner, and accommodation.

 Hotel Accommodation

Participants can get accommodation close to the workshop venue at an average rate of $80 $100 per night. For more options on hotel accommodation, please visit the online booking site: www.agoda.com

Cancellation

For cancellation of registration fee, 70% of the fee will be refunded, if cancelled at least seven (7) days to the workshop and the information communicated to us by sms or email, using: info@pharmanewsonline.com

There will be no refund if cancelled thereafter.

Method of Payment

Participants should pay registration fee into Pharmanews Ltd account in Zenith Bank Plc (A/c No.

1010701673) or Access Bank Plc (A/c No.0035976695) and send their full names and bank deposit slip

numbers by sms or email to Pharmanews Ltd. Payments in dollars should be made to Pharmanews Domiciliary Accounts: GTB A/c No. 0005082226

Payment Online

Payments can also be made through our payment portal on GTBank SME market hub facility. To make payment online, visit: https://pharmanews.smemarkethub.com

Please note that payment in naira can only be accepted in Nigeria. In Dubai, the dollar equivalent will be paid.

 Financial Transactions in Dubai

Your financial transactions in Dubai will be done in the local currency, UAE Dirham. The current rate is 3.7 Dirham to 1 US$.

Arrival and Departure

Participants are expected to arrive on or before Sunday, 17th and depart Friday, 22nd.

City Tour

For the tour, temperature will be at an average of 34° Celsius. We advise casual wear with shoes suitable for walking. Cameras will be useful for pictures.

Travel Information

 By Air

Intending participants are advised to make reservation for flight ticket to Dubai through these online booking sites: www.wakanow.com or www.opodo.co.uk. Available airlines on the booking sites are Emirates, Kenyan Air, Etihad, Ethiopian Airways, and Qatar Airways, among others.

Visa

After registration, participants will be contacted on the procedures for visa procurement. The visa fees are covered in the registration fee.

For further information, please contact:

Cyril Mbata                                –  +234 706 812 9728

Nelson Okwonna                         –  +234 803 956 9184

Ernest Salami                               –   +234 703 986 8837

Elizabeth Amuneke                     –   +234 805 723 5128

Click here to download a pdf version of the Dubai workshop invitation

 

Kick Depression out for good with Setral

0

Indication:
Sertraline is used for treating depression, obsessive-compulsive disorder (OCD), panic disorder, and post-traumatic stress disorder and postmenstrual dysphoric disorder (PMDD).

Contraindication:
Drug abuse or dependence. Servere hepatic or renal function impairment, seizures disorder, sensitivity to sertraline

Setral – 50
Each film coated tablet contains:
Sertraline Hydrochloride
Equivalent to Sertraline          50mg
Excipients                                      q.s
Colour:                    Approved colour

Setral – 100
Each film coated tablet contains:
Sertraline Hydrochloride
Equivalent to Sertraline          100 mg
Excipients                                          q.s
Colour:                        Approved colour

Setral

 

Giving back life to the mind with Olanza

0

Olanzapine Tablets is indicated for the treatment of schizophrenia.
Olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.
Olanzapine is indicated for the treatment of moderate to severe manic episode. In patients whose episode has responded to olanzapine treatment, olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Olanza

 

 

 

 

 

Hitting BPH where it matters most… Finstal-5

2

Hitting BPH where it matters most with Finstal-5 (Marketed by PharmacyPlus Limited)

Finstal-5

 

 

Emzor (ZORAMIN)

1

It Contains Essential Elements Such as:
Amino Acids
Multivitamins
Minerals

It helps in:
Cell building & Stress relief
Effective antioxidant & General Well-being
Improved metabolic activities & Suitable for all agesemzor2

Kezitil achieves first time success in community acquired bacterial infections

0

Kezitil achieves first time success in community acquired bacterial infections
Kezitil is active against a wide range of resistant bacteria.

emzor3

Government debt crippling pharma industry – Drugfield MD

0

In this exclusive interview with Pharmanews, Pharm. Olakunle Ekundayo, managing director and chief executive officer of Drugfield Pharmaceuticals Limited spoke on the challenges facing the pharmaceutical manufacturing sub-sector of the Nigerian economy and argued that the greatest undoing to the sector presently is the billions of naira owed pharmaceutical companies by the government. He also spoke on how the recent devaluation of the naira, the insurgency in the north and policy inconsistency are hindering the development of the pharmaceutical manufacturing industry. Excerpts:

The manufacturing sector of the economy, including the pharmaceutical manufacturing sub-sector, depends heavily on imported inputs for its production. How are issues such as the devaluation of the naira and the recently released new classification of imports by the Central Bank of Nigeria (CBN) affecting the industry?

 The devaluation of the currency has so many implications for manufacturing. The number one implication is that we now need more working capital to import and pay for essential items which are used in manufacturing. The number two effect is that, with the low inflow of foreign exchange into the economy, we now have a situation whereby the raw materials used for pharmaceutical manufacturing are now re-classified as finished products. We really don’t know why the government should do that. Maybe it’s because of the scarcity of foreign exchange. This is why they have come up with some of these tricks to push manufacturers to source foreign exchange through other means, like the Interbank or even the black market. They just want to reduce pressure on the government Dutch option system.

The number three effect is that even when we now have to patronise the Interbank foreign exchange, the bank now puts up a trading system full of instabilities. For instance, they can tell you that the exchange rate as at this minute is185 naira to one US dollar, but that that rate is valid for only ten minutes. You can imagine that, as a manufacturer. What decisions or conclusions can you make within ten minutes to ensure you secure that rate? So there is so much confusion in the system.

When you put all these together, you begin to ask yourself how manufacturing operations can be run with such level of instability and confusion. Right now, it is really affecting the industry. I know, at least, two big companies around here who went on Christmas shutdown late last year and asked the staff not to resume in the new year until the situation had become conducive. This is the real challenge confronting us, with the devaluation of the naira and the drop in the price of oil which accounts for at least 70 per cent of the country’s foreign exchange income.

In trying times like this, governments are expected to be proactive by coming up with palliative measures to keep industries going. Are there steps the government can take to keep the pharmaceutical manufacturing industry afloat in the current situation?

 There is nothing the government is doing or has done so far. And we cannot see any measure being taken even in the immediate future. The government, I think, seems to be in a confused state because of the oil price that keeps falling. Yet it must be recognised that drugs are essential items that should not be played around with. This is because, with drugs, it is the health of the people that is at stake.

I think that the government should look into the sector and do things that will provide respite to the pharmaceutical industry, as well as giving the necessary concession that can keep the sector going and ensuring that prices of drugs are reasonably affordable to Nigerians.

The year 2014 was quite turbulent for the health sector generally, with strikes of health workers and insurgency in the north affecting pharmaceutical businesses. Looking at those challenges, what are your expectations for the sector in 2015?

 Your observations are correct. The insurgency in the north has reduced area of coverage for business. The northeast for us as a company was a very good outlet for our products getting across our borders into neighbouring countries. That has stopped completely. Even in certain towns and cities in the northeast, like Maiduguri, we cannot do business. That has reduced the incomes of our company and other companies who do business in that area.

However, beyond insecurity and insurgency, the government has also refused to pay drug manufacturers who supplied drugs on tender to the Federal Ministry of Health and to different government agencies. I think this is one of the greatest injustices to the sector. They owe the drug industry in billions and they forget that these supplies were mostly done with borrowed funds. It is thus a double jeopardy for manufacturers. We all know the situation that the banks are in today. Government owes manufacturers, and delay in payment of this debt is making the situation worse for the sector and for the banks. There is even no ray of light at the end of this dark tunnel because there is no sign that the payment is imminent.

We are also calling on the government to change the classification of the pharmaceutical manufacturing sector. We want them to do what they have done in other sectors like the textile or automotive industry and get the sector moving. It will be a tragedy if Nigeria allows the pharmaceutical sector to collapse. No country in the world should allow that to happen. In these days of all sorts of warfare including biological warfare, no country should rely on imports of drugs for its own people. That can be a veritable tool by the enemy to wipe out a whole population.

The refusal of the US government to give ZMapp to Nigeria during our trying period of Ebola crisis last year once again reinforced the need for Nigeria not to depend on external sources for local medicine needs. What other lessons should we learn from that incident and how can we institutionalise Research and Development (R&D) in the pharmaceutical manufacturing sector to ensure we are able to solve our health problems?

 I think the lesson to learn should be on the side of the government. Government should take the lead in this effort. When Ebola came, there was very little the local pharmaceutical industry could do other than to support government and provide palliative drugs that could help, which we actually did. In fact, it was surprising that we donated drugs but they were never officially received by the Federal Ministry of Health. The Pharmaceutical Manufacturing Group of the Manufacturers Association of Nigeria (PMG-MAN) asked members to donate drugs to support government efforts in taming Ebola, which we actually did; but no one could receive the drugs on behalf of the government.

Beyond that, in the last few years, a number of Nigerian companies have signed on to upgrade their facilities for the World Health Organisation Good Manufacturing Practice (WHO-GMP) qualification and the United States Pharmacopoeia (USP) standard. Very expensive ventures! A lot of investments have been made by these companies. We are grateful to God and also to NAFDAC which facilitated the process that, at the end of the day, four Nigerian companies have received WHO-GMP certification at very high costs. And that was just the first phase to the whole process. The end-point is when you have products that are pre-qualified by the WHO. Therefore, what the four companies have received is the first phase approval. They now must come forward with the products they want WHO to prequalify so that they can compete in international tenders.

As we speak, the Nigerian government has not done anything to encourage the sector or these companies. They have not said that “because of the huge investment you have made and the honour you have brought to Nigeria, we are giving you tax break, we are paying off the debts we owe to your sector or we are going to support you with this to enable you invest in research and development to come up with new drugs or even vaccines.” Nothing like that has come from the government.

Many of our colleagues are disappointed that, having invested huge amounts of money on this upgrade, not even proper recognition of what they have done has come from the government. But we are Nigerians and this is our country. We must continue to strive and work hard and talk when we need to do so and be hopeful that things will change.

Last year, Drugfield was celebrated for introducing Chlorxy-G (Chlorhexidine) Gel, an innovative low cost product for prevention of umbilical cord infections in newborn and a drug said to be quite invaluable in our quest as a nation to reduce infant mortality. What prompted your decision to manufacture this product and is this an indication that Drugfield will be doing more in the area of infant care medicines?

 Thank you very much for this question. First, as a company, we pride ourselves on always looking for opportunities and areas of healthcare where there are gaps and needs to be filled. We have always tried to make products available in areas where there is scarcity. This has been our philosophy all along. Therefore when we saw in the newspapers that the United States Pharmacopoeia (USP) was asking Nigerian companies to express interest in producing Chlorhexidine Gel, we quickly jumped at it.

We did that for a number of reasons. One, as at that time, we had four products in gel form in our portfolio which we manufactured locally. So we have a lot of experience in the manufacture of gel. The second reason is that since the product was a United Nations (UN) commodity, we thought “why not give it a shot to show how experienced we are to the global community?”The third reason is that we know that the product could launch us into the international market and contribute to maternal and child health care in a way that could be positively effective.

One thing which we never imagined was that, as simple as the product is, it could put us in the limelight. By the time the USP visited Nigeria to look at the companies that had shown interest, we already had the packaging material made. We were already waiting to clear the raw materials at the airport. They were pleasantly surprised that we moved so rapidly. It helped us in a lot of ways. We already had TSHIP (Targeted States High Impact Project)’s support. TSHIP is an NGO financed by the United States Agency for International Development (USAID) and a few other world bodies working with Chlorhexidine Gel imported from Nepal in a few states in the North. They were using it in Sokoto and Bauchi States in umbilical cord care. The product was imported from Nepal which was then the only country in the world producing it. We then became a kind of a partner to USP and TSHIP. USP was providing the Good Manufacturing Practice (GMP) coverage, looking at what we had on ground and the necessary improvement we needed to make because the product is an international one.

Before they came for their second visit, the product samples were ready and we sentone to their office in Washington DC. USP was happy and TSHIP was also very happy. Subsequently, there was to be a world meeting of the different partners who were involved in Chlorhexidine development in May 2014 and TSHIP said we should come to be a part of the meeting. They got Bill and Melinda Gates Foundation to co-finance the trip with us and we took the product along and introduced it at the meeting to the group. At that meeting, Drugfield Pharmaceuticals was admitted into the World Chlorhexidine Working Group. We thus became the second country in the world and the number one in Africa to produce Chlorhexidine Gel for umbilical cord care. We were getting calls from all over the world. Calls were coming from many of the NGOs and foundations. Many of them visited us.

The usage of the gel also received a boost in Nigeria, with states signing on to its usage and we were supplying. But the real issue is that government agencies that are supposed to be the biggest buyers are the worst to do business with. Notwithstanding, many of what we have supplied have been paid for by some of the interested NGOs and we are hopeful that the business of Chlorhexidine Gel will grow.

We have sent samples to a few others African countries like Kenya, Mali and even Haiti in South America, based on the request they made to us. We supplied to them free of charge to also let them know how to undertake the development of this product in these countries. We are hopeful that if they want it in the future and cannot produce it, we can supply them finished products to use because we have the capacity.

How is the Nigerian government taking this product?

 The sad thing, really, is that, even though our government has put this product on the Essential Drug List, the kind of awareness we expected the government to give to such a lifesaving product is not forthcoming. Before this product, which has now helped to save the lives several new born babies, was introduced, Nigeria was the number one in Africa with cases of umbilical cord infection and number four in the world. So, one would have expected that our government would take advantage of the fact that we now produce the product in Nigeria to change the situation.

One Dr Ado Yobo, a Ghanaian, who works for USAID, came visiting us because of this product. After a tour of our facility, he said he would talk to the Ghanaian government that Nigeria had the capacity to supply Chlorhexidine Gel for use in Ghana. He also said if the development of the product had taken place in Ghana, he was very sure that the government would have banned the use of methylated spirit and all manners of life-threatening materials for the treatment of umbilical cord in newborns, and legislate that only Chlorhexidine Gel should be used in all hospital delivery rooms across the country. He wondered why Nigerian had not done that. We know things don’t work that way here. But we hope that, one day, Nigeria will get it right.

Drugfield has, over the years grown to become a reputable indigenous pharmaceutical manufacturer with over 140 registered products, what is the philosophy driving your processes and operation?

 Let me first of all thank God for what he has enabled us to achieve since our establishment. I am not the only one who worked with a multinational company before venturing into pharmaceutical manufacturing. So, I am not the only one who has experience. However, one thing that has helped us is that we have always looked for opportunities and products that are needed in the country and are essentially being imported. That was why we started with ointment and creams. When we started, people thought they were not significant products, until recently when everybody is now going in that direction. I must say that these are products that all the people use, irrespective of social class. So, to look at areas of need and gaps to fill has always been the driving philosophy of our business and it has paid off over the years.

Our philosophy also informed our decision to go into sterile manufacturing processes – making eye drops, small volume injectables and large volumes infusion products. These are areas of opportunity that we don’t have many companies going into. So, we believe Nigeria has a lot of opportunity to offer to those who can see it. This is why a lot of foreigners come into this country. They see these opportunities and take advantage of them. This is a huge country with a large population. The country has the potential to be a rich nation if our resources are well managed. The future also looks good for pharmaceutical manufacturing if the right things are done.

Towards effective cancer management in Nigeria

0

The annual World Cancer Day was marked on 4 February, 2015. The goal was to intensify awareness campaign on the disease, as well as discuss new methods of curbing it. This year’s theme, ‘Not beyond us’, gives hope to cancer patients and their relatives, as it implies the possibility of cancer remedies across the globe and within our reach.

According to a report on World Cancer Day 2015, the campaign will explore the implementation of existing preventive measures, early detection, treatment and care, and in turn, open up to the exciting prospect that can impact the global cancer burden – for the better. Four key areas will constitute the focal point of the campaign, which are: choosing healthy lives; delivering early detection; achieving treatment for all; and maximising quality of life.

If all stakeholders would give this crusade all it takes to be a success, the alarming rate of 100,000 new cases of cancer recorded annually in the country will be drastically reduced.

A professor of radiotherapy and Oncology with the College of Medicine, University of Lagos, Akoka, Aderemi Ajekigbe, had while leading a campaign against cancer in January, asserted that Nigeria records 100,000 new cases of cancer annually. He added that except a timely intervention of government occurs, through the provision of functioning radiotherapy machines across the country, more cases will be recorded.

Ajekigbe attributed the increasing rate of the disease in developing countries like Nigeria to the poor state of health facilities, poor funding of cancer care, late diagnosis and detection of the deadly disease in the country. He emphasised the need for government to play a major role in the crusade as there are many poor Nigerians groaning under the pain of cancer, who cannot afford the treatment option.

“We cannot afford to lose more Nigerians to cancer. Government should dedicate the proceeds from an oil block to the provision of cancer equipment and treatment. It is a need,” he said.

What is cancer?

Cancer is a class of diseases characterised by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected.

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumours (except in the case of leukaemia where cancer prohibits normal blood function by abnormal cell division in the blood stream). Tumours can grow and interfere with the digestive, nervous, and circulatory systems and they can release hormones that alter body function. Tumours that stay in one spot and demonstrate limited growth are generally considered to be benign.

More dangerous or malignant tumours form when two things occur:

  1. a cancerous cell manages to move throughout the body using the blood or lymph systems, destroying healthy tissue in a process called invasion
  2. that cell manages to divide and grow, making new blood vessels to feed itself in a process called angiogenesis.

When a tumour successfully spreads to other parts of the body and grows, invading and destroying other healthy tissues, it is said to have metastasized. This process itself is called metastasis, and the result is a serious condition that is very difficult to treat.

 Symptoms of cancer

  1.  Persistent cough or hoarseness. While a cough here and there is nothing to worry about, a consistent cacophony or a cough accompanied by blood is definitely a cause for concern. “Most coughs are not cancer,” says Therese Bartholomew Bevers, M.D., professor of clinical cancer prevention and the medical director of the Cancer Prevention Centre at the MD Anderson Cancer Centre. “But certainly a persistent cough needs to be evaluated to see if it could be lung cancer.” Your physician should recommend a chest X-ray or CT scan to rule out cancer as a possibility.

 

  1. Persistent change in bowel habits. When your bowel movements aren’t as easy as they once were or your stool appears larger than normal or somewhat deformed, this could be a sign of colon cancer, says Bartholomew Bevers. “It could be a sign that there is a mass impeding the transit of the stool from the bowel,” she says. “This is a symptom where a person should go to the doctor and schedule a colonoscopy to see if there indeed is a mass.”
  1. Persistent change in bladder habits. “If there is blood in the urine, that could be indicative of bladder or kidney cancer—but more commonly this is a sign of a urinary tract infection,” says Bartholomew Bevers. Check for an infection first, then pursue other treatment options.
  1. Persistent unexplained pain. “Most pain is not a sign of cancer, but persistent pain must be checked out,” says Bartholomew Bevers. “If you have persistent headaches, for example, you likely don’t have brain cancer—but it is still something that must be looked into. Persistent pain in the chest could be a sign of lung cancer. And pain in your abdomen could be ovarian cancer.”
  1. Change in the appearance of a mole. While not all moles are indicative of melanoma, spotting a new mark or one that has changed is something you should bring up with a dermatologist who can screen for skin cancer, says Bartholomew Bevers.
  1. A sore that does not heal. If you have a sore that’s hanging on past the three-week mark, you should bring it up with your doctor. “We would have expected our body to have healed itself by now,” says Bartholomew Bevers, “and you should absolutely get that checked out.” That kind of sore could be a sign of carcinoma.

 

  1. Unexpected Bleeding. Vaginal bleeding—outside of your normal cycle—could be an early sign of cervical cancer, while bleeding from the rectum could indicate colon cancer, says Bartholomew Bevers.

 

  1. Unexplained weight loss. “As adults, we try very hard to lose weight,” says Bartholomew Bevers. “But if weight is falling off of you without any effort on your part, that is a big concern and can be indicative of a serious medical problem.” One of those problems, she says, could be malignancy or a tumour.

 

  1. An unexplained lump. “Any time you have a lump that is new or a lump that is changing, that is something you should absolutely have looked at by your doctor,” says Bartholomew Bevers. While it could be a benign cyst (and likely is), it could also be “a cancer that is in the subterranean tissue. A lump in the chest, of course, is a very common symptom of chest cancer.” See your physician to get more information.

 How is cancer classified?

There are five broad groups that are used to classify cancer.

  1. Carcinomas are characterised by cells that cover internal and external parts of the body such as lung, breast, and colon cancer.
  2. Sarcomas are characterised by cells that are located in bone, cartilage, fat, connective tissue, muscle, and other supportive tissues.
  3. Lymphomas are cancers that begin in the lymph nodes and immune system tissues.
  4. Leukaemias are cancers that begin in the bone marrow and often accumulate in the bloodstream.
  5. Adenomas are cancers that arise in the thyroid, the pituitary gland, the adrenal gland, and other glandular tissues.

 

Cancers are often referred to by terms that contain a prefix related to the cell type in which the cancer originated and a suffix such as -sarcoma, -carcinoma, or just -oma. Common prefixes include:

*    Adeno- = gland

*    Chondro- = cartilage

*    Erythro- = red blood cell

*    Hemangio- = blood vessels

*    Hepato- = liver

*    Lipo- = fat

*    Lympho- = white blood cell

*    Melano- = pigment cell

*    Myelo- = bone marrow

*    Myo- = muscle

*    Osteo- = bone

*    Uro- = bladder

*    Retino- = eye

*    Neuro- = brain

 How fast does cancer spread?

Scientists reported in Nature Communications that they have discovered an important clue as to why cancer cells spread. It has something to do with their adhesion (stickiness) properties. Certain molecular interactions between cells and the scaffolding that holds them in place (extracellular matrix) cause them to become unstuck at the original tumour site, they become dislodged, move on and then reattach themselves at a new site.

The researchers say this discovery is important because cancer mortality is mainly due to metastatic tumours, those that grow from cells that have travelled from their original site to another part of the body. Only 10 per cent of cancer deaths are caused by the primary tumours.

The scientists, from the Massachusetts Institute of Technology, say that finding a way to stop cancer cells from sticking to new sites could interfere with metastatic disease, and halt the growth of secondary tumours.

In 2007, cancer claimed the lives of about 7.6 million people in the world. Physicians and researchers who specialise in the study, diagnosis, treatment, and prevention of cancer are called oncologists.

Malignant cells are more agile than non-malignant ones. Scientists from the Physical Sciences-Oncology Centers, USA, reported in the journal Scientific Reports (April 2013 issue) that malignant cells are much “nimbler” than non-malignant ones. Malignant cells can pass more easily through smaller gaps, as well as applying a much greater force on their environment compared to other cells.

Professor Robert Austin and team created a new catalogue of the physical and chemical features of cancerous cells with over 100 scientists from 20 different centres across the United States. The authors believe their catalogue will help oncologists detect cancerous cells in patients early on, thus preventing the spread of the disease to other parts of the body.

Prof. Austin said. “By bringing together different types of experimental expertise to systematically compare metastatic and non-metastatic cells, we have advanced our knowledge of how metastasis occurs.”

 How is cancer diagnosed and staged?

Early detection of cancer can greatly improve the odds of successful treatment and survival. Physicians use information from symptoms and several other procedures to diagnose cancer. Imaging techniques such as X-rays, CT scans, MRI scans, PET scans, and ultrasound scans are used regularly in order to detect where a tumour is located and what organs may be affected by it. Doctors may also conduct an endoscopy, which is a procedure that uses a thin tube with a camera and light at one end, to look for abnormalities inside the body.

Extracting cancer cells and looking at them under a microscope is the only absolute way to diagnose cancer. This procedure is called a biopsy. Other types of molecular diagnostic tests are frequently employed as well. Physicians will analyse your body’s sugars, fats, proteins, and DNA at the molecular level. For example, cancerous prostate cells release a higher level of a chemical called PSA (prostate-specific antigen) into the bloodstream that can be detected by a blood test. Molecular diagnostics, biopsies, and imaging techniques are all used together to diagnose cancer.

 How can cancer treated?

Cancer treatment depends on the type of cancer, the stage of the cancer (how much it has spread), age, health status, and additional personal characteristics. There is no single treatment for cancer, and patients often receive a combination of therapies and palliative care. Treatments usually fall into one of the following categories: surgery, radiation, chemotherapy, immunotherapy, hormone therapy, or gene therapy.

 Surgery

Surgery is the oldest known treatment for cancer. If a cancer has not metastasised, it is possible to completely cure a patient by surgically removing the cancer from the body. This is often seen in the removal of the prostate or a breast or testicle. After the disease has spread, however, it is nearly impossible to remove all of the cancer cells. Surgery may also be instrumental in helping to control symptoms such as bowel obstruction or spinal cord compression.

Innovations continue to be developed to aid the surgical process, such as the iKnife that “sniffs” out cancer. Currently, when a tumour is removed surgeons also take out a “margin” of healthy tissue to make sure no malignant cells are left behind. This usually means keeping the patients under general anaesthetic for an extra 30 minutes while tissue samples are tested in the lab for “clear margins”. If there are no clear margins, the surgeon has to go back in and remove more tissue (if possible). Scientists from Imperial College London say the iKnife may remove the need for sending samples to the lab.

 Radiation

 

Radiation treatment, also known as radiotherapy, destroys cancer by focusing high-energy rays on the cancer cells. This causes damage to the molecules that make up the cancer cells and leads them to commit suicide. Radiotherapy utilises high-energy gamma-rays that are emitted from metals such as radium or high-energy x-rays that are created in a special machine. Early radiation treatments caused severe side-effects because the energy beams would damage normal, healthy tissue, but technologies have improved so that beams can be more accurately targeted. Radiotherapy is used as a standalone treatment to shrink a tumour or destroy cancer cells (including those associated with leukaemia and lymphoma), and it is also used in combination with other cancer treatments.

 Chemotherapy

Chemotherapy utilises chemicals that interfere with the cell division process – damaging proteins or DNA – so that cancer cells will commit suicide. These treatments target any rapidly dividing cells (not necessarily just cancer cells), but normal cells usually can recover from any chemical-induced damage while cancer cells cannot. Chemotherapy is generally used to treat cancer that has spread or metastasised because the medicines travel throughout the entire body. It is a necessary treatment for some forms of leukaemia and lymphoma. Chemotherapy treatment occurs in cycles so the body has time to heal between doses. However, there are still common side effects such as hair loss, nausea, fatigue, and vomiting. Combination therapies often include multiple types of chemotherapy or chemotherapy combined with other treatment options.

 Immunotherapy

Immunotherapy aims to get the body’s immune system to fight the tumour. Local immunotherapy injects a treatment into an affected area, for example, to cause inflammation that causes a tumour to shrink. Systemic immunotherapy treats the whole body by administering an agent such as the protein interferon alpha that can shrink tumours. Immunotherapy can also be considered non-specific if it improves cancer-fighting abilities by stimulating the entire immune system, and it can be considered targeted if the treatment specifically tells the immune system to destroy cancer cells. These therapies are relatively young, but researchers have had success with treatments that introduce antibodies to the body that inhibit the growth of breast cancer cells. Bone marrow transplantation (hematopoietic stem cell transplantation) can also be considered immunotherapy because the donor’s immune cells will often attack the tumour or cancer cells that are present in the host.

 Hormone therapy

Several cancers have been linked to some types of hormones, most notably breast and prostate cancer. Hormone therapy is designed to alter hormone production in the body so that cancer cells stop growing or are killed completely. Breast cancer hormone therapies often focus on reducing estrogenic levels (a common drug for this is tamoxifen) and prostate cancer hormone therapies often focus on reducing testosterone levels. In addition, some leukaemia and lymphoma cases can be treated with the hormone cortisone.

 Gene therapy

The goal of gene therapy is to replace damaged genes with ones that work to address a root cause of cancer: damage to DNA. For example, researchers are trying to replace the damaged gene that signals cells to stop dividing (the p53 gene) with a copy of a working gene. Other gene-based therapies focus on further damaging cancer cell DNA to the point where the cell commits suicide. Gene therapy is a very young field and has not yet resulted in any successful treatments.

 Using cancer-specific immune system cells to treat cancer

Scientists from the RIKEN Research Centre for Allergy and Immunology in Yokohama, Japan, explained in the journal Cell Stem Cell (January 2013 issue) how they managed to make cancer-specific immune system cells from iPSCs (induced pluripotent stem cells) to destroy cancer cells.

The authors added that their study has shown that it is possible to clone versions of the patients’ own cells to enhance their immune system so that cancer cells could be destroyed naturally.

Hiroshi Kawamoto and team created cancer-specific killer T-lymphocytes from iPSCs. They started off with mature T-lymphocytes which were specific for a type of skin cancer and reprogrammed them into iPSCs with the help of “Yamanaka factors”. The iPSCs eventually turned into fully active, cancer-specific T-lymphocytes – in other words, cells that target and destroy cancer cells.

 How can cancer be prevented?

Cancers that are closely linked to certain behaviours are the easiest to prevent. For example, choosing not to smoke tobacco or drink alcohol significantly lowers the risk of several types of cancer – most notably lung, throat, mouth, and liver cancer. Even if you are a current tobacco user, quitting can still greatly reduce your chances of getting cancer.

Skin cancer can be prevented by staying in the shade, protecting yourself with a hat and shirt when in the sun, and using sunscreen. Diet is also an important part of cancer prevention since what we eat has been linked to the disease. Physicians recommend diets that are low in fat and rich in fresh fruits and vegetables and whole grains.

Certain vaccinations have been associated with the prevention of some cancers. For example, many women receive a vaccination for the human papillomavirus because of the virus’s relationship with cervical cancer. Hepatitis B vaccines prevent the hepatitis B virus, which can cause liver cancer.

Some cancer prevention is based on systematic screening in order to detect small irregularities or tumours as early as possible even if there are no clear symptoms present. Breast self-examination, mammograms, testicular self-examination, and Pap smears are common screening methods for various cancers.

Researchers from Northwestern University Feinberg School of Medicine in Chicago reported in the journal Circulation that the 7 steps recommended for protection against heart disease can also reduce the risk of developing cancer,. They include being physically active, eating a healthy diet, controlling cholesterol, managing blood pressure, reducing blood sugar and not smoking.

 

Other means of combating cancer

 Exercise and cancer

Exercise can help control fatigue, muscle tension, and anxiety in those with cancer. Patients tend to feel better if they do exercises such as walking or swimming. Exercise has also been shown to improve the outcomes associated with cancer treatment.

 Mind/body medicine for cancer

Some mind/body therapies improve quality of life for cancer patients through behaviour modification; others encourage expression of emotions. Behaviour therapies such as guided imagery, progressive muscle relaxation, hypnotherapy, and biofeedback are used to alleviate pain, nausea, vomiting, and the anxiety that may occur in anticipation of, or after, cancer treatment. Individual or group counselling allows patients to confront problems and emotions caused by cancer and receive support from fellow patients in a group setting. Patients who pursue these types of therapies tend to feel less lonely, less anxious about the future, and more optimistic about recovery.

 Nutrition, diet, and cancer

Scientific evidence suggests that nutrition may play a role in cancer prevention. Observational studies have shown that cancer is more common in some people with certain dietary habits — such as colorectal cancer in people who have diets rich in meat products. So far, data has not supported the use of any vitamins or supplements to decrease the risk of cancer. In fact, studies show some supplements may increase cancer risk, such as lung cancer risk in smokers taking beta carotene and prostate cancer risk in men taking high doses of vitamin E.

Also, experts don’t recommend stopping standard treatment in place of complementary medicine, but many therapies can help people with cancer feel better.

 Acupuncture and acupressure

Acupuncture and acupressure are examples of “complementary” medicine for cancer. While neither claims to cure the disease, some evidence shows that they help reduce symptoms and side effects of the illness and its treatment.

Other tips:

*    Join a cancer support group.

* Get plenty of rest, balanced with light exercise.

*    Rather than feeling compelled to maintain a “positive attitude,” express your emotions honestly. Don’t worry if you sometimes feel depressed or afraid: These are normal feelings and legitimate reactions that will not affect your cancer.

*    Fill your days with activities you enjoy. Reading a good book, listening to music, and talking with friends are surprisingly therapeutic.

 

Report compiled by Temitope Obayendo with additional information from:

WebMD Medical Reference; World Cancer Day 2015; womenshealthmag.com

 

NANTMP president seeks proper documentation in herbal medicine

2

In this exclusive chat with Pharmanews, President of the National Association of Nigeria Traditional Medicine Practitioners (NANTMP), His Royal Highness Chief (Prof.) T.O. Omon Oleabhiele highlights the importance of clinical record keeping in traditional medicine, urging every practitioner to strictly adhere to the rules. He also pinpoints the various misconceptions about alternative medicine practice, while calling on the government to assist herbal practitioners financially. Excerpts:

How would you assess the performance of herbal practitioners in the last two years?

It is in two folds, if you mean assessment in the production of traditional medicines, they are actually trying; however I will reprove them for their unscrupulous behaviour in displaying fake certificates, which they use for dubious purposes. Nonetheless, we are working on curbing this malpractice in the profession.

One major challenge of alternative medicine practice is lack of proper documentation. Is there any plan by NANTMP to correct this?

Presently, we have devised our own means of record-keeping in the profession, which the government is ready to collaborate with us on; but it appears medical doctors are not prepared to acknowledge the documented lists of patients certified cured with herbal treatment, which we have as our evidence. We have the list of patients who were so bad at the time they came to us, but they are now very well, to the point that one can hardly believe they were once ill. There are physical results that are verifiable, because the patients are well, and they have started bearing children, building houses, and so on.

Every traditional doctor does not only document his formulas, but he documents patients’ medical history, places visited, stages of illness, and recovery time. All this information is now documented in trado-medical homes. So, documentation is really vital, and every traditional doctor must ensure he keeps patients’ bio-data and medical history.

There is widespread assumption that traditional medicines lack peer review and scientific scrutiny, which make them untested for safety and efficacy. How true is this?

That is a wrong assumption because most traditional medicines, as at today, are registered by NAFDAC, and NAFDAC registration shows that the toxicological aspects of the medicines are valued, viewed, scrutinised, and certified safe for consumption. In fact, NAFDAC has a pharmacovigilance section which monitors drug adverse effects on patients, and also confiscates those drugs capable of affecting patients negatively. In order to control the circulation of such drugs, the pharmacovigilance department checks them batch by batch, to detect the harmful drugs and curtail their spread. Traditional medicine is standardised now.

The practice whereby alternative medicine practitioners refuse to reveal active ingredients in their products for the fear of losing their patent right is on the increase. How can this challenge be best resolved?

The issue is that what their grandfathers passed down to them is their source of information. However, the situation is changing gradually, as the leadership of NANTMP is leading by example for others to emulate and change their unethical practices. For instance, someone called me from Akure in Ondo State recently, and said he was surfing the web on remedies for an infection in his body. He said he discovered I could cure the case with a plant called cassia prodocappa. If I didn’t reveal the content of the medicine, it would be difficult for the patient to know cassia prodocappa. To this end, I will say that we normally reveal our active principles – though not all practitioners are practising on a level ground. However, since my humble self as the president of NANTMP has started the campaign, others have no choice than to do same.

On dosage, from time immemorial, dosage has always been available for various herbal medicines, but break in communication creates confusion among patients. It is the practitioner who formulates a compound that can actually give the right dosage for the compound. Dosage of traditional medicines is either half a teaspoon, a teaspoon, a shot or half a shot, and it could be powder or liquid.

In what ways can the government and research institutions assist traditional practitioners to make their products safety and efficacy compliant?

Government can give grants to herbal practitioners or instruct the bank of industry to create soft loans for manufacturers, with laid down criteria for beneficiaries to fulfil. This will go a long way in expanding our traditional herbal medicine industry. Such grant has never been in the past.

As the president of NANTMP, what is your vision for the practice in 2015?

Traditional medicine is gradually becoming the household medicine everybody is embracing because it is less hazardous, compared to artificially synthesised drugs. Intellectuals, especially, are shifting to traditional medicines, particularly those that are NAFDAC certified and are decently packaged.

Years back, the elite rejected herbal medicines due to unprofessional packaging. Now that the industry is advancing in knowledge, with fascinating packs for local drugs, majority of the elite now prefer alternative medicines to conventional drugs. With this development, I can confidently say that traditional medicines will dominate the market in 2015, with revolutionised packaging.

PCN threatens sanction against erring pharmacists and health care providers

4

…As UNN inducts 121 pharmacy graduands.

Irked by the high rate of unprofessionalism among health care providers, especially pharmacists in the country, the registrar, Pharmacists Council of Nigeria (PCN), Pharm. NAE Mohammed, has threatened that the council would withdraw the professional licence of any member tarnishing the image of the pharmacy profession in the country.

Mohammed stated this at the induction and oath-taking ceremony of the 2013/2014, graduates of the Faculty of Pharmacy, University of Nigeria, Nsukka, which was held at the Princess Alexandra Auditorium Hall, University of Nigeria, Nsukka, last December.

Pharm. Mohammed, who was a guest of honour at the event, disclosed that some members of the council, through their unethical acts, were bringing the profession to disrepute, saying the council was putting measures in place to ensure that, before 2016, registration of members would commence online to monitor every pharmacist in the country.

“It is because of the mad rush for money that fake drugs have been on a daily increase, claiming many innocent lives and making it impossible for certain illnesses to be cured. Join the pharmacy profession today; ensure you abide by the ethics of the profession by respecting the do’s and don’ts of the profession. Also, your first mission should be to save lives, and in the course of saving lives, money will get into your hands,” he said.

In his keynote address, titled, “Networking: A tool for Digital Wealth Creation”, Pharm. Clifford Emenike, chief executive officer, Eagles Vision Investment Concept, explained networking as a process or practice of building up and maintaining informal relationship, especially with people whose friendship could bring advantages, like job and business opportunities to one. He further explained that networking is a tool for health creation, advising that the graduands should be prepared to be consummate team players, in order for them to create digital wealth that would last for generations.

Speaking in the same vein, Prof. Emmanuel Chinedu Ibezim, dean, Faculty of Pharmacy, UNN, said the theme of the induction, “Networking as a Tool for Digital Wealth Creation”, was aptly chosen to capture the global heartbeat of the moment, adding that there were lots of veritable resources flying around, accessible only to those who were well informed. He therefore advised the graduands to translate the laudable feat, they had achieved, to their future life endeavours.

While urging the staff and students of the faculty to contribute their quotas to ensuring a successful re-accreditation of the faculty in 2015, the university don disclosed that pharmacy profession was currently going through a period of positive transformation by trying to key into its proper place in the health sector.

The highpoint of the event was the award presentation to the 2013/2014 best graduating student, Miss Ibeanu Nkiru Ozioma, who graduated with 21 distinctions. Prizes she won include the PSN-Enugu Award for Best Graduating Student, and cash prizes from Nemel Pharmaceuticals Company Limited, Enugu; O’NELL Pharmaceuticals and Health Care Limited, Lagos; and Impact Pharmaceuticals Limited, Enugu.

Speaking with an emotion-laden voice, Ibeanu Nkiru recalled that life was not pleasant throughout her five years as an undergraduate, but her determination and perseverance help her surmount all challenges and graduate in flying colours.

“It has been a journey of difficulties, many ups and downs, successes and failures; but I am grateful that the journey which started about five years ago has finally reached its pinnacle today. I cannot but acknowledge the role of our dean, Prof. Chinedu Ibezim, in shaping and molding us all through the years.”

Other dignitaries at the event include, Pharm. (Sir) Jasper K. C. Onyeka, FPSN, MD/CEO, Impact Pharmaceuticals; Prof. A.A. Attama, chairman, Induction Ceremony Planning Committee; Pharm. Prof. S.I. Ofoefule, head, Pharmaceutical Technology; Pharm. Prof. K.C. Ofokansi, head, Department of Pharmaceutics; Pharm. Prof. Stella Inya-Agha; Prof. Vincent Okorie, former Dean, Faculty of Pharmacy, UNN; Pharm. Dr T.C. Okoye; and many other dignitaries.

Commercial transactions (2): Accepting a business offer

29

Badagry Local Government Council has just announced plans to establish a health centre. Local Purchase Orders are being issued for the supply of goods and services for the new facility. An LPO is sent to Ojo & Sons, wholesale distributors in Ibadan, for the provision of anti-malaria drugs. The terms are that payment will be made on supply of goods with a crossed cheque in favour of the distributor. Unknown to the council, the letter is never delivered, due to an error in the postal office.

Another LPO for the same order is sent to Francis Pharmaceuticals, a Lagos-based distributor. Francis replies immediately, accepting the order, with a request that payment be made with an open cheque to enable them recover their expenses after the drugs have been supplied.

The Local Government chairman sends an LPO, for the same order, to a neighbourhood pharmacy the council has been dealing with. He attaches a personal note saying, “Femi, if you cannot deliver these drugs, please let me know.” Femi receives the message and decides to supply the drugs the following week.

By the end of that week, a letter is received from Ojo & Sons. Apparently, they have heard about the establishment of the health centre and sent a Sales Quotation for anti-malaria drugs at the approved price. They promise to be able to deliver by Monday.

On that fateful Monday, all three distributors arrive at the health centre with the required drugs. Each of them has been sent an LPO. All of them have made investments in the purchase of anti-malaria drugs and need to recover their expenses. Now, which of these distributors has a valid contract with Badagry Local Government?

A contract has been defined as an agreement between two parties which is enforceable. For a contract to be valid,there must have been an offer by one party and then an acceptance by the other. Acceptance must be a final and unqualified expression of agreement.

The situation above involves the following legal issues:

1. The effect of a counter-offer in a transaction.

2. The validity of a cross-offer in securing a contract.

3. The communication of acceptance for a valid contract.

The rules guiding the acceptance of offers were clearly defined by Justice Tobi in the case of Orient Bank (Nig.) Plc. v. Bilante International. In the words of the learned judge, “An acceptance of an offer is the reciprocal act or action of the offeree to the offer in which he indicates his agreement to the terms of the offer as conveyed to him by the offeror… It is the element of acceptance that underscores the bilateral nature of a contract.”

Clearly then, for an acceptance to be valid, there must be a notification of assent to the terms of offer by documentation, by words or by conduct. Any amendment of the terms will constitute a counter-offer which cancels the original offer.

With Badagry Local Government, Francis Pharmaceuticals purported to accept the offer with a request for a variation in payment system. Subsequently, that qualified acceptance resulted in a new offer being presented. In the case of Hyde v. Wrench, where a party sought to vary the terms of transaction, it was declared that the party had rejected the original offer and was in effect making a counter-offer. Consequently,there was no obligation whatsoever between the parties.

On the part of Ojo & Sons, a company made an offer to supply goods, totally unaware of the fact that an LPO had already been sent to them for the supply of the same goods. When two offers, identical in terms, are sent by two parties to each other, the resultant effect is a cross-offer. However, for there to be a contract, there must be an acceptance in response to a specific offer. In essence, there will be a consensus ad idem (a meeting of minds). In the classic case of cross-offers, Tinn v. Hofman, it was held that in such a situation, there were merely “two simultaneous offers”. There was no contract.

Finally, the neighbourhood pharmacy managed by Femi received the LPO and fully intended to fulfil the terms of the offer. It is noteworthy that a personal relationship existed between the pharmacist and the chairman of the local government. Furthermore, the note sent by the chairman requested for a notification in the event that the goods would not be deliverable. This seems to have rendered unnecessary the need to communicate acceptance, in view of the fact that the drugs would be supplied.Nevertheless, the rules of acceptance require a definite notification to the offering party. In Felthouse v. Bindly, a man had agreed to sell his horse to his uncle but failed to communicate his intention. The court held that there was no valid acceptance for the sale.

In conclusion, it is apparent that none of the distributors had a valid contract. Not Francis, on the basis of his counter-offer. Not Ojo, on account of a cross-offer. Not even Femi, for the reason of non-communication.

Acceptance of contracts must involve the external manifestation of an internal agreement with a specific proposal. As Justice Achike puts it, “if acceptance were to be based on silence or mental assent, then its ascertainment is bound to be illusory and at best, a guesswork, unless the judge was a superhuman who would be bound to unfold the innermost recesses of the heart of the party making the mental assent.”

Principles and cases are drawn from Sagay: Nigerian Law of Contract

 

Former PCN registrar, Mora, gives daughter’s hand in marriage

0

It was a great day for the family of Dr Ahmed Tijjani Mora (Wakilin Maganin Zazzau), as the former registrar of the PCN and current dean of the Faculty of Pharmaceutical Sciences, Kaduna State University (KASU), Main Campus, Kaduna, gave out his daughter, Fai’zah Ahmed Mora, a Law graduate from ABU, Zaria, in marriage to her heartthrob, Mallam Muhammad Bello Abdulkareem, a lecturer with the Nasarawa State University, Keffi, Nasarawa State.

Many people from within and outside Kaduna State attended the wedding fatihah which took place on Saturday, 3 January, 2015 at the family house in Tudun Wada, Zaria.

Among those who attended were Alhaji (Dr) Bashari Aminu (Iyan Zazzau), district head of Sabongari Zaria, who represented His Highness, the Emir of Zazzau, Alhaji Shehu Idris, CFR at the event. Others include Professor Abdullahi Mustapha, FPSN, Vice Chancellor, ABU, Zaria; Professor E.M. Abdurahman, FPSN, Vice Chancellor, Bauchi State University (BASU), Gadau, Bauchi State; Professor Abdulmumini Hassan Rafindadi, Vice Chancellor, Federal University, Lokoja (FUL) and former Barewa College classmate of Dr Mora; Professor M.A Mainoma, Vice Chancellor, Nasarawa State University, Keffi; Honourable Ahmed Ibrahim Yakasai, FPSN, one-time Honourable Commissioner, Kano State, and many professors of Pharmacy, including Professors J.A Onaolapo, A. Anuka, Isa Marte Hussaini, Ibrahim Adamu Yakasai and others.

Drug fakers should be treated as armed robbers – Pharm. Adeleke

1

getratric pix 1

In this interview with Adebayo Folorunsho-Francis, Pharm. Ebenezer Adeyeye Adeleke, FPSN, a former chairman of PSN Board of Fellows and national treasurer of the Pharmaceutical Society of Nigeria (PSN), goes down memory lane on the activities of the PSN, including the struggle pharmacists put up before the government officially upgraded them to Scale A salary structure. He also disclosed why he thinks convicted drug counterfeiters should be treated as armed robbers. Excerpts:

What was your childhood like?

I finished my primary school in 1957. I later went to Titcombe College for my secondary school, Egbe, Kogi State. Subsequently I went to Plateau State for my higher school certificate in Gindiri Secondary School for two years. I taught for some time and later moved to the University of Ife (now Obafemi Awolowo University) in 1966 after I got admission to study Pharmacy on Northern Nigerian government’s scholarship. Before then, Ife used to be known as the Nigerian College of Arts, Science and Technology. I had my honours degree in June 1970.

What was your work experience like?

I started work as an intern pharmacist at State Hospital, Abeokuta, from June 1970 to June 1971. There was no youth corps programme during our time. After my internship, I got employment with Nicholas Laboratory at Ilupeju as a medical representative. I rose to become the marketing manager. In those days, things were quite good. We finished our examinations on Friday and start work the following Monday even before the results were released. It was as simple as that. The chief pharmacist of the Western State just came to us and announced that anybody who wanted to work with the Western state should put down their names. From there, they allocated us to different towns. I was sent to Abeokuta, some to Ijebu Ode, and so on. When the exams results came, those who were unsuccessful returned to the school.

Is it true that the School of Pharmacy, University of Ife, wasn’t a degree awarding institution?

The school of Pharmacy started at Yaba where Chemists and Druggist diploma was awarded. Thereafter it moved to Ife where Diploma in Pharmacy was awarded. However the school changed to a degree awarding institution and produced its first graduates in 1966.

What was people’s impression of Pharmacy during your time?

At that time, Pharmacy was looked upon as a very noble profession. When we were in school, we walked with our shoulders high and we were highly respected. While other students were playing, we were often going about in our laboratory coats. Also, to gain admission to study Pharmacy was not easy at all. To breakthrough, you had to be very well above average.

 

Do you have any regret studying Pharmacy as a course?

In truth, I have not regretted studying Pharmacy at all. To date, pharmacists still have an edge when they are looking for employment anywhere. It is a professional course. If anybody wants to study Pharmacy, I will always encourage him.

One thing I know is that there is no profession without challenges. The feeling is that the grass is greener on the other side. I once met a medical doctor who wished he had studied Pharmacy because he thought we didn’t have challenges. Whereas I knew we had our own challenges. Two of my children are medical doctors and I know they have their own challenges too. Various professions, of course, have their various challenges. In summary, I will say Pharmacy is still a good course

Tell us about controversies and scandals during your time

Pharmacy practice has been faced with challenges –the gradual movement from diploma course in dispensary training to moving on to chemists and druggists level. I remember the School of Pharmacy in Zaria. The school went on strike in 1967 because, although the training was free and the students were fairly treated, they (the students) felt that they needed to pursue a degree course instead of diploma. So the school was closed down. That was a real challenge. With time, however, the degree programme came.

What about the challenges you encountered during the clamour for Scale A salary struggle?

The scheme that pharmacists were running then was CT Scale (technical grade) which obviously wasn’t the same with those on Scale. A salary structure (degree holders’ scale). It was a serious struggle for pharmacists to move up from CT Scale to Scale A. Can you imagine? Pharmacists who had three A-Levels and had gone to the university to study and on completion of course were not entitled to Scale A; whereas other students who didn’t have three papers would gain admission and come out with a degree and would be on Scale A. How would you feel? It was a serious struggle.

Eventually, we achieved the needed Scale A recognition. My set was the first to receive Scale A salary month by month. The set before us got theirs in arrears. That was in the Western States. The East was luckier because they got their Scale A before others across the country.

What is your view about the frequent face-off between doctors and other healthcare workers, especially pharmacists?

The issue of rivalry between doctors and pharmacists has always been there. It didn’t just start today. Yet, it should be that when you are under the firmament of the sky, you note that there is room for everybody. There is no need whatsoever to start proving to the other that you are superior. My feeling is that the patient is your focus. Make your own contribution to the health of the patient and I will make mine. But if the professionals stand aloof and each one argues, you know the saying that when two elephants fight, it is the grass that suffers. It is the country that will suffer the consequences more than anything at the end of the day.

I believe the country has spent a lot of resources and money to train all these professionals. So the best thing we can do for this country is do our best. We should learn to live with one another for the improvement of the citizenry. When we fail to do that, we have failed. It doesn’t matter whether we are laboratory scientists or pharmacists, doctors, radiographers, radiologists etc. No, we have failed totally.

Is there a role the government can play in this direction?

Pharmacists are not fully fulfilled. When you consider the level of education they have and what they are practising. The gap is a bit wide. Let us also consider the issue of recognition by the government. There is no need to give preferential treatment to one profession at the expense of others. The government should create the necessary environment. Because the environment is not conducive, many of our colleagues have moved out in droves to America, the United Kingdom and other countries abroad. Some of those still in the country have been forced to change professions and they are doing well. The sort of training we have received is that you can raise your head anywhere you may be.

How best do you think the issue of drug counterfeiting can be handled?

The issue of charlatans, people who have little care for professionalism, is another headache. The essence is just to make money. You have forgotten that drug is special commodity. It is just like a double-edged sword. You can use it wisely to attack enemy and you can use wrongly to attack yourself. If care is not taken, you can kill your neighbour. A good use of the sword is to attack the enemy. But if you misuse it and start killing yourself, it is pitiable.

Drugs are not commonplace items. You still find people selling drugs around, not creating the enabling environment. Some are exposed to the sun, adverse effects and other weather conditions which people are largely ignorant about. Once somebody is able to speak well – a lady who is not even properly educated can just sweet-talk you and you just start buying her products. It is just a chaotic situation. We still have problems with distribution of drugs, problem of faking and so on.

What should be done to dissuade people from faking drugs?

To me, those who fake drugs should have the same punishment as those burglars and armed robbers who go about killing people. They should not be treated with kid gloves. There was a time I was in a place to buy a drug. When I saw the place in which it was kept, I told them, “This drug is meant to be kept in a refrigerator.” The man in charge looked at me and said “Oga, wait! I will quickly put it in the fridge and it will get cold. Then you can take it.” That is the level of ignorance in which we find ourselves

How do you see the annual PSN national conferences?

It has provided a forum where we look at challenges and possible solutions. It is a place where seasoned speakers are also invited. It has also provided a forum where elections are held. This last one was an experiment by elongating it by a further day. I am not sure whether it has gone well with many people. But I remember the last one that was held at Akwa Ibom. Many people left before the end of the conference.

 What do you think was responsible?

Maybe many of them were not fully ready to sacrifice an additional day. So the PSN should look into that and see how to marry things together. It is not easy seeking solutions to problems and having many topics without enough time for relaxations. Or to find out whether these professionals will be ready to sacrifice an additional day. There must be a balance. Unless the organisers will make the features so attractive that people wouldn’t find an additional day boring.

Anyway I still think it was an experiment. They will make some trials and then see whether it can work or not. I will never subscribe to people saying that the annual conference is not useful or has lost focus. I had been the chairman of the conference planning committee years ago when I was highly involved. Now I think it is even more complex. Fortunately, the computer age has come in and they have been able to get in touch more, getting the day-to-day activities done, preparing for the conference, and even when the conference is on-going, getting across to participants, etc. I can say during my time when I was chairman of the organising committee, it was like analogue. Everything has now gone digital. Getting in touch with participants was quite stressful. In fact there were some days even the phone would not work. You then start writing letters, some would receive, some won’t. But right now, you just press buttons and everything is right there in their palms. And I specially commend the chairmen of these conference committees.

If you were not to be a pharmacist, what other profession would you have opted for?

When I was in secondary school, I had a fall and two of my teeth were broken. So it became necessary for me to visit a dentist. After some time, I was so fascinated with his office, appearance, dressing – everywhere was sparkling white so much that I told myself this was one profession I would like to do. He left a lasting impression on me that I said I would like to study dental surgery. But, in the end, I opted for Pharmacy.

How deeply involved were you in pharmaceutical activities?

My interest in pharmaceutical activities developed during our school’s Pharmacy Week where we got orientation about what the profession was all about, what we should prepare for, what our lot was when we finished and so on. It was then I knew that pharmacy graduates were not placed on Scale A and I wasn’t happy about it. Since then, I had developed a keen interest and my pharmacy struggle started.

How did you end up becoming PSN treasurer?

Immediately I started work, I had a boss who took an interest in me. Whenever they were going to PSN meetings, he took me along. On one of the occasions, there was an election. There and then, I was elected financial secretary. That was in 1972. I held on for two years before becoming state treasurer. I then moved on to become national treasurer in 1977 and occupied same office for seven years. Then I came back to the Lagos State branch and got elected as vice chairman. The new salary scale that came almost pitched pharmacists and doctors at the same level, except that the doctors were two steps ahead. It was during the tenure of Prof. Olikoye Ransome-Kuti that the doctors carved a new scale for themselves. During my time, I called several conferences where I commended those ministers who were doing well and scolded those who were not. At that time, there was a Commissioner for Health in Kwara State whom doctors stood against simply because he wasn’t a doctor. They regarded him as a square peg in a round hole. They were indeed very wrong.

Was the case resolved?

Yes.I fought against such stand saying that if he was being described as such, were they saying that just because somebody studied Pharmacy, he could no longer be a commissioner or minister? I told them the ministry of health should be viewed like the ministry of works where you had engineers, architect, surveyors and all sorts. The interesting thing is that any of them can rise to be a permanent secretary or a minister. Of course, we have had ministers of health from different professions. Aminu Kano was a minister of health, yet he did not study medicine. Dr. Adetoro, at a time, was minister of health, he too never read medicine. In UK for instance, they appoint lawyers as secretary for health. The same thing applies to the United States and other climes. I felt very happy when Prince Adelusi-Adeluyi became minister of health. Kafaru Tinubu was also minister of health but he never read medicine. He was a police commissioner.

Were there some major awards given to you in recognition of your selfless service?

Sure. When I presented my financial report in 1984 at the Benin conference in my capacity as the treasurer, the entire gathering was impressed and gave me a standing ovation. Anytime I remember that, I feel elated. That was the year I left voluntarily. In fact, there was no limit to the number of years you could spend in office as at that time. I was one of the longest serving treasurers. I was also among the first set of merit award recipients in Lagos State. In fact, we started the merit award itself in 1988. When the first set (ten of us) first compiled the list, some enraged notable members reported us to the national president that I was creating awards that were parallel with Fellowship awards.

Were you sanctioned?

No. I was not reprimanded because not all our people making contributions would be able to have Fellowship award. But it was obvious that they are making several contributions in their individual states. In 1991, I was given Fellowship award along with 24 other recipients at the Enugu conference. You know Fellowship award is the highest honour the PSN can give anybody. Lest I forget, I became the chairman of the PSN board of fellows (2003 – 2006).

I have served in various committees as chairman or secretary, whether it was building, finance conference or any other. I have represented the PSN on the Pharmacists Board (now PCN). Even in the PCN, I have served at various committees. For instance, I was chairman of the sub-committee in charge of the PCN secretariat in Idu, Abuja.

 

Combining leadership with academics was tough – former PANS president

0

Arinze Awiligwe is a recent graduate of Pharmacy from the University of Lagos (UNILAG). He was president of the Pharmaceutical Association of Nigerian Students (PANS) in the 2012/2013 session and vice-president, PANS-UNILAG. In this exclusive interview with Pharmanews, Awiligwe, who is presently a research intern with R20, a Swiss-based non-governmental organisation (NGO), spoke on some of the challenges that he encountered as PANS president, as well as some of the achievements of his administration. Excerpts:

Tell us about PANS

The Pharmaceutical Association of Nigerian Students (PANS) was established in 1972 and, since then, it has been the foremost leading advocacy organisation of all pharmacy students in Nigeria. We are a group of pharmacy students with interest in promoting improved public health through provision of information, education, networking, and a range of publications and professional activities in the country.

 Now that you’re out of office, do you still have any relationship with PANS?

Yes, by virtue of my positions then as president, PANS national, and vice-president, UNILAG Chapter, and with the support of the leadership of the Pharmaceutical Society of Nigeria (PSN) I was instrumental in the registration of PANS with the International Pharmaceutical Students Federation (IPSF). As a result, I am recognised by the body. I am presently a part of the policy and public health committee of IPSF. It means I still participate actively in PANS and IPSF, directly or indirectly.

 What were your greatest challenges as PANS National president?

One of my greatest challenges as president was having to work with people from diverse backgrounds and students from different schools. Even though we shared the common goal of upholding the constitution and fighting for the right of pharmacy students, it wasn’t easy as such as the diverse backgrounds we had prevented us from implementing many of our objectives. However, I am happy we were able to record some tremendous achievements and part of it was the successful registration of PANS with IPSF.

Also, we were able to create a meaningful network between pharmacy students and pharmaceutical companies, because we found out that one of the biggest challenges of young pharmacists was detachment between the old players in the industry and the incoming ones. Many young pharmacists graduate, do their internship and youth service, after which they develop little or no passion to go further in the profession because there is lack of network between them and the experienced ones. So we end up having young pharmacists who are merely driven by money, materials and things that are not really needed to progress in the profession.

As an individual, my greatest challenge was that of combining the responsibilities of being a national president with being a student. It was not easy but God saw us through.

 How did you cope with the challenge of being a Lagos-based president who had to work with executives from other schools?

Actually, the goal of running a students’ association like PANS is to ensure that the interest of every member is protected and as well to ensure they all have a sense of belonging. It is clearly stated in the constitution that there must be rotation of presidency among pharmacy schools. It is also stated that if the national president comes from a particular school, the chapter president of that school automatically becomes the vice-president at the national level and same thing also applied to other chapters’ presidents. So no one is actually elected as vice-president. Also, the general secretary, as well as some key officers like treasurer and financial secretary, also comes from the same school as the national president, while the remaining positions are thrown open to other schools.

However, when I took over from my predecessor, we had the challenge of continuity as we didn’t have the platform to engage the incoming leaders into embracing the vision of our predecessors. In advanced countries, there is a programme called ‘Leadership in Training’ which allows the next set of leaders to be trained on the nitty-gritty of leadership position. We lack such here and that has been affecting the successive leaderships of the association, as every new administration that comes in has to start from the scratch. I really suggest that PANS improves on this and ensure that the succeeding executives learn from the outgoing leadership.

Also, each incoming leadership should be made to learn from the structure of our parent body, the PSN, as well as an international organisation like the IPSF. The two bodies have a lot in common.

One thing that I held as a priority during my administration was the importance of IPSF, because so many advanced countries that have partnered with this global organisation were able to learn so many things about best pharmacy practice and international pharmacy practice.

 

Some people believe you were too gentle to be an effective leader, what can you say about this?

I know so many great leaders who are not today categorised as being great based on their agility or loudness, so to say. I believe that there is a difference between a leader and a politician, because as a leader, you want to, as much as possible, carry everybody along, protect the interest of your members and ensure that the rules and regulations guiding the association are followed to the letter.

An association like PANS is not a business venture; it is a strong association that has made many marks and we want to maintain that culture of greatness. This is why I have remained who I am. My humility and gentleness cannot be confused with being cowardly or ineffective, even though there were disadvantages in this regard during my time as president as I devoted more time to listening to people before taking actions. That affected us a little because student unionism requires a lot of aggressiveness and agility which were not there on my part. Still, we had a fantastic administration as we achieved a lot within one year that we were in office.

 How do you think PANS will benefit from IPSF?

Pharmacy students are in for a great time, because PANS is registered with IPSF on a national basis; that is, every university that is accredited in Nigeria is registered. Therefore, every pharmacy student in Nigeria is a potential member of IPSF and the benefits are immense. Membership will afford them networking opportunities, through social media and other means, with other pharmacy students that are also members of IPSF across the world.

Also, the IPSF national congress allows every member to relate and share ideas, exchange scientific knowledge, engage in meaningful discussion and also learn from one another. So it’s a two-way thing.

PANS also benefits through the adoption of IPSF methods in approaching pharmacy education and learning process.

What is your aspiration in life?

My aspiration in life is to constantly be a better person than I am, and to improve the life of everyone around me in the best possible way.

 

Symptoms of poor blood circulation

0

Heart disease

(By R. Sharp)

Circulatory problems do not begin in a day. In other words, you could call the heart a very patient organ, which can take years of abuse and when it cannot take it anymore, breaks out with symptoms.

At the outset, we need to remember that poor circulation is an outcome of certain lifestyle choices which we make which are detrimental to our health. Coupled with these are factors like imbalanced diet and lack of physical exercise. All these factors lead to fatty deposits on the arterial walls, which, when hardened, are called plaques. These plaques then block or create obstructions to the smooth passage of blood to and from the heart.

Plaques take a long time to be formed; that is the reason, we find circulatory problems affecting the elderly more often than they affect children. Our food habits also add to an unhealthy build-up of cholesterol which may increase the viscosity of the blood, which again creates anomaly in the smooth flow through arteries and veins.

Since the circulatory system covers our entire body, the problems can also be manifested in numerous ways. For instance:

 

The brain – Our brain receives 20 per cent of the blood circulated in our body. With a drop in the flow, our brain functions sub-optimally, resulting in feeling lethargic, loss of memory, lack of mental clarity, etc. Frequent unexplained headaches and sudden attacks of dizziness are also seen as symptoms of poor blood circulation to the brain.

 

The heart – When poor blood circulation affects the heart, the symptoms would be chest pain, high blood pressure and rise in the level of cholesterol. Difficulty in performing any common task, like climbing stairs; walking a stretch could make you very tired and breathless.

 

The liver – When you suffer from lack of appetite or experience sudden weight loss and your skin looks lustre-less, it is quite possible that your liver is getting ‘sluggish’ and these are the early symptoms of poor blood circulation to the liver.

 

The kidneys – This organ plays an important role in regulating and monitoring our blood pressure other than eliminating the waste and excess water from our bodies. When poor blood circulation affects the kidneys, we notice swelling of hands, feet and ankles, rise in blood pressure, altered heart rate and we feel tired all the time.

 

The limbs – Poor blood circulation can have serious impact on our arms and legs. We can experience sudden numbness of our hands, feet and fingers or suffer painful leg cramps. Symptoms of serious blood circulation problems can be varicose veins or a condition called cyanosis – which is when part of our skin turns blue or black due to lack of adequate oxygen to the concerned tissues.

 

Sex drive – Poor blood circulation can affect our reproductive organs as well. The symptoms are lack of sex drive and fatigue. Symptoms would also include lack of vitality. Serious blood circulation problems could also make one impotent.

 

Source:www.healthguidance.org

 

Lakeshore Cancer Centre opens in Nigeria

1

In a renewed effort to bring quality care closer to patients, Lakeshore Cancer Centre (LCC) has formally launched its operations in Nigeria.

lakeshore
L-R: Bindiya Chugani, business manager at Lakeshore Cancer Centre; Dr Chumy Nwogu, the CEO &medical director, special oncologist and cancer prevention expert, Lakeshore; Dr Yinka Akinyemiju, pain & palliative care specialist, Lakeshore; and Dr Jimoh Mutiu Akin, consultant radiation/clinical oncologist, Lakeshore, during the media launch of Lakeshore Cancer Centre in Lagos

The ribbon-cutting ceremony, which took place in the state-of-the-art facility in Victoria Island, Lagos, on 24 January, 2015 witnessed a massive turnout of participants.

Aside offering skeletal services since July 2014, LCC is solely designed by a team of global experts on surgical and radiation oncology, for high quality prevention and treatment of cancer.

Affiliated to the Roswell Park Cancer Institute (RPCI) in Buffalo, New York, USA, Lakeshore Cancer Centre is the oldest cancer centre in the world. The RPCI provides training, education and clinical care oversight and research programmes to the centre.

Speaking at the event, Chief Executive Officer and Medical Director at LCC, Dr Chumy Nwogu, noted that cancer kills more people globally than malaria, HIV and Tuberculosis (TB) combined, and disproportionately affects low to middle income countries like Nigeria.

He explained that the 2012 data of the International Agency for Research on Cancer, stipulates 102,079 new cancer cases every year and 71,571 cancer deaths annually in Nigeria.

“This is probably a marked underestimation, as cancer registration is really poor in Nigeria. Over 70 per cent of patients die despite the fact that we do not capture all of them – over 20 percent of people with cancer are still not captured. This is because many patients usually seek alternative treatments, traditional healers or prayer houses. These numbers are predicted to rise dramatically over the next few years,” Nwogu disclosed.

The medical director, who is a highly respected cancer epidemiologist and thoracic surgical oncologist, further stated that, “the World Health Organisation (WHO) estimates that one third of cancers can be prevented, one third cured and one third effectively palliated; hence the great need for education, screening and early detection.”

He said the LCC is committed to providing cancer patients with tools for early detection, diagnosis and consultation with excellent oncologists, without having to travel away from loved ones at home.

The centre also launched the Foundation for Cancer Care in West Africa (FCCWA) to provide cancer care to the less privileged in Nigeria and across West Africa.

“The treatment for cancer is capital intensive and long term, so most individuals cannot sustain the cost. The Foundation is therefore focused on fostering collaboration between government agencies, corporate organisations, various medical facilities and advocacy groups. Philanthropic donations are always welcome and much appreciated for the care of cancer in West Africa,” Nwogu explained.

Also speaking at the event, Associate Professor of Oncology at the RPCI, Dr Tracey O’Connor, said that early screening and detection are indispensable in the prevention and management of cancer.

“Three cancers – breast, cervical and prostate – claim the highest number of lives in Nigeria. But all of them, if brought to medical attention early in their development, are highly curable. So, basically, testing and early detection can hugely reduce fatalities,” she stated.

O’Connor counselled Nigerians to go for screening. She also recommended the Human Papillomavirus (HPV) vaccine for young girls of 11 to 12 years.

“The vaccine is to prevent the human papillomavirus which cause most cervical cancers,” she explained.

Wife of the Lagos State Commissioner for Transport, Mrs Abiodun Opeifa, who represented the First Lady, Mrs Abimbola Fashola, commended the LCC for establishing “this great cancer facility in Lagos State. This will sure increase awareness about cancer prevention and treatment; and drasticallyreduce incidences of preventable cancer deaths.”

The LCC provides diagnostic imaging services, mammography, pap smear, laboratory services, public education awareness, tissue biopsis, outpatient operative procedures chemotherapy services, and palliative care. The facility also provides minor surgery, oncology consultation, cancer treatment planning as well as outpatient pharmacy.

Now that JOHESU’s strike is over.

1

I know what its takes for a staff to be off work for almost three months, all in the name of an industrial action.The good news is that the prolonged strike has been called off after the intervention of Mr President, who had promised to look carefully into all there demands.
Pharmanews Limited- the West Africa’s Foremost Health Journal, seizes this opportunity to wish all health workers happy resumption, and quick recovery on all lost grounds while at home.

Professor Paul Akubue becomes Professor Emeritus

2

4x6 main

The Vice-Chancellor, University of Nigeria, Professor Benjamin C. Ozumba (left), congratulates Professor Paul Akubue (right) after conferring on him the title of emeritus professor of the university and presenting him the certificate, during the 44th convocation ceremony of the university, held on 24 of January, 2015. Next to Prof. Akubue on his right is his wife, Associate Professor Felicia N. Akubue.

I’m set for ACPN national chairmanship – Pharm. Alkali

0

Pharm Alkali

In this exclusive interview with Pharmanews, current national vice-chairman of the Association of Community Pharmacists of Nigeria (ACPN) Pharm. Albert Kelong Alkali Pharm. spoke on some of the achievements of the present administration under the leadership of Pharm. (Alh) Olufemi Ismail Adebayo, as well as his aspiration to become the next national chairman. Excerpts:

 

Briefly tell us about yourself, especially your academic background

I am Albert Kelong Alkali, a community pharmacist and managing director, Medisal Pharmacy, Abuja. I graduated from Ahmadu Bello University, Zaria, Kaduna State, in 1991, after which I went into the industry as medical representative for Roche Pharmaceuticals Nigeria Limited (before they changed to Swipha), covering the north/east zone. Since leaving Rochi in 1999, I have been in community practice. I am currently a final year student in Pharm. D conversion, and in some couple of months, I will be Pharm. Doctor Alkali Albert Kelong.

Our pharmacy, Medisal Pharmacy, Abuja, has two premises – one in the National Assembly’s Quarters and the other at Wuse Zone 6.

 

How do you combine running a community pharmacy in Abuja with the responsibility of being a national vice-chairman of ACPN?

It all depends on planning.It also boils down to the fact that I have had enough experience, being a former chairman of ACPN, before becoming the national vice-chairman.So, I have mastered my planning and I know the way I plan my activities, so that my personal business and the national assignment do notdisturb each other. I am the superintendent pharmacy for one of the outlets, while the other one is being superintended by another pharmacist. Although it is not an easy task as it entails a lot of sacrifices, but with God, we are doing well and this has inspired me to go a step higher – I am hoping to become the next national chairman of the ACPN by the grace of God.

 

Why did you choose community pharmacy practice ahead of other aspects of the practice?

Let me be sincere with you, community pharmacy practice is very interesting. I started with the industry as a young man because the industry had prestige then, and you were also well-remunerated and well-trained. As medical reps then, we could do presentation and we underwent series of trainings that were quite interesting.Meanwhile, hospital practice was the least interesting then because the environment was not conducive. But I want to tell you that community practice is an embodiment of both the hospital practice and the industrial, because you combine all. Some people come with prescriptions, while others come without any. I think it has been the most interesting as it affords you the opportunity to meet people, solvetheir problems, put smiles on their faces, while you also make money.

 

Why do you intend to vie for the office of national chairman of ACPN?

I know I am capable to be the national chairman after having understudied my present chairman, Pharm. Olufemi Ismail Adebayo from day one in office. I have also been in the Council as the state chairman, FCT branch, in the past.So I know some of the challenges that we are facing and I have the pedigree to be able to lead the association well and achieve greatness for the association.

I also have deep passion for this association and I’m glad that I’m a pharmacist because it has improved and equipped me with a lot of knowledge. With vision and focus, I am ready to steer the association to the next level. Also, with the calibre of chairmen we have had and the wealth of knowledge of the outgoing chairman, coupled with the direction I have set for myself, I think I will be able to, at least, match or supersede what the outgoing chairman has done because I am one of his loyal students (Laughs).

 

What gives you confidence that you can lead an association as complex as the ACPN?

As the national vice-chairman, I have worked closely with my chairman and whenever I advise and he feels the advice is useful, he takes it.Also, from the experience I have garnered working with him, I have developed many ideas for projects and programmes for the advancement of the profession and the association which I would love to implement when I emerge the national chairman of our association.

This administration, under the able leadership of Alh. Ismail has done its best and I am hoping to continue wherever it stops. At the end of the day, I would love to see community pharmacy practice members that are doing well, giving back to the society and providing the public with the needed therapeutic attention, as well ridding the society of fake and counterfeit medicines.

With 23 years’ post-graduation experience and having been a Fellow of the WAPCP since 2005, state chairman and member, National Executive Council (NEC) for five years, and being a national vice-chairman for three years or so, I am quite mature for the job, and I am willing to take this association to the next level by the grace of God.

 

Tell us some of the achievements and challenges as of the present administration in the last three years in office.

 

Well, under the able leadership of my national chairman, Pharm. (Alh) Olufemi Ismail Adebayo, we have been able to come up with the mission and vision statements for the association which have defined our focus and goals from inception. The association now has a new logo and, of course, the public is now better enlightened on whom a qualified and registered community pharmacist is compared to those days when quacks and charlatans almost took over the practice from the professionals.

In addition, we have done enough to improve the welfare of our members and also enhance their practice. However there is still much to be done because we cannot work in isolation. The regulatory agencies also have to do their work so that the practice can be better than it is now. I am very happy that we have a new registrar at the level of PCN and the new board of council. From the way they are going, they are charting a new course for the profession, and if things continue this way, I think pharmacy practice will be much better than what it is now.

 

How do you see pharmacy practice today compared to what it used to be?

It is getting a lot better and I will also like to say that my own pharmacy practice has been enhanced by the fact that I enrolled in the Pharm. D conversion programme, which, to me, is the best thing that has ever happened to pharmacy in Nigeria. I am saying this because, by the time you graduate as a Pharm. D holder, you become well-grounded. The University of Benin that is presently doing the conversion is doing well. Today, I have patients who come to my premises for immunisation, some for counselling, some with chronic ailments such as hypertension, diabetes and others; while some come specifically because they want to see and talk to the pharmacist. This can only be possible when they have confidence in you. So, in a nutshell, pharmacy practice, from my point of view, is now better practised than what it used to be.

 

Are you suggesting that all pharmacists who have B.Pharm. should also go for Pharm. D?

Definitely yes, that is the way forward. All pharmacists should go for Pharm. D, while those who already have B.Pharm. should go for conversion. This doesn’t mean it’s a must for everybody but all those intending to be pharmacists should go for the Pharm. D because it is a unique degree that brings one closer to the patient.

The reason some set of people are trying to take away the practice from us is because we are not close to the patients. So, if we are close to the patients as well as the molecules, other healthcare professionals will respect us as being important in healthcare delivery.

 

As someone who has been in the practice for a while, how would you assess pharmacy practice in the country?

Pharmacy is a profession that is highly specialised and thrives well in a properly regulated society and that is why in the US and the UK, pharmacists are in the top class of society. However, in our country today, the practice environment needs to be sanitised and that is why we have so many of our colleagues not doing too well.

However, despite the chaotic situation we find ourselves, if, as a pharmacist, you are able to define yourself and do what you are supposed to do in your practice area, you will realise that your community will appreciate what you are doing and you will be popular in their midst. So, the practice is highly rewarding for those who know what to do, in terms of pharmaceutical care and others.

 

As one of the stakeholders, what is your view on the happenings in the healthcare sector in the country?

The healthcare sector today, to me, leaves much to be desired. We are supposed to do better than we are doing now, but some doctors (don’t let me say all) continue to see pharmacists as rivals in the industry. I know that it’s just specialisation that separated the two because pharmacy and medicine are the same as they aim at achieving the same result, which is healthcare provision. Also, none of the healthcare providers can work in isolation, because the physician may not be able to work effectively without the pharmacists, while the same applies to others. So, as far as I am concerned, it is just ego problem, which is not good for the sector. Healthcare provision should be about patients.

 

Re: Now that ACTs appear to be failing

0

 Below is an insightful rejoinder I received from Professor David T. Okpako on my article, “Now that ACTs appear to be failing.

 

The article in the January 2015 issue of Pharmanews, page 46, with the above title, written by Pharm. Nelson Okwonna, caught my attention and compelled me to write this brief response.

The article dealt with the important issue of emerging Plasmodium falciparum resistance to the artemisinin-based combination therapies (ACTs), now the drugs of choice for the treatment of malaria disease throughout Nigeria. The author raised the apocalyptic scenario of an ‘epidemic of monumental proportions’ for Nigeria, the epicentre of malaria disease, in the event of resistance to ACTs.

I have also raised such alarm before and, again, in a forthcoming book, where I drew attention to modern medicine’s historical experience with the disease caused by tubercle bacillus (TB) which was treated successfully with effective affordable drugs in the 1950s, but which later developed resistance to such drugs, and then to every generation of anti-TB drug that science could invent. Today there are some strains of TB (extensively resistant TB) which do not respond to chemotherapy –a nightmare scenario and one of today’s most intractable chemotherapeutic problems, even in the western world.

Among Nelson’s recommended solutions is a most telling point, i.e., “heading home for answers” -where he suggests that, in our attempt to tackle the problem of multi-drug resistance in malaria,we should look at the possibility of combining our local herbs with known existing therapies. This is a most insightful suggestion for which there is strong scientific evidence, which I may very briefly point to. Basically, malaria is a disease whose pathology is underpinned by inflammatory mechanisms triggered by the presence of the plasmodium parasite.The evidence that malaria is an inflammatory disease is now overwhelmingly incontrovertible. And the herbal remedies used by various indigenous communities in Nigeria to treat fever, aches and pains (FAP), the quintessential manifestations of the inflammatory reaction, have been shown by Nigeria scientists in the last 30 to 40 years to possess anti-inflammatory pharmacological properties.

We can thus say with confidence that ancient Nigerians, in their malaria endemic zones, evolved a rational method of treating what must have been a common ailment, malaria fever,with herbs, that worked.There is no evidence that Africans were near extinction due to malaria disease, before modern chemotherapy came to the rescue.

The ancients were ignorant of the mosquito/parasite origin of the disease, but they treated the symptoms (many people in Nigeria still do).I argue that such successful treatment of malaria-induced FAP is tantamount to cure in Africans living continuously in contact with the anopheles mosquito.This is because the people have partial immunity conferred on them by anti-plasmodium antibodies and numerous genetic protective adaptations e.g., sickle cell gene and glucoe-6-phosphate dehydrogenase enzyme deficiency; their immune system was primed ready to deal with the plasmodiumparasite whenever it showed its presence. In such people, all that is needed is a successful amelioration of the malaria-induced inflammation (some mediators of inflammation, e. g., the cytokine, tumour necrosis factor, TNF, actually suppress immune activity in the sufferer); the resulting surge in anti-plasmodium immune activity in such people would eliminate the parasite, resulting in a cure of the disease. Moreover, the immune status of the individual against the plasmodium was strengthened after every bout of malaria-induced FAP, and successive attacks would be less severe in a process of natural attenuation of the parasite. This was how Africans living in malaria endemic areas came to attain a state of biological equilibrium with the disease before European introduction of modern chemotherapy with plasmodicidal drugs less than 500 years ago.As we now know, the use of plasmodicidal drugs in the treatment of malaria runs against the grain of that age-old biological equilibrium.

An important advantage of herbal treatment is that the parasite is not provoked into mobilising its considerable arsenal of resistance mechanisms, which is what happens when we use plasmodicidal anti-malaria drugs such as chloroquine and the ACTs whose aim is to kill the plasmodium.The malaria multi-drug drug resistance that we see in Plasmodium falciparum is a defence reflex against extinction by an ancient parasite that sees itself threatened.

Drug resistance was an unknown phenomenon in Africa before the extensive use and abuse of anti-malarial drugs, following the introduction of modern chemotherapy. Even when fully fleshed out, this hypothesis is, at best, a most plausible hypothesis; but it can be tested and represents a challenge to the Nigerian medical community which, up till now, seems to accept foreign prescriptions on malaria without question.

Pharmacists and doctors and all who are familiar with this science must work together and pressurise the government to fund concerted research into traditional anti-FAP herbal remedies for development as anti-malaria therapies, or as adjunct to conventional therapies, as Nelson wisely suggested in his article. This is to ensure that not every adult otherwise healthy Nigerian with a competent immune status and partial immunity should have to take powerful resistance-provoking plasmodicidal drugs such as the ACTs for the treatment of FAP that has not been diagnosed as malaria disease. This, plus other smart designs in the use of effective plasmodicidal drugs, will increase their life-span by minimising the chances of drug resistance.

I am thus in full agreement with Nelson Okwonna that we should head home for answers by turning to indigenous herbal remedies. The world is turning to plants for anti-inflammatory medicines because the array of anti-inflammatory chemical entities present in plants is mind-boggling and cannot be matched by non-steroidal anti-inflammatory drugs produced by synthetic chemists in the pharmaceutical industry.

All in all, the time has come (aided by science!) for us in West Africa to begin to see malaria disease as our ancestors understood it – that is, a common ailment treatable with available herbal remedies, not a deadly disease of epidemic proportions as we have been conditioned to perceive it by international experts guided by a persisting fear of the disease; a fear reinforced by their memory of numerous malaria deaths of non-immune Europeans in their first encounter with the disease in West Africa in the 19th century.

David T. Okpako, FPS, FAS.

Quality measurement and management in health care systems

1

Maintaining leadership in health care management is unachievable if the quality of health care cannot be measured. A good health care system allows for effective evaluation in order to know what exactly the quality of care is, and how well it is delivered.

Sadly, in most developing countries, there is no mandatory national healthcare system to track the quality of care delivered to the citizens. Much of what is done is spontaneous delivery of health care within an existing cyclic health structure that has existed for many years without recourse to change.

On the other hand, in developed countries, interest in measuring quality of health care has initiated dramatic transformations of health care systems, accompanied by new organisational structures and reimbursement strategies that could affect quality of care.

Why is the measurement of quality in health care difficult in the developing ones? Apart from a lack of documentation about how major illnesses are treated in most health care systems, there are other factors, which include:

  1. A lack of systematic outcome assessment.
  2. A lack of resource evaluation related to quality for specific diseases.
  3. Persisting variations among providers in care for similar patients.
  4. Paucity of formal monitoring systems by health care providers or regulators.

 Assessing quality care

Understanding quality of care is quintessential to effective leadership in health care management. Quality carecan be defined as the degree to which health services for individuals and populations increase the likelihood of desired health outcomes, become consistent with current professional knowledge, and divided into different dimensions according to the aspects of care being assessed. This cannot be achieved without effective management; in fact, management is the commitment required to achieve quality health care objectives. It involves coordinating, leading and motivating people in order to achieve a set objective. It entails the efficient use of all available resources.

Our focus here is the measurement of the quality of health care. How do we know how well we are doing? Are there precise measurement tools for measuring an existing health care system?

There are quantitative measures that can be used to monitor and evaluate the quality of important governance, management, clinical, and support functions that affect patient outcomes. These quantitative measures are carried out using indicators.Indicators aremeasures that assess a particular health care process. They provide a quantitative basis for clinicians, organisations and planners aiming to achieve improvement in care, and the processes by which patient care are provided. Indicators are a form of clinical quality measures (CQMs).

 About clinical quality measures

      Clinical quality measures(CQMs) are tools that help measure and track the quality of health care services provided by eligible professionals, eligible hospitals and critical access hospitals (CAHs) within a health care system. These measures use data associated with providers’ ability to deliver high-quality care or relate to long term goals for quality health care.

CQMs measure many aspects of patient care, including, health outcomes, clinical processes, patient safety, efficient use of health care resources, care coordination, patient engagements, population and public health, and adherence to clinical guidelines.

The importance of using an effective indicator cannot be overemphasised. Indicators serve crucial purposes. They make it possible to:

  1. Document the quality of care;
  2. Make comparisons (benchmarking) over time between places (e.g. hospitals);
  3. Make judgements and set priorities (e.g. choosing a hospital or surgery, or organising medical care);
  4. Support accountability, regulation, and accreditation;
  5. Support quality improvement; and
  6. Support patient choice of providers

Also,the use of indicators enables professionals and organisations to monitor and evaluate what happens to patients as a consequence of how well professionals and organisational systems function to provide for the needs of patients.

However, indicators are not a direct measure of quality. This is because quality is multidimensional; hence, in order to understand and measure quality, different measures must be employed. Although indicators are not sole determinants of measuring quality, they must be ideal indicators. They are said to be ideal if they are based on standards of care. These ideal indicators can be evidence-based and derived from the academic literature. Where scientific evidence is lacking, it can be determined by an expert panel of health professionals in a consensus process, based on their wealth of experience. Thus, indicators and standards can be described according to the strength of scientific evidence for their ability to predict outcomes

 Characteristics of an ideal indicator

An ideal indicator:

* Is based on agreed definitions, and described exhaustively and exclusively;

* Is highly or optimally specific and sensitive; that is, it detects few false positives and false negatives;

* Is valid and reliable;

* Discriminates appropriately;

* Relates to clearly identifiable events for the user (e.g. if meant for clinical providers, it is relevant to clinical practice);

* Permits useful comparisons; and

* Is evidence-based. Each indicator must be defined in detail, with explicit data specifications in order to be specific and sensitive.

It is important to know that indicators may vary in their validity and reliability. Validity is the degree to which the indicator measures what it is intended to measure. This means the result of a measurement corresponds to the true state of the phenomenon being measured. A valid indicator discriminates between cares, otherwise known to be of good or bad quality, and concurs with other measures that are intended to measure the same dimension of quality.

Reliability, on the other hand, is the extent to which repeated measurements of a stable phenomenon by different data collectors, judges, or instruments, at different times and places, get similar results. Reliability is important when using an indicator to make comparisons among groups or within groups over time. These two qualities must be considered when choosing an indicator.

Types of indicators

There are different classifications of indicators that may be useful when considering which should be used for a given purpose in an organisation. An indicator can be any of the following:

* Rate-based or sentinel;

* Structure/process/outcome-related; and

* Generic or disease-specific.

* Type of care, function, and modality-related

Rate-based and sentinel indicators

A rate-based indicator uses data about events that are expected to occur with some frequency. These can be expressed as proportions or rates (proportions within a given time period), ratios, or mean values for a sample population.

To permit comparisons among providers or trends over time, proportion- or rate-based indicators need both a numerator and a denominator, specifying the population at risk for an event and the period of time over which the event may take place. An example of rate-based indicator is: “clean and contaminated wound infection” where the numerator is the number of patients who develop wound infection from fifth post-operative day after clean surgery and the denominator is the total number of patients undergoing clean surgery within the time period under study who have a post-operative length of stay for five days.

Moreover, a sentinel indicator identifies individual events or phenomena that are intrinsically undesirable, and always triggers further analysis and investigation. Each incident would trigger an investigation. Sentinel events represent the extreme of poor performance and they are generally used for risk management. Example is the number of patients who die during surgery.

2.Indicators related to structure, process and outcomes

There are indicators that can be related to structure, process and outcome of health care. ‘Process’ denotes what is actually done in giving and receiving care; that is, the practitioner’s activities in making a diagnosis, recommending or implementing treatment, or other interaction with the patient.

On the other hand, ‘outcome’ measures attempt to describe the effects of care on the health status of patients and populations. Improvements in the patient’s knowledge and salutary changes in the patient’s behavior may be included under a broad definition of outcome and, so, may represent the degree of the patient’s satisfaction with care.

Further,‘structure’ refers to health system characteristics that affect the system’s ability to meet the health care needs of individual patients or a community. Structural indicators describe the type and amount of resources used by a health system or organiSation to deliver programmes and services, and they relate to the presence or number of staff, clients, money, beds, supplies, and buildings.It is important to note that the assessment of structure is a judgement on whether care is being provided under conditions that are either conducive or inimical to the provision of good care.

* Process indicators: Process indicators assess what the provider did for the patient and how well it was done. Processes are a series of inter-related activities undertaken to achieve objectives. Process indicators measure the activities and tasks in patient episodes of care. An example of process indicator is the proportionof patients treated according to clinical guidelines. Some authors include the patient’s activities in seeking care and carrying it out in their definition of the health care process; others limit this term to the care that health care providers are giving. It may be argued that providers are not accountable for the patient’s activities and these, therefore, do not constitute part of the quality of care, but rather fall into the realm of patients’ characteristics and behaviour that influence patients’ health outcomes.

* Outcome indicators: Outcomes are states of health or events that follow care and that may be affected by health care. An ideal outcome indicator would capture the effect of care processes on the health and wellbeing of patients and populations. Outcomes can be expressed as ‘The Five Ds’: (i) Death – a bad outcome if untimely; (ii) Disease – symptoms, physical signs, and laboratory abnormalities; (iii) Discomfort – symptoms such as pain, nausea, or dyspnea; (iv) Disability – impaired ability connected to usual activities at home, work, or in recreation; and (v) Dissatisfaction – emotional reactions to disease and its care, such as sadness and anger.

It should be noted that intermediate outcome indicators reflect changes in biological status that affect subsequent health outcomes. Some outcomes can only be assessed after years, for example, five-year cancer survival. It is, therefore, important to assess intermediate outcome indicators. They should be evidence-based and reflect the outcome (e.g. HbA1c in diabetes). They can be regarded as short-term outcomes.

Therefore, outcome measures must be adjusted for factors outside the health system, if fair comparisons are to be made. In quality assessment, components that relate to the medical care system should be isolated, which is accomplished by controlling for significant confounding factors that contribute to the outcome.

 

  1. Generic and disease-specific indicators

Generic indicators measure aspects of care that are relevant to most patients, while disease-specific indicators are diagnosis-specific and measure particular aspects of care related to specific diseases. Both generic and disease-specific indicators can focus on structure, process, or outcome.

Generic indicators may be difficult to interpret, especially when making comparisons among hospitals or providers, because there may be profound differences in patient mix. Examples of generic indicators are proportion of specialists to other doctors, registered patients in the emergency department, unscheduled returns to the operating room and in-patient mortality.

Disease-specific outcome indicators can be used to compare hospitals and plans, when data are risk-adjusted. Confounding factors, such as prognostic factors for specific diseases, are likely to be found in the scientific literature for these diseases, thereby, indicating the need for risk adjustment. Example of this type of indicator is the proportion of cardiologists to other doctors treating patients with heart failure at the department of cardiology.

  1. Indicators related to type of care, function, and modality

There are indicators that can be classified according to type of care, function, and modality. These set of indicators, classified by type of care, may be preventive, acute, or chronic.Also, quality measurement can be done based on health care functions such as screening, diagnosis, treatment and follow-up. This must be done alongside the modalities through which the health care process is done. Modalities in the health care process includehistory, physical examination, laboratory/radiology study, medication, and other interventions.

It is critical to evaluate and re-evaluate healthcare performance among professionals and organisations. These indicators can serve as a plumb line if indeed we seek leadership in health care management.

The table below captures this group of indicators and illustrates how they can be classified in quality of care measurement systems, especially in multiple clinical topics. The table displays examples of indicators classified according to type of care, function and modality

Indicator Type of Care Function Modality
Sickle cell disease: children with a positive sickle cell    Chronic Treatment Medication screen of children suspected of being positive for sickle cell disease should be placed on daily penicillin prophylaxis from at least 6 months of age until at least 5 years of age
Urinary tract infection: children with a diagnosed urinary tract infection should be reassessed at 48hours to determine if there is clinical improvement Acute Follow-up Other contact
Well-child care: the child’s weight should be measured at least four times during the first year of life. This information must either be plotted on a growth curve or be recorded with the age/gender percentile Preventive Screening Physical Examination

 

As always, our passion at the Pharmanews Centre for Health Care Management Development is to drive effective leadership through qualitative healthcare management. It is crucial to know that the measurement of health care quality is greatly aided by the use of relevant quantitative indicators, supplementing other approaches that may include qualitative analyses of specific events or processes. For a healthier Nigeria, indicators can also be important with regard to prevention, quality of life, and satisfaction with health care.

We believe that a more effective health care system is possible with the continuous education of health care personnel and the design of an effective platform for discourse among health care professionals. This explains the reason for our aggressive 2015 training campaigns across Nigeria and beyond.Join us as we advance the development of health care management around the globe.

Mentorship in health care leadership

0

In health care, leadership positions are continually emerging. There is someone rising to a new position somewhere; at another place, someone is just being replaced, while some others have initiated leadership by creating a position that was previously not in existence, either by a new discovery or leadership simply initiated by knowledge. Though leaders are daily emerging, no one seems to be asking: who is mentoring these neophyte leaders?

Pharmanews Dudai workshop
Participants on a facility tour of the Medcare Hospital during the Health Care Financing and Innovation Workshop held in Dubai last year

Mentorship is principal in ensuring effective and continuous leadership in health care. No other system requires more precision and less error than health care; hence, the need for workers, even leaders, to seek mentorship. Sadly, mentoring in health care is not deliberately carried out, especially in most countries in Africa, where workers or new leaders are thrown in the wild to survive. In fact, there are only a few health mentorship programmes in Nigeria. Many health care organisations do not pay close attention to deliberate mentorship or other leadership development initiatives.

There are those who believe that a mentor-mentee relationship should occur naturally,rather than being a planned programme of action. As Byrne describes it, “mentorship though appears ubiquitous, yet elusive, not deliberately initiated but left to chance.”Developed countries like the United States of America have planned mentorship programmes. For example, the USACentre for Disease Control and Prevention sponsors a formal mentorship programme for Public health advisors – a strategy for developing new managers. So also does the American Dental Education Association (ADEA). Recognising the dearth of women in executive positions and serving as deans of dental schools, ADEA, in 1992, created a programme for women liaison officers (WLOs) appointed by dental school deans.The purpose of the programme was simple: to develop new women leaders.

According to Hawkins and Fontenot (2010), an important gift health leaders can give to their professions is to serve as mentors to those who will lead health care organisations and institutions into the next decades.

 

Requisite skills

Mentors in health care should possess certain qualities for effective mentorship. First, they should be highly cognisant of the professional landscape. They should not only be experienced, but should be fully aware of how the health system works – they should be abreast of long-standing structures and cultures.

Second, mentors should be visionary; they should have strategic insight into events that will later shape the climate of most circumstances in their chosen fields. They need this to provide direction for new leaders. In addition, mentors should be creative, risk-takers, inspirational and possess good communication skills.

Hawkins and Fontenot further add that mentors should be politically astute, sensitive to ebbs and flows of human life, and should possess self-knowledge.

Though these qualities are attractive,the style employed by a mentor can affect the quality of leadership he provides for a mentee in health care.

 

Relevant styles

There are different styles of mentorship adopted by mentors.Mentors’ styles are as varied as the persons who choose careers as health professionals.

According to Hawkins and Fontenot, some mentors appear to have a philosophy of mentoring that one can best characterise as trial by fire or critical, and others appear to have more nurturing styles. Both styles can either be effective or a hindrance for a mentee. The key is to discover the right match between mentor and mentee that will be beneficial to both parties.

Mentors who are toxic can do more harm than good for their mentees. They (Hawkins and Fontenot) quoted Darling (1985) as saying there are four categories of toxic mentors: avoiders who are seldom, if ever available and impossible to reach; dumpers, who believe in the sink or swim approach to surviving as professionals; blockers, who either micromanage or withhold information; and destroyers whose goal seems to be to undermine anything and everything the mentee proposes.

The trial-by-fire mentors may bombard their mentees with criticisms of their work in the extreme. The underlying philosophy appears to be that such hazing will toughen the mentees up for the real world of academia or clinical practice or whatever the field and role for which the mentee is preparing.

The nurturing style of mentoring is one in which the mentor assumes more of a parental role, creating a safe, open environment that allows the mentee to both learn and try new ideas and methods by himself. It is a more participatory style of leadership.

 

Rational strategies

Mentorship can be done in two forms. Byrne (1991), as quoted by Ehrich (1999), says mentoring can be traditional or formal. Under the traditional mentoring system, mentors employ their personal resources to assist their mentees to develop their career. The senior member in the organisation initiates a relationship with young members who he recognises as having certain potentials that could be developed. In this case, the mentor chooses his mentee. This form of mentorship is left to happen naturally, and though it appears sentimental, some best mentor-mentee relationships have been produced by this “natural selection” process.

In the twilight of the twentieth century, Byrne notes, mentorship became formal. Under formal mentorship, raising new leaders is a systemic policy issue and a standard part of management practice. Most times, the effectiveness of the policy rests on the following factors: mentor’s commitment to the programme, mentor’s compatibility with mentees, and mentor’s competences in terms of technicality and interpersonal skills. This type of mentorship is not voluntary.

Additionally, there is the professional mentorship system. This form of mentorship is voluntary. It is a process which is promoted and encouraged by top leadership as part of mainstream staff development. Leaders are simply encouraged to mentor young managers.

 

Resultant success

Studies conducted among health care leaders proved that those who have mentors were more likely to succeed than those who were not on any form of mentorship programme. In other words, mentorship, no matter the form, provides the mentee, as well as the mentor, with immense benefits.

First, the mentee enjoys rapid career advancement. Mentoring helps mentees navigate through the career path because they are being guided by those who have been there. They also enjoy personal support in carrying out their duties as they work under the supervision of a mentor. Mentees in a mentorship programme have the chance of increasing in learning and personal development.The strong sense of being under supervision can also help to increase mentee’s confidence.

Second, those who volunteer to or participate in mentorship programmes enjoy personal fulfilment. Mentors in health care, as in other fields, derive a sense of satisfaction for providing guidance to emerging leaders. This state, psychologists say, is a major motivation for mentors’ participation in a training programme. Also, they getassistance on projects as neophyte leaders can serve as research fellows and help to manage projects.

Third, a well- planned mentorship programme can befinancially rewarding for the mentor. Health care organisation may pay those who get involved in a mentorship programme, as it requires extra work and effort to successfully guide emerging leaders. In the same vein, coaches enjoy increased confidence. Success recorded from a mentorship programme will spur mentors to adopt more protégés and re-vitalise their interest in work.In addition, there are immense benefits for organisations that organise a mentorship programme.

 

Result-oriented structures

As earlier discussed, health care organisations in Africa need to plan, prepare and adopt monthly or yearly mentorship programmes for staff members. These mentorship programmes can be organised in-house or outsourced to health care training providers.

However, there are factors that influence the success of mentoring programmes.First, is the availability of time for mentoring. This often constitutes a major setback in mentoring, as those who should mentor sometimes complain of being short of time. Mentoring leaders require time, attention and a close follow-up on the activities of the mentee. For effective mentoring to take place, senior health executives should be ready to give their time, which in most cases, is very limited.

Second, is the training of mentors. Mentorship can only be as effective as the skills and personality of the mentor. For effective mentoring to happen, mentors must be thoroughly and continuously trained to be able to succeed in both group and individual coaching. A good mentoring programme is designed to train mentors to communicate with rather than talking to the mentee, andto network with other mentors.

Third, matching mentors and mentees can be a challenge to effective mentoring. Issues such as ethnicity, gender, and religion can influence a mentorship process. A good mentorship programme is planned to discourage outright rejection of any mentee or overly sentimental displays by senior executives in the choice of those to mentor.

Other factors include overdependence of mentee on the mentor, possibility of sexual attraction and clash between mentors and chief executives.

Despite all these, organisations still benefit greatly from mentorship programmes in that they lead to the development of their staff. According to Hawkins and Fontenot, physicians, nurses, physical and occupational therapists, dieticians, veterinarians, dentists, pharmacists, psychologists, social workers, and other health professionals assume their first leadership positions often with some trepidation. With formal mentoring, however, the confidence of such personnel is bolstered.

Similarly, mentoring increases staff commitment to the organisation. By enrolling a staff for leadership training, the employee views his organisation as committed to his welfare, and will in turn give away heartily his loyalty. Leadership programmes for mentors and mentees are cost effective, especially, on the long run. A lot is saved by encouraging mentorship among senior executives. Neophyte leaders, entrepreneurs and managers need to embrace mentorship programmes.

 

Recap/summary

In order for organisations to stay ahead in health care, there should be a constant improvement in leadership. The Pharmanews Centre for Health Care Management Development, for over 20 years, has continued to provide relevant and qualitative leadership training for mentors, managers and emerging leaders in the health care system. It is Nigeria’s leading healthcare platform for developing and networking health care leaders. Our leadership development programmes run for different months in the year, each designed to meet specific leadership and management objectives.

We believe that a more effective health care system is possible with a deliberate and well-planned programme of action for emerging leaders in the Nigerian health care industry. Attention needs to be paid to effective leadership through the discourse and implementation of pragmatic leadership models. Our trainings are not just events but well thought-out campaigns designed to initiate change in participating organisations and the health care industry.

We sustain a strong trainer-trainee network as well as promote open channels for mentor-mentee relationships. You can send nominations for any of our 2015 health leadership workshops, starting with the Health Care Entrepreneurship Workshop,scheduled for 24–25 March in Lagos.

Stay on this page, as we begin, from the next edition, a panorama of distinguished leaders in the Nigerian health care Industry.

 

References

Hawkins J. and Fontenot,H. Mentorship: The heart and Soul of health care Leadership. Journal of Healthcare Leadership. 2010: (2) 31-34

Naicker, I.; Chikoko, V. and Mthyiance, S. Does Mentorship Add Value to In-Service Leadership Development for School Principals? Evidence from South Africa.Anthropologist 2014, 17(2) 421-431

Ehrrich, L. Mentoring: Pros and Cons for HRM. Asian Pacific Journal of Human Resources. 1999: 37 (3) 92-107

Colgate Palmolive launches MCP toothpaste

4

In its efforts to combat dental cavity and enhance oral health in the country, Colgate Palmolive Nigeria has introduced new toothpaste, Colgate Maximum Cavity Protection (MCP), produced with Pro-Argin Technology, a new anti-cavity technology.

The new toothpaste, which is also a sugar acid neutraliser, was recently presented to dental care professionals at the Sheraton Hotels and Towers, Lagos.

Colgate
L-R: Dr(Mrs) Bimpe Adebiyi, head, dentistry, Federal Ministry of Health (FMOH) and Mrs Hannah Oyebanjo, marketing director, Colgate Palmolive Nigeria during the event.

In its efforts to combat dental cavity and enhance oral health in the country, Colgate Palmolive Nigeria has introduced new toothpaste, Colgate Maximum Cavity Protection (MCP), produced with Pro-Argin Technology, a new anti-cavity technology.

The new toothpaste, which is also a sugar acid neutraliser, was recently presented to dental care professionals at the Sheraton Hotels and Towers, Lagos.

Speaking at the event, Dr Olabode Ijarogbe, president, Nigeria Dental Association (NDA), commended Colgate Palmolive for first introducing the product to dental care professionals before releasing it to the general public. He noted that what the company was introducing to the experts was revolutionary for oral health care.

Dr (Mrs) Bimpe Adebiyi, head, dentistry, Federal Ministry of Health, in her remarks, also commended the company’s initiative, noting that the successful convergence of NDA and other dental care professionals was a proof that the oral health community in Nigeria was united.

In her welcome address, Mrs Hannah Oyebanjo, marketing director, Colgate Palmolive Nigeria, said that the company had a lot of initiative for the country, adding that the introduction of Colgate MCP was just one of such.

Presenting the new product to the professionals at the event, Dr Ogechukwu Mac-Johnson, oral consultant, Colgate Palmolive Nigeria, said Colgate MCP was the first and only family toothpaste with a unique sugar acid neutraliser technology and fluoride.

She said the company was introducing the best cavity-protection toothpaste to the professionals, adding that research had shown that the product was so advanced that it decreased early decay by half.

Fluoride, she added, does not neutralise sugar or prevent cavity, unlike Colgate MCP, which is the future of cavity protection and would make things easy for the dentists.

Colgate MCP, Dr Mac-Johnson said, neutralises acids before they can harm the teeth, strengthens enamel with fluoride and calcium to prevent cavities from forming, decreases early teeth decay by half and reduces new cavity formation by 20 per cent.

 

The Living Sacrifice

0

My friend, Ralph, drove some miles to my area of residence in Lagos one Saturday morning, some years ago. He was invited to the wedding ceremony of his nephew and was to serve as the chairman of the wedding reception after the church programme. Ralph drove round, looking for the church but could not locate it. Therefore, he decided to stop over at my house to help him locate the church. I was glad to see him but was not sure of the particular church he was looking for because there were many small churches in the area. I took him to one I suspected to be his target. However, on getting there, there was no life in the premises. The building was not impressive and the entire compound was deserted and unkempt that Saturday morning. Ralph looked around with disappointment and impulsively uttered, “Ifeanyi, let’s leave this place. God cannot be in this kind of place.”
Obviously, Ralph’s understanding was that God would only reside in well-built and attractive churches and would be uncomfortable in poorly maintained and dirty ones. He is not alone in this thinking. Some people still believe that the church is where God lives and you need to go there to meet Him. This is the reason we invest heavily on churches to make them habitable for God and provide conducive environment for the worshippers.
The truth is that, historically, God has always sought to dwell with His people. In the Garden of Eden, He had fellowship with Adam. After Israel left Egypt, He instructed them to build a portable tabernacle where His presence would dwell. In the land of Canaan, God dwelt with His people in the Ark of Covenant. The temple was built in Jerusalem under King Solomon.
However, the coming of Jesus Christ has changed this situation. God now dwells in us and not in buildings made by man. His children and not structures are now the temples or sanctuaries or churches. This truth can only be revealed to us by the Holy Spirit.
There are inherent responsibilities in God taking up His residency in us. God is holy and perfect, and, therefore, His presence demands a particular atmosphere in which to dwell. The totality of our being is to be presented as living sacrifices, holy and pleasing to God (Romans 12:1).
Romans 6:12-13 says, “Let not sin therefore reign in your mortal body, that ye should obey it in the lusts thereof. Neither yield ye your members as instruments of unrighteousness unto sin: but yield yourselves unto God, as those that are alive from the dead, and your members as instruments of righteousness unto God.” Our total being is for serving God. Our hands, eyes, feet, lips, mind and so on are for the service of God. The tragedy is that some people use these organs to work against Him and serve the devil. Being temples of God demands that we guard ourselves against the defilement of the world.
We are temples of God because when Christ saved us, He purchased us as a dwelling place. 1 Corinthians 6:19-20 says, “What? know ye not that your body is the temple of the Holy Ghost which is in you, which ye have of God, and ye are not your own? For ye are bought with a price: therefore glorify God in your body, and in your spirit, which are God’s.” This implies that we have lost the ownership of our bodies. We are merely stewards or caretakers of the dwelling-place of God.
It is indeed a great honour and privilege to be a dwelling place of God. I met one colleague during a conference I attended in Finland some years ago. He was the President of a large pharmaceutical company and he invited me for a tour of his facility. The report was published in Pharmanews. We exchanged phone calls a few times and then stopped. Surprisingly, he phoned me last year to inform me that he was visiting Nigeria for a few days and would like to spend the first one night with my family and then check into a hotel to receive his business associates. He told me to ask my wife to prepare local dishes for him to enjoy. As soon I got this message we started cleaning every part of our house and planning for the type of food to serve him. We purchased some fresh local fruits and also invited two family friends for dinner with our guest. We did all these because he was actually honouring us by spending one night with us.
Now I compare the visit of my friend with God coming to reside in our body. The body must be made ready, fit and pleasing to Him. This implies that we must keep the body clean. The type of clothes we put on the body matters to God. What we eat and drink is important to Him. The exercise we give to the body, the sleep we have, the medicines we take and the general care we give to the body are all important to God, who is the owner of the body.

Prof. Okogun tasks scientists on drug production from plant extracts

0

Emeritus professor of Chemistry, Joseph I. Okogun, has said that for Nigeria’s indigenous herbals to be fully harnessed for the improvement of health care delivery, production of drugs from active principles is no longer an option but a necessity.

HERBALS
Okogun, who spoke extensively during the public lecture organised by the Nigerian Academy of Science (NAS), held at the Nigerian Institute of Medical Research, Yaba, on 28 January, 2015, called on all scientists, including biologists, chemists, pharmacologists and clinicians in the country to form a formidable team for the formulation of drugs from active principles on a large scale.
Speaking on the topic, “Drug Production Efforts in Nigeria 2: Anti-Cancer Remedies Emerge through Herbs, Chemistry and Biology”, the erudite don asserted that a smooth collaboration could enhance the development of some natural drugs as well as their formulation into prescribed drugs, with the use of the country’s plant extracts.
Okogu chided Nigerian scientists for their negative behaviour towards the efforts of herbal practitioners in the country, noting that such actions would not lead to the development of the health care sector.
He said it was high time researchers supported traditional practice by assisting in standardising the practice through clinical trials and other activities that would promote indigenous plants resources.
Analysing the manufacturing capabilities of the country, the renowned scholar said the country had, among other things, availability of human resources; presence of active principle isolation in over 99 per cent purity; extensive documentation by FDA and NAFDAC; as well as intellectual property protection and maintenance, which make the formulation of local herbal drugs a huge possibility.
He explained further that local manufacturers would be doing themselves and the nation a great disservice, if they persist in importing active principles, rather than utilising local medicinal plants, which can play better roles in the body chemistry of the populace.
Citing the example of a medicinal plant in Nigeria called gedunin, as published in Research Gate with the title: “An unprecedented gedunin rearrangement reaction converts a methyl group into the methylene group of a cyclopropyl ring”, he said the plant has several medicinal and commercial values, as indicated by the publication.
“Some of the activities of gedunin, when tested in the laboratory showed the following medicinal activities: anti-ovarian cancer, anti-colon cancer, anti-malaria, anti-allergy, and insecticides”, he listed.
In his own remarks at the event, Prof. Oyewale Tomori, President of the Nigerian Academy of Science, urged the federal government to give science the priority it deserves in the country. He said there was need to fund and develop drug researches, to reduce the burden of diseases and save many Nigerians.
“With the significant changes taking place in the country, science has not fared well, even with all the steps taken,” he observed. “The federal government should invest in basic science and drug researches to support the growth of the drug industry and other manufacturing industries. This initiative will encourage indigenous drug makers to take bold, strategic steps in local drug production and, in effect, spur the growth of the industry in Nigeria,”
President of the National Association of Nigeria Traditional Medicine Practitioners (NANTMP) Chief Omon Oleabhiele, also contributed by making a comparison between China and Nigeria, stating that if the Chinese could succeed on their native medicine of Acupuncture, which was initially kicked against by the World Health Organisation, then Nigerian scientists were inexcusable for not harnessing their local herbs for the development of drugs for their citizens.
He further mentioned that if government could allow traditional doctors to record the experiences of patients who were successfully treated with native herbs and became well, it would serve as a good platform for clinical trials, a development that would accord local traditional medicines global recognition.

Fever has benefits, says medical expert

3

….. as GSK unveils Panadol Suspension, Scott’s Emulsion for kids

In an apparent bid to quell the fears often associated with fever, a consultant neonatologist has hinted that the health challenge is not as serious as many believe.

L-R: Dr Dorothy Esangbedo, president, Union of National African Paediatric Societies and Associations (UNAPSA); Prof. Oluyinka Ogundipe (retired), formerly in charge of paediatrics and child health in Lagos University Teaching Hospital (LUTH); Kerry Alexander, marketing director, GlaxoSmithKline (Consumer) and Dr Bode Adesoji, GSK’s medical director for Anglophone West Africa, during the unveiling of two brands Panadol Suspension and Scotts’ Emulsion, at Oriental Hotel, Victoria Island, Lagos, on 15 January
L-R: Dr Dorothy Esangbedo, president, Union of National African Paediatric Societies and Associations (UNAPSA); Prof. Oluyinka Ogundipe (retired), formerly in charge of paediatrics and child health in Lagos University Teaching Hospital (LUTH); Kerry Alexander, marketing director, GlaxoSmithKline (Consumer) and Dr Bode Adesoji, GSK’s medical director for Anglophone West Africa, during the unveiling of two brands Panadol Suspension and Scotts’ Emulsion, at Oriental Hotel, Victoria Island, Lagos, on 15 January

Addressing participants during GlaxoSmithKline (Consumer) Nigeria Plc’s launch of two new brands – Scott’s Emulsion Cod Liver Oil and Panadol Suspension for Children, which took place at Oriental Hotel, Victoria Island, Lagos on 15 January, 2015, Dr (Mrs) Mariya Mukhtar-Yola, a consultant neonatologist with the National Hospital, Abuja, said there was no universal definition for fever.
She added, in her presentation on “Management of Pain and Fever in Children,” that unlike what many people think, fever is a neurochemical response common to many animals.
“If this definition appears complex, perhaps, we should take that of English physician, Thomas Sydenham which states that ‘fever is nature’s engine which she brings into the field to remove her enemy.’ Isn’t it funny to note that, until recently, I never knew that even cats develop fever?” she quipped.
While attributing the major causes of fever to infection, vaccines, biologic agents, trauma, rheumatic disorder and genetic disorder, Mukhtar Yola disclosed that it was also pertinent to consider its benefits.
“For those who don’t know, fever has its own merits in the sense that it plays a protective role on the immune system, inhibits growth and replication of micro-organisms, and aids in acute body reaction,” she said.
Buttressing Mukhtar-Yola’s claims, Dr Yinka Osho, GlaxoSmithKline’s expert detailing manager, remarked that this is one area Panadol suspension (for children) is different.
“Panadol suspension provides fast and effective relief from pain and fever. It is also gentle on tiny tummies, easier to administer and has a pleasant strawberry-flavoured taste,” he said.
While appreciating the efforts of the key speakers, Dr Bode Adesoji, GSK’s medical director (Anglophone West Africa), said the presentations bordered on three domains, namely pharmacovigilance, clinical research and medical information.
In terms of pharmacovigilance, Adesoji said that today GSK’s products are notable for their robust link to the concept.
“Also, when we talk about clinical research, GSK is ahead. We are different from the kind of people you meet in Molue (Lagos commercial shuttle) who sell all-in-one products (that cure diarrhea, headache, fever etc). Our brands come with quality you can trust.
“Finally, in the third domain where we have medical information and promotional practice. It might interest you to know that GSK has moved from the old practice of paying speakers to participate in our programmes. As part of our transparency policy, we believe that once you have something genuine and important to present to the public, the speakers will willingly agree to participate,” he stressed.
Speaking on Scott’s Emulsion Cod Liver Oil, D. Chikara Nwoke, another GSK’s expert detailing manager said that the product was a brainchild of Scott and Bowne Company, established in 1876 in New York City.
Labelled as “Scott’s Emulsion Cod Liver Oil,” it is said to be rich in cod liver oil, which is a natural source of Omega-3 Vitamin A & D, calcium and phosphorus. It is also said to help children to build their natural body resistance to infections like coughs and colds and develop strong bones and teeth during their growing years.
Nwoke described the product as a brand trusted by mothers for generations to help protect their children from coughs and colds, so that they will grow strong and healthy.
The products’ unveiling had several pediatricians, pharmacists, physicians, neonatologists and nurses in attendance. Notable among them were Prof. Olowu Adebiyi, president, Paediatric Association of Nigeria (PAN); Pharm. Olumide Akintayo, president, Pharmaceutical Society of Nigeria (PSN), Pharm. Ismail Adebayo, chairman, Association of Community Pharmacists of Nigeria (ACPN) and T. S. Dayanand, managing director, GlaxoSmithKline (Consumer).
Others were Dr Dorothy Esangbedo, president, Union of National African Paediatric Societies and Associations (UNAPSA); Prof. Oluyinka Ogundipe (retired), formerly in charge of paediatrics and child health in Lagos University Teaching Hospital (LUTH); Dr Olufemi Dosunmu, managing director, Bomi Clinics, Sango-Ota; and Kerry Alexander, marketing director, GlaxoSmithKline (Consumer).

Dons, pharmacists mourn Prof. Sofowora

1

UntitledDistinguished pharmacist, scholar and researcher, Prof. Abayomi Sofowora, former Chairman of WHO Regional Expert Committee on Traditional Medicine is dead.

Sofowora died on 22 January, 2015 after a brief illness. Prior to his death, the erudite pharmacist had lectured Pharmacognosy for over 45 years. He spent 40 year in the Department of Pharmacognosy, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife (October 1967–December 2007). He was head of the Drug Research Unit; Head of Department of Pharmacognosy and dean of the Faculty of Pharmacy. He also served as consultant to WHO, OAU (now AU), UNDP, UNIDO, ADB, ECA and TCDC.

From February 2010 to January 2013, Sofowora was visiting professor to the University of Maiduguri. He spent another two years as adjunct professor in the Department of Pharmacognosy, Delta State University, Abraka.

Speaking on his passing, Prof. Fola Tayo, pro-chancellor, Caleb University described the late don as a luminary and great teacher of Pharmacognosy.

“He came back very active after his training at University of Nottingham. Sofowora was a frontliner in the 1970s. In Ife (OAU), he remained committed and trained quite a number of students,” Prof. Tayo said, adding that, “Sofowora represented so many things – from Fagara project to his mark in sickle cell treatment.”

Prof. Paul Akubue, retired vice chancellor of Madonna University, Port Harcourt, Anambra State told Pharmanews that the news came to him as a shock.

“Honestly, I am still in shock. He was such an active researcher, very much involved in traditional research. Even though I wouldn’t be able to say much about him, I can tell you that we were contemporaries and travelled together on a couple of occasions. This is quite painful!” he lamented.

In his own remarks, Pharm. (Sir) Ifeanyi Atueyi, publisher of Pharmanews, described the death of the celebrated don as a great loss to the pharmacy profession and the entire academic community.

“Professor Sofowora devoted his life to academic pursuit and fully served at the Obafemi Awolowo University, Ile-Ife,” Atueyi said.”The inauguration of the Nigeria Academy of Pharmacy last year offered him the opportunity to share his wealth of experience on academies and constitutional issues. His exit reminds us that death is the lot of mortals and all we need to do is live right while there is life and fulfill our destiny.”

Also commenting on the sad event, veteran pharmacist and Fellow of the Nigeria Academy of Pharmacy, Pharm. Godfrey Obiaga, noted that Sofowora would be greatly missed by the scientific community and the nation as a whole.

“He was a great teacher. Many students of Pharmacy passed through him, one way or the other. He will be greatly missed, but we cannot question God,” he stated.

While praying for the family of the deceased for consolation and fortitude, Obiaga equally challenged fellow pharmacists to sustain the legacies of the departed icon.

“Pharmacists must honour him greatly and do what we can to build upon what this great pharmacist started,” Obiaga enthused.

As reward for his selfless service to pharma research and the community at large, he was honoured with special recognitions, including Fellow of the Nigeria Academy of Pharmacy (FNAP), Fellow of the Pharmaceutical Society of Nigeria (FPSN), Fellow of the West African College of Pharmacy, Great Achievers Award of Obafemi Awolowo University, Fellow of the Nigerian Society of Pharmacognosy (FNSP) and an award by the Sickle Cell Association of Nigeria, Ibadan.Untitled

ACPN cautions against self-medication during strikes

0

In view of the unending strike actions in the health sector, the Association of Community Pharmacists of Nigeria (ACPN) has urged members of the public not to resort to self-medication and arbitrary consumption of local herbs.

L-R: Pharm. Christy Ediomo, ACPN national treasurer; and Pharm. (Alhaji) Ismail Adebayo, ACPN chairman at a recent event
L-R: Pharm. Christy Ediomo, ACPN national treasurer; and Pharm. (Alhaji) Ismail Adebayo, ACPN chairman at a recent event.

Speaking exclusively with Pharmanews, ACPN chairman, Pharm. (Alhaji) Ismail Adebayo, explained that the association was fully aware of the sufferings experienced by patients and their loved ones during industrial actions such as the recently suspended strikes by the Joint Health Sector Union (JOHESU) and the Nigerian Medical Association (NMA).

“Whenever we have issues like this, you discover that patients will always seek alternatives. Some are forced to visit hospitals and that can be very expensive. Secondly, the quality of the service, especially when it comes to pharmaceutical care, will be poor”, Adebayo said.

“Besides we know that most private hospitals don’t even have pharmacists. And by virtue of that, it is going to affect the quality of health care delivery that will be given to the citizens,” he added.

The ACPN chairman however noted that the most worrisome fallout of health workers’ strikes is the number of people who resort to self-medication, which could be dangerous for them.

“As the national chairman of ACPN, what we preach when we see patients is proper enlightenment and education on what to do. But how many of them can afford even the consultation fees that private hospitals charge? Consequently, they may resort to self-medication. What can we do? One thing is for pharmacists to give advice, another thing is for people to take to it,” he remarked.

According to Adebayo, self-medication is not limited to those who use local herbs, but also those using cheap and substandard medicines because they cannot afford to visit private hospitals or pharmacies during strikes.

“Of course, we know how much it takes to treat ordinary malaria in this country. By virtue of this, I will implore the government to look at this matter holistically,” Adebayo urged.

It would be recalled that the Nigerian Medical Association (NMA), after several dialogues with the federal government, was compelled to call off its 55 days strike on 25 August, 2014. According to a communiqué released to announce the Call-off, the decision was based on current challenges in the country.

Similarly, the Joint Health Sector Union (JOHESU), embarked on strike on 12 November, 2014 over non-implementation of the agreement entered into by the government, which bordered mainly on issues of improved welfare for health workers. The strike was eventually suspended on 2 February 2015. This was sequel to a meeting between President Goodluck Jonathan and JOHESU during which salient issues regarding the grievances of the union were discussed.

5,000 underage girls give birth Everyday- UN reports

1

pregnant-girls

February 12 of every year is set aside as world sexual and reproductive health day, when nations and organizations discuss issues on teenage pregnancy, and enlighten both parents and teenagers why they should shun the habit.

According to a director at the United Nations Population Fund (UNFPA) Werner Haug, “some 7.3 million teen women give birth every year. 2 million of these are under 15 years of age, and every day, roughly 5,000 girls give birth. Yearly, 70 million young women lose their lives during pregnancy and childbirth”.

In his report,Motherhood in Childhood, released two years back, he said it shows that adolescent pregnancy perpetuates poverty and hampers development in poor countries.

He further noted that adolescent pregnancy is related to a “whole string of human rights violations” and so it must gain more attention in global development policy.

 

 

How daily consumption of coffee reduces cancer risk from the National Cancer Institute.

2

Cup-with-full-of-coffeeHere’s one more reason to feel good rather than guilty about your near-religious java habit: Drinking coffee may lower your risk for melanoma, the deadliest form of skin cancer, suggests new research from the National Cancer Institute.

For 10 years, researchers tracked the coffee-drinking habits and skin cancer rates of nearly 450,000 adults over age 50. After adjusting for factors like UV exposure, age, BMI, physical activity, smoking history, and alcohol intake, they found that coffee drinkers were less likely to be diagnosed with malignant melanoma than coffee skippers. In fact, those who drank four cups of caffeinated coffee per day had a 20% lower risk of skin cancer. Decaf didn’t offer any significant benefit.

What’s the connection? Previous studies show that the morning mud is loaded with compounds like caffeine and polyphenols that appear to suppress UV-induced tumor growth. The bean roasting process, too, spurs the formation of B vitamins that might offer another layer of protection against tumor formation, researchers say.

Still, all that caffeine can come with a cost. Guzzling more than 400 mg of the stimulant can lead to anxiety, restlessness, irritability, headaches, and more. Too much caffeine can also amp up your body’s production of the stress hormone cortisol, which can lead to weight gain (especially around your middle), digestive issues, and even heart disease.

Since an eight-ounce cup of coffee can pack anywhere from 95 to 200 mg of the stuff, it’s smart to stick with just one or two cups per day, says Jacqui Justice, MS, CNS, nutrition director at New York Health & Wellness Center. Drink 12 ounces of water before and after each cup, to counteract caffeine’s dehydrating effects, she says. Once you’ve hit your limit, switch to green tea: A serving maxes out at 45 mg caffeine, and is packed with some of the same skin-saving antioxidants as coffee. Plus, studies show that three cups of green tea a day can increase your metabolism and lead to weight loss.

prevention.com

 

 

 

 

 

Job vacancy for Operations Manager

0

Pharmanews Limited requires the services of an Operations Manager.

Job Title: Operations Manager
Location: Lagos

Job Description

  • Coordinate, manage and monitor the workings of various departments
  • Design training programmes and manage training workshops
  • Prepare and control operational budgets; plan effective strategies for the financial wellbeing of the company
  • Develop operation policies and ensure their adequate execution
  • Plan and support sales and marketing activities
  • Assist in the development of strategic plans for operational activity

 Qualifications

  • Minimum of Bachelors in Pharmaceutical Sciences.
  • A post graduate qualification would be an advantage.
  • Excellent written and verbal communication skills, including technical writing skills.
  • Understanding of business processes.
  • Computer literacy
  • Managerial experience
  • Age: 25-40 yearsRemuneration: Attractive

    Application Closing Date: 27th February, 2015
    Method of Application
    Interested candidates should send their CVs and application letters to: jobs@pharmanewsonline.com by Friday 27th February, 2015

    Only shortlisted candidates will be contacted.

Pharmanews Workshop on HEALTH CARE ENTREPRENEURSHIP

3

          A capacity development workshop that inspires and equips health professionals for efficient and productive service delivery is essential in achieving sustainable outcomes. For 21 years now, Pharmanews Ltd has offered training and consult ancy services to health care personnel in Nigeria. The company is accredited by the Centre for Management Development (CMD) as a management training institution. Our programmes have benefited pharmacists, doctors, nurses, medical laboratory technicians, pharmacy technicians, distribution managers, store officers, and other health care practitioners.

We do request that you nominate/participate in the upcoming training workshop for the course below.

COURSE:         HEALTH CARE ENTREPRENEURSHIP

Date:                 Tuesday 24 – Wednesday 25 March, 2015

Time:                 9:00am – 4:00pm

Venue:            Pharmanews Training Centre, 8, Akinwunmi Street, Mende, Maryland, Lagos

Target Participants: Health care entrepreneurs, community pharmacists, doctors, managers and executives of NGOs and HMOs.

Course Contents:

  • Elements of Business Plan Development
  • Business Financing and Cash Management
  • Elements of the Emerging Wellness Industry
  • Essentials of Health Care Marketing
  • Leading Effective Organizational Development Strategies
  • Comparative Study of Global Health Care Entrepreneurship Models

Course Objectives:

At the end of the workshop, participants will be able to:

  • Understand the processes and considerations involved in developing a viable business plan for a health care organisation.
  • Identify and apply strategies for achieving effective business financing and cash management.
  • Understand the emerging wellness industry and position their organisation for optimum contribution and profitability.
  • Understand the elements of health care marketing, ethical issues in health care entrepreneurship and modalities for an effective marketing drive.
  • Develop the necessary skill-set and attitude required to lead an effective organisational renewal and development strategy.
  • Learn global best-case models for driving health care entrepreneurship ventures.

Registration:

Registration fee is N50, 000 per participant before 24/02/2015 and N55, 000 after 24/02/2015. On-site registration of N55, 000 could also be made at the workshop venue.

Registration fee covers tea break, lunch, workshop materials and certificates ONLY.

Group discounts: 3 – 5 participants: 10%,   6 and above participants: 15%

 Cancellation: For cancellation of registration fee, 90% of the fee will be refunded, if cancelled at least seven (7) days to the workshop and this information communicated to us by sms or email, using: info@pharmanewsonline.com. There will be no refund if cancelled thereafter.

Method of Payment:

Participants should pay into Pharmanews Ltd account in Zenith Bank Plc (A/c No. 1010701673) or Access Bank Plc (A/c No. 0035976695) and send their full names and bank deposit slip numbers by sms or email to Pharmanews Ltd.

For further information, please contact:

Cyril Mbata                                –  +234 706 812 9728

Nelson Okwonna                         –  +234 803 956 9184

Ernest Salami                           –   +234 703 986 8837

Elizabeth Amuneke                     –   +234 805 723 5128

 

Herbals and pharmaceuticals are complementary – Prof. Iwu

1

Chairman of Bioresources Development Group (BDG), Professor Maurice Iwu, has stated that integration of scientific components to empirical information, as well as initiating motivation for herbal practitioners, is key to bridging the gap between the development of local herbs and pharmaceuticals.

herbals - prof Iwu
L-R: Prof. Elijah Sokomba, commissioner, Federal Character Commission; Prof. Maurice Iwu, chairman, Bioresources Development Group (BDG); and His Royal Highness, Chief, Prof. T.O. Omon Oleabhiele, president of the National Association of Nigerian Traditional Medicine Practitioners (NANTMP) at the occasion.

Iwu, who co-hosted HerbFEST 2014, a conference on herbs, health foods and natural products in Lagos, noted that there were two different industries in the production of herbal medicines, the local herbal industry and the phytomedicine industry. He assured that the problem of authentication and standardisation was being resolved by NAFDAC, urging practitioners to submit their products for verification in due time, as some approved natural products were already in the market.

He however decried the non-availability of Level 4 Biosafety Laboratory in the country, saying this had caused a whole lot of setbacks for researchers in the country, as they had to travel abroad to access the facility for research purposes.

“We can fight diseases with natural plants, but the challenge is that we don’t have Level 4 Biosafety Laboratory in the country and that is a critical factor, because there are leads but no laboratories; the work being done is done with foreign laboratories system.”

The optimistic BDG’s boss however mentioned that plans were on the way to develop a local biosafety laboratory. He said the researchers would, in the meantime, continue to collaborate with nations who have the laboratories for the job, stressing that the development of a Level 4 Biosafety Laboratory will be in the near future.

Also speaking at the occasion, the Minister of Science and Technology, Dr Abdul Bulama called on researchers, entrepreneurs, traditional medicine practitioners, and other stakeholders in the health sector to intensify efforts towards promoting and improving indigenous bioresources, natural medicine knowledge, natural products resources ,as well as initiating means of connecting these resources to the wellbeing of the citizens.

Speaking on the theme of the workshop, “Herbs, Health Foods, Herbal and Natural Products: Shifting the Boundaries of Health Care”, Dr Bukama said it was very relevant at such a time as this, when the government is aiming at using all available resources of the nation to improve on the welfare of citizens.

He described HerbFEST as a laudable initiative which had potentials to promote the production of healthy indigenous foods and herbal therapies that would assist in addressing local and global food nutrition and health challenges, encourage sustainable utilisation of local biological resources, facilitate conservation of local environment, and assist in job and wealth creation to the nation through industrial expansion, commerce, science, technology and innovation.

Bulama, who was represented by Dr Menesa Gwoza, noted that Nigeria possesses about 40 per cent of medicinal plants. He assured that the Federal Ministry of Science and Technology would continue to provide a credible platform for the development of indigenous natural resources, as well as support innovative research to assist in developing herbal resources research and development outputs, which would ultimately contribute to job and wealth creation and also improve the lives of the people.

In his own contribution, Director General of NNMDA, Dr T.F. Okujagu, who is a co-host of the event, said the overall goal of HerbFEST was to showcase the rich biodiversity and investment opportunities of Nigeria and the West African sub-region to the world. He added that the event would equally enhance the patronage/recognition, productive capacity and income status of small producers of herbal and other natural products through a combination of market promotion, enterprise development, scientific session and training, and simultaneously promote trade and investment in the bio-business sector.

Okujagu further emphasised the uniqeness of HerbFEST 2014, stating that it was targeted at bridging the health gaps created by inefficient use of natural products, showcasing research and products used from nutrition to health and promoting the activities of traditional practitioners and community health workers. He said the event was also to stimulate investment in the herbal and natural products field and contribute to transforming the country by improving health care delivery, creating jobs, wealth and contributing to national socio-economic growth and development.

In her own contribution, Pharm. Ngozi James, executive director (BRG), noted that HerbFEST represents healthy and holistic medicine. “This acts as a platform to showcase the herbal products and orthodox medicine, bringing them together under one umbrella, bridging the gap between the two is our goal”, she stated.

Pharm. James further explained that gone were the days when people went about with the mentality that natural medicines were fetish and related to the occult.

“Most of the natural products are from natural plants. Enough of importing embarrassing products from China and India. We can develop our own natural plants. We are blessed and our bio-resources are enormous. It’s time to harness our biodiversities for the benefits of man. Showcasing what we have is enough to bring investors and encourage practitioners to do better”, she said.

Pharmaceutical events in 2014

0

 JANUARY

Pharmacy Plus Limited held its 2014 Annual National Sales Meeting at Solab Hotel & Suites, Ikeja, Lagos, on 24 January.

The Annual Distributors’ Reward Function of Ranbaxy Nigeria Limited was held at Amber Residence in Ikeja, Lagos, on 29 January.

 FEBRUARY

The National Executive Committee (NEC) and past presidents of the Pharmaceutical Society of Nigeria (PSN) paid a courtesy visit to recuperating Governor of Taraba State, Pharm. Danbaba Suntai on 11February

The Golden Jubilee anniversary of the Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, took place from 27 February to 2 March.

The loss of Pharm. Isaac William Osisiogu (Ogbuagu of Old Umuahia), a professor of Pharmacy at the University of Nigeria, Nsukka, and a Fellow of the Pharmaceutical Society of Nigeria (FPSN) was announced on 8 February. He was aged 84.

The management and staff of LASUTH held a befitting retirement party for Dr Femi Olugbile, former chief medical director of Lagos State University Teaching Hospital (LASUTH) and outgoing permanent secretary, ministry of health, Lagos State, at the Medical Research Centre Hall of LASUTH, Ikeja, Lagos, on 28 February.

MARCH

Dr Mu’azu Babangida Aliyu was conferred with an honorary Fellowship of the West African Postgraduate College of Pharmacists (WAPCP) at the college’s 26th Annual General Meeting (AGM)/Scientific Symposium and 56th Council Meeting, held in Accra, Ghana from 10 to 14 March.

Prince Julius Adelusi-Adeluyi was elected president of the Nigeria Academy of Pharmacy at the inaugural meeting of the academy, held at Sheraton Hotels and Towers, Ikeja, Lagos, on 20 March.

Fidson Healthcare Plc won Pharmaceutical Company of the Year 2013 award, at the Nigerian Healthcare Excellence Award (NHEA), which was organised at Eko Hotel and Suites, Victoria Island, Lagos, on 21 March.

Dr Patrick Lukulay, a Sierra Leonean author, officially launched his bestseller – “The Executive in You” – at the Muson Centre, Onikan, Lagos, on 27 March.

The Pharmaceutical Society of Nigeria (PSN), Lagos State branch, held its 2014 Annual General Meeting (AGM) at its Lagos office on 14 March.

 

APRIL

Swiss Pharma Nigeria Limited (Swipha) made history when the World Health Organisation (WHO) declared its manufacturing and laboratory facility as the first West African Pharmaceutical Company to be compliant with the WHO GMP on 2April.

The Pharmacists Council of Nigeria (PCN) inducted 39 graduands from Madonna University at the school conference hall on 11 April.

The 9thAfribaby Babycare and Mothercare Expo took place at the Lagos State University Teaching Hospital (LASUTH), Ikeja, Lagos on 15 April.

  •  The PSN announced the passing away of Pharm. Uford Inyang, former director general of National Institute for Pharmaceutical Research and Development (NIPRID) on 22 April.

The Nigerian Medical Association held its Annual General Conference/Delegates Meeting in Benin City, Edo State, from 27April to 4 May.

 Reckitt Benckiser announced the 50th anniversary of Dettol during the scientific session of the Nigerian Medical Association (NMA) in Benin, Edo State,held on 27 April to 4 May.

 

MAY

UNILAG Faculty of Pharmacy held its 1st annual alumni lecture and luncheon in honour of the 2012/2013 graduating students at the Old Great Hall of the Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, on 5May.

The 2014 annual luncheon of the Pharmaceutical Society of Nigeria (PSN), Lagos State branch, took place at the Sheraton Hotel & Towers, Ikeja, Lagos on 4 May.

UNILAG Faculty of Pharmacy inducts 141 graduates at the New Great Hall, University of Lagos, Idi Araba on 8May.

Dr Ahmed T. Mora, dean of the Faculty of Pharmaceutical Sciences, Kaduna State University has launched two new books on pharmacy practice – The Contributions of Students and Alumni Associations in Promoting Pharmacy Education and Practice in Nigeria&The Lizard Shape Model in Drug Distribution in Nigeria at an event held at Arewa House, Kaduna on 17 May.

A 3-day workshop on “Effective Leadership in Health Care Delivery” was organised for doctors, pharmacists, nurses and other clinical professionals by Pharmanews Limited at its Training Centre in Maryland, Lagos from 20 to 22May.

The management of Seagreen Pharmaceuticals announced the passing away of their managing director, Pharm. James Ibeh (aged 54 years), who died on 20 May, after a brief illness.

SKG Pharma Limited rewarded its trade partners for their loyalty, at a function held at the De-renaissance Hotel, Ikeja, Lagos, on 21May.

The Pharmacists Council of Nigeria (PCN) officially confirmed the appointment of Pharm. N.A.E. Mohammed as registrar of the Council,at its secretariat in Abuja on 28 May.

 

JUNE

The Association of Community Pharmacists of Nigeria (ACPN) hosted its 33rd Annual National Conference tagged “Harmony at Midland 2014” at the Cultural Centre in Ilorin, Kwara State from June 2 to 6.

Pharm. Kunle Amusan, a community pharmacist from Ibadan, Oyo State emerged winner of the maiden edition of the Ahmed Yakasai Community Pharmacy Practice Support Award held at the 33rd Annual ACPN National Conference in Ilorin, Kwara State on June 4.

 

The Association of Lady Pharmacists (ALPS) paid a condolence visit to Dr. Paul Orhii, Director General of the National Agency for Food and Drug Administration and Control (NAFDAC) over the death of his predecessor, Prof. (Mrs) Dora Nkem Akunyili, who died in an Indian hospital on 7 June.

 

Neimeth International Pharmaceuticals Plc launched Norduet, a new antihypertensive product at its head office in Ikeja, Lagos on 11June.

 

The 8th edition of the Annual Heart & Soul Gala organised by Chike Okoli Foundation was hosted at the City Hall, Lagos Island, on 14 June.

 

The two-day Nigeria-Pakistan Pharma Investment Forum (NIPIF 2014) took place at Eko Hotels & Suites, Victoria Island from 16 to 17June.

 

Biofem Pharmaceuticals Limited launched Biobetic, a new anti-diabetic drug during a three-day training programme for its marketing staff at the Lagos Chamber of Commerce and Industry (LCCI) building, Alausa, Ikeja, on June 16.

 

The official inauguration of the Nigeria Academy of Pharmacy (NAP) took place at the Sheraton Hotels and Towers, Ikeja, Lagos on 26 June.

 

JULY

UNILAG Faculty of Pharmacy introduces White Coat ceremony into its academic calendar at the Old Great Hall of the Lagos University Teaching Hospital (LUTH), on 2 July.

University of Ibadan Faculty of Pharmacy inducts 40 graduands at a ceremony held in the school’s lecture theatre, on 3 July.

Swiss Pharma Nigeria Limited (Swipha) launched five new over-the-counter (OTC) products during an event at Sheraton Hotel & Towers, Ikeja, Lagos on 10July.

A 6-day international workshop on ‘Healthcare Financing & Innovation’ for healthcare professionals was organised by Pharmanews Limited in Dubai, United Arab Emirates,from 19 to 26 July.

Pharm. Simon Okey Akpa, managing director, SKG Pharma Limited, was elected chairman of the Pharmaceutical Manufacturers Group of Manufacturers Association of Nigeria (PMG-MAN) during its Annual General Meeting on 23July.

 

AUGUST

The 1stAnnual Scientific Symposium of the National Association of Pharmacists in Academia (NAPA) held at the Lagos University Teaching Hospital, Idi-Araba, on 18August.

Sir Ifeanyi Atueyi and Pharm. Elijah Mohammed were honoured as Fellows of the Nigerian Institute of Management (NIM) in Lagos on 28August.

The International Pharmaceutical Federation (FIP) hosted its 2014 Annual Congress in Bangkok, Thailand in collaboration with the Pharmaceutical Association of Thailand under Royal Patronage (PAT) from 31 August – 4 September.

 

SEPTEMBER

May & Baker Nigeria Plc, a foremost pharmaceutical company marked its 70th anniversary at Muson Centre, Onikan, Lagos on 11September.

 

The 17th Annual National Conference of the Association of Industrial Pharmacists of Nigeria (NAIP) took place at Welcome Centre & Hotels, MurtalaMuhammed International Airport Road, Isolo, Lagos on 11September.

 

The new bus procured for the Inspectorate by the Pharmacists Council of Nigeria (PCN) was unveiled at the 17th Annual National Conference of the Association of Industrial Pharmacists of Nigeria (NAIP) which held at Welcome Centre & Hotels, Isolo, Lagos on 11September.

 

Pharm. Tony Akhimien, Pharm. Azubike Okwor and Dr. (Pharm) Edward Agulanna were awarded fellowship of the Nigerian Institute of Management (NIM) in Warri on 15 September.

 

The 8th Annual Scientific Conference and Exposition of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA), took place September from 18 – 21 in Orlando, Florida.

 

Sir (Pharm.) IfeanyiAtueyi, managing director of Pharmanews Limited was conferred with a Fellowship of the Professional Excellence Foundation of Nigeria (PEFON) at Hotel Victoria Palace on 27 September.

 

UNIBEN Faculty of Pharmacy wins the maiden edition of Sir IfeanyiAtueyi National Essay & Debate Competition which took place in the school’s conference hall on 24 September.

 

OCTOBER

The 2014 Faculty of Pharmaceutical Sciences Research Fair and Luncheon was held at the Juhel Auditorium of UNIZIK, Awka, Anambra State, on 9 October.

World Wide Commercial Ventures Limited (WWCVL) rewarded its 78 Partners for their unflinching commitment at a function at Intercontinental Hotel, Victoria Island, Lagos on 9 October.

The 2014 Annual Medic West Africa Exhibition held at the Eko Hotels, Lagosfrom October 15–17.

The Association of Community Pharmacists of Nigeria (ACPN) celebrated the 2014 Global Handwashing Day on 15 October at his National Office in Lagos.

May & Baker Nigeria Plc earned WHO GMP Certificate for its manufacturing facility in Ota, Ogun state on 13October.

As part of its Corporate Social Responsibility (CSR), Sanofi held training for officials of Ogun State Ministry of Health on “Advanced Care Clinical Leadership” from 21 to 22October.

Biofem Pharmaceuticals rewarded winners of its ‘Read to Lead’ promo at the company’s premises in Wemabod Estate, Ikeja, Lagos, on28October.

 

NOVEMBER

The 87th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) held in Uyo, AkwaIbom State, from 3 to 8 November.

Pharm (Mrs.) Margaret Obono, a Fellow of the Pharmaceutical Society of Nigeria (PSN) was announced winner of the 10th edition of the May & Baker professional service award in Pharmacy at the 87th PSN Conference in Uyo, Akwa Ibom State on 7 November.

The United States Pharmacopeia (USP)’s Centre for Pharmaceutical Advancement and Training (CePAT) honoured a former Director General of NAFDAC, Prof. Dora Akunyili (posthumously), and CEO of Emzor Pharmaceutical Industries Limited, Dr Stella Okoli on 8 November, at the Moevenpick Hotel, Accra, Ghana.

Mega LifeSciences Nigeria Limited launched prostacare for the treatment of mild to moderate BPH symptoms at the company’s Lagos office on 8 November

Sanofi, a leading multinational pharmaceutical company and Paediatric Association of Nigeria (PAN) held a media parley to mark 2014 World Pneumonia Day (WPD) at Protea Hotel, Ikeja, Lagos, on 12 November.

As part of activities to mark 2014 World Diabetes Day, Biofem Pharmaceuticals organised a two-day free health screening exercise for the residents of Wemabod Estate, Ikeja, Lagos on 14 November.

Pharm. Regina Ezenwa’s not-for-profit organisation, Rose Ministry celebrated its annual Widows Day Programme at National Population Commission (NPC) secretariat in Surulere, Lagos, on 27 November.

 

DECEMBER

A three-day workshop on ‘Clinical Leadership: Driving Service Improvement’ was organised for pharmacists, doctors and other health care personnel by Pharmanews Limited from 2 to 4December

Emzor Pharmaceuticals 2014 annual thanksgiving party took at the Muson Centre, Onikan, Lagos, on 6 December

  • HealthPlus Pharmacy held its 7th annual thanksgiving dinner and awards ceremony at Civic Centre, Victoria Island, Lagos on 15 December.

Managing rheumatism and arthritis

1

Osteoarthritis-kneeRheumatism” is derived from the Greek word “rheuma,” which means a swelling.

It refers to an acute or chronic illness, which is characterised by pain and swelling of the muscles, ligaments and tendons or of the joints. It is a crippling disease, which causes widespread invalidism, but seldom kills.

This disease affects men and women, both young and old. Quite often, it extends to the heart and the valves, and the lining of this vital organ becomes inflamed. It is the most common cause in 80 per cent of the cases of valvular organic diseases of the heart.

Rheumatism, perhaps, more than any other disease, although readily diagnosed, is never the same in any two individuals. There are too many variations in the development of the disease.

Broadly speaking, however, rheumatism, which may be acute or chronic, can be roughly grouped into two classes. These are: muscular rheumatism, which affects the muscles; and articular rheumatism, which affects the joints. The muscular variety is, however, far less common than that affecting the joints.

In the acute form, it is found among children and young people. But in the chronic form, it is generally confined to the adults.

 

Arthritis: Not a single disease

Arthritis literally means joint inflammation. Arthritis is not a single disease. Arthritis refers to a group of more than 100 rheumatic diseases and other conditions that can cause pain, stiffness and swelling in the joints.

Any part of your body can become inflamed or painful from arthritis. Some rheumatic conditions can result in debilitating, even life-threatening complications or may affect other parts of the body, including the muscles, bones, and internal organs.

The two most common types of arthritis are osteoarthritis and rheumatoid arthritis. The incidence of arthritis increases with age, but nearly three out of every five sufferers are under age 65.

If left undiagnosed and untreated, many types of arthritis can cause irreversible damage to the joints, bones, organs, and skin.

 

Osteoarthritis

Osteoarthritis, also known as degenerative joint disease, results from wear and tear. The pressure of gravity causes physical damage to the joints and surrounding tissues, leading to:

*    pain

*    tenderness

*    swelling

*    decreased function

 

Initially, osteoarthritis is non-inflammatory and its onset is subtle and gradual, usually involving one or only a few joints. The joints most often affected are the:

*    knees

*    hips

*    hands

*    spine

Risks of osteoarthritis increase with age. Other risk factors include joint trauma, obesity, and repetitive joint use.

 

Rheumatoid arthritis

Rheumatoid arthritis is an autoimmune disease that occurs when the body’s own immune system mistakenly attacks the synovium (cell lining inside the joint). Rheumatoid arthritis is a chronic, potentially disabling disease which causes:

*    joint pain

*    stiffness

*    swelling

*    loss of joint function

While the cause remains elusive, doctors suspect that genetic factors are important. Rheumatoid arthritis can be difficult to diagnose early because it can begin gradually with subtle symptoms.

 

Juvenile arthritis

Juvenile arthritis is a general term for all types of arthritis that occur in children. Juvenile rheumatoid arthritis is the most prevalent type of arthritis in children. There are three major types:

*    polyarticular (affecting many joints)

*    pauciarticular (pertaining to    only a few joints)

* systemic (affecting the entire    body)

Signs and symptoms of juvenile rheumatoid arthritis vary from child to child. No single test can conclusively establish a diagnosis. Juvenile arthritis must be present consistently for six or more consecutive weeks before a correct diagnosis can be made.

 

 

 

Psoriatic arthritis

Psoriatic arthritis is similar to rheumatoid arthritis. About five per cent of people with psoriasis, a chronic skin disease, also develop psoriatic arthritis. In psoriatic arthritis, there is inflammation of the joints and sometimes the spine.

 

Fibromyalgia

Fibromyalgia syndrome is a painful condition characterised by muscle pain, chronic fatigue and poor sleep. The name fibromyalgia means pain in the muscles, ligaments and tendons. Fibromyalgia is a type of soft tissue or muscular rheumatism and does not cause joint deformities.

 

Gout

Gout is a painful type of arthritis that causes sudden, severe attacks of pain, tenderness, redness, warmth, and swelling in the joints, especially the big toe. The pain and swelling associated with gout are caused by uric acid crystals that precipitate out of the blood and are deposited in the joint.

 

Pseudogout / CPPD

Pseudogout, which is also known as Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD), is caused by deposits of calcium phosphate crystals (not uric acid) in the joints. CPPD is often mistaken as gouty arthritis. Since CPPD is a different disease from gout, treatment is not the same as gout.

 

Scleroderma

Scleroderma is a disease of the body’s connective tissue that causes thickening and hardening of the skin. It can also affect the joints, blood vessels and internal organs.

 

Lupus / SLE

Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can involve the skin, kidneys, blood vessels, joints nervous system, heart and other internal organs.

Symptoms vary, but may include a skin rash, arthritis, fever, anaemia, fatigue, hair loss, mouth ulcers, and kidney problems. Symptoms usually first appear in women of childbearing age, but, can occur in children or older people. About 90 per cent of those affected are women.

Recognising signs and symptoms of arthritis

Because there are over 100 different types of arthritis, symptoms of the disease can be variable, but there are certain signs which point to the disease.

You might suspect you have arthritis if you have signs and symptoms which include the following:

*Persistent joint pain.

*    Pain or tenderness in a joint    which is aggravated by movement or to fill out a written questionnaire at your first appointment.

Be ready for your medical history by having a list of current medications, medication allergies, past and present medical conditions you are being treated for, and the name of your primary doctor and other specialists, along with their contact information.

Keep a symptom diary. A symptom diary can help you keep track of pertinent facts about your condition and also help you track changes that may occur. With the diary, you are more inclined to give your doctor a good overall picture of the symptoms you are experiencing.

 

Physical examination

Your doctor will perform a physical examination to try to see any visible signs and symptoms that point to arthritis:

  • Redness/warmth around a joint (inflammation)

*    Joint stiffness or tenderness

*    Joint fluid or swelling

*    Bumps or nodules

*    Pattern of affected joints (e.g. symmetric or asymmetric)

*    Limited range of motion

*    Fever

*    Fatigue

 

Laboratory tests

After a medical history and physical examination have been completed, your doctor will likely need more information. Blood tests can provide more specific information and often serve to confirm what the doctor suspects is the diagnosis. Blood tests are also used to monitor disease activity and treatment effectiveness after a diagnosis has been established.

 

Treatment of arthritis

An effective arthritis treatment regimen can help manage the disease. There are many treatment options which you should know about. Over time, you may try several different treatments and change your treatment plan. Finding the best treatment for you can be a long process.

 

Goals of arthritis treatment

The goals of arthritis treatment are to:

*    Decrease arthritis symptoms

*Slow progression of the disease

*    Prevent or minimise joint damage and deformities

*    Maintain joint function

*    Preserve mobility and range-  of-motion

People with early symptoms of arthritis are often inclined to self-treat with over-the-counter medications, topical creams, or conservative measures such as ice and heat. The Arthritis Foundation recommends seeing a doctor if you have joint pain, stiffness, or swelling which persists for two or more weeks, whether or not your symptoms began suddenly or gradually. Only a doctor can diagnose arthritis. An accurate diagnosis is needed so treatment can begin.

A rheumatologist (arthritis specialist) will help you understand all of your treatment options and also help you steer clear of unproven remedies. Discuss the potential benefits and risks of each treatment option with your doctor.

 

Arthritis medications

Medications are considered traditional treatment for arthritis. Depending on the severity of your arthritis symptoms when you first consult with your doctor, one or more medications will likely be prescribed.

Drug classes used to treat arthritis include:

*    NSAIDs (nonsteroidal anti-inflammatory drugs)

*    COX-2 Inhibitors

*    Pain Medication (analgesics)

*    Corticosteroids

*    DMARDs (disease-modifying anti-rheumatic drugs)

*    Biologic Response Modifiers (i.e. Biologics)

 

Injections into a joint

There are several types of injections which can be given locally into the joint. Viscosupplementation is a procedure that involves the injection of gel-like substances (hyaluronates) into a joint (currently approved for knee) to supplement the viscous properties of synovial fluid. The five types are:

*    Synvisc

*Orthovisc

*    Supartz

*    Euflexxa

*    Hyalgan

Local steroid injections can be used for a specific, painful joint.

Three steroid injections per year into a joint is the maximum allowed by most doctors. Steroid injections were used long before viscosupplementation became a treatment option. Both are still used though, depending on patient preference.

 

Natural treatments

Some people are more interested in natural treatments than traditional medications. If you prefer a natural approach to treating arthritis, it’s still imperative that you tell your doctor what you are taking or what you want to try. There are many natural treatment options, also referred to as alternative treatments, which are popular but not fully endorsed for effectiveness and safety. Be aware.

*    Acupuncture / Acupressure

*    Biofeedback

*    Chiropractic

*    Magnets

*    Massage

*    Meditation

*    Tai Chi

*    Yoga

*    Supplements such as fish oil, glucosamine, chondroitin, MSM

 

Complementary medicine

The terms, complementary medicine and alternative medicine, are sometimes used interchangeably. The difference is that complementary treatments are used together with your usual treatment regimen. Alternative treatments imply that they are used instead of your usual treatment.

Regular exercise is strongly recommended for arthritis patients. Exercise can reduce pain and improve physical function, muscle strength, and quality of life for people with arthritis.

Eating a nutritious diet is important for maintaining ideal weight and for bone health too. There is no known diet which can cure arthritis, but eating well is important.

Stress management may also be useful as a complementary treatment. Reducing stress helps to reduce pain and stiffness associated with arthritis.

 

Surgical options

Joint surgery is usually considered a last resort treatment option. Joint surgery is typically considered if other more conservative treatment measures are unsatisfactory or have stopped working. When joint damage is severe and when pain interferes with daily activities, joint surgery may be an option with the goal of decreasing pain and restoring function.

 

Pain relief

Pain is debilitating and can greatly interfere with daily living. Better treatments are always being sought, so people living with arthritis pain can achieve pain relief.

 

When symptoms affect normal activities

If symptoms are severe enough to interfere with normal functioning and your ability to perform usual activities early in the course of rheumatoid arthritis, you may bite the bullet and go to the doctor. The disruption in your life serves as the incentive to consult with a doctor.

If symptoms are not terribly disruptive, you may choose to wait before consulting a doctor. It is really quite simple is there a sense of urgency? A sense of urgency, or lack of, dictates when a doctor is consulted.

 

Explanation of symptoms

How did your aches and pains begin? Was there an event, such as an injury, that caused your symptoms? Did the symptoms begin gradually or suddenly, without obvious cause?

Typically, patients who feel comfortable with the explanation of their symptoms will wait before consulting a doctor. For example, if you walked into a wall and you developed aches and pains, you are more likely to give the symptoms a chance to subside on their own. But if there is no logical explanation surrounding your symptoms, you likely will choose to see a doctor, so the symptoms can be evaluated.

 

Knowledge of rheumatoid arthritis and treatment options

If you know much about rheumatoid arthritis, you know that an accurate diagnosis and early treatment is essential. Early treatment with DMARDs (disease-modifying anti-rheumatic drugs) and biologics may help prevent joint damage and subsequent disability.         With new treatments treatments that were marketed since 1998 the prognosis for rheumatoid arthritis is better. Realising that early treatment is important, is it not worth consulting a doctor and agreeing on your treatment regimen, so you can be assured that you are on the right path?

 

Attitude towards the medical profession

If you have had positive experiences with doctors in the past, you are more likely to consult with a doctor about your aches and pains sooner rather than later. If you have respect for doctors in general, and if you trust those you have had in the past, you likely will not balk at getting your symptoms checked out.

The problem occurs if you have a history of bad medical experiences, or if you find it difficult to trust doctors. There are even conspiracy theorists who think doctors like to keep us sick because drug companies give them kickbacks to do so.

 

Point to remember

Simply put, if your symptoms are interfering with normal life, if you understand that early treatment is important, and if you trust your doctor to know what to do and how to help you, you are more likely to see the doctor.

 

Misconceptions about arthritis

There are many misconceptions about arthritis. The most common misconceptions about arthritis seem to persist. Patients need facts and valid information, not myths and misconceptions, so they can better manage their illness.

 

Misconception #1 – Arthritis is an old person’s disease

Fact: Anyone can have arthritis.

The most common misconception about arthritis is that it is a disease only of old people. In actuality, arthritis can affect anyone at any age, not just the elderly, including children, young adults and middle-aged people.

Arthritis is not age or gender specific. There are over 100 different types of arthritis and related rheumatic conditions and some are more commonly found in particular groups.

Rheumatoid arthritis, fibromyalgia, and lupus are more commonly found in women than men. Gout and ankylosing spondylitis appear more often in men than women. In terms of gender, psoriatic arthritis affects men and women nearly equally. Older people are more inclined to have osteoarthritis, the degenerative form of arthritis.

 

Misconception #2 – Arthritis is induced by a cold, wet climate

      Fact: Climate itself is neither the cause, nor the cure.

It has long been theorised that arthritis is caused by a cold, wet climate. Moving to a warm, dry climate has been regarded by some as the cure. Logically, one can infer that if a warm climate cured arthritis, no one in other warm regions would have arthritis. Bone rubbing on bone after cartilage has worn away causes pain in any climate. However, warmth can be soothing. People without arthritis often feel better in warm climates too.

Warmth may relieve symptoms of arthritis, as does soaking in a hot-tub or taking a hot shower.

 

Misconception #3 – Arthritis can be cured

      Fact: There has been no scientific evidence that a cure for arthritis exists.

The notion that arthritis can be cured is a fallacy. To date, there is no known cure for the disease. Much has been discovered, in terms of better treatment options and slowing down the disease progression, but nothing yet has been found to successfully halt the disease. Since there are so many different types of arthritis, the prognosis varies.

Since arthritis is a lifelong process, the importance of gaining knowledge and understanding of your own health condition cannot be overstated.

 

Misconception #4 – Arthritis is caused by a poor diet

      Fact: There is no scientific evidence that specific foods prevent or cause arthritis.

There has been an abundance of speculation about the importance of diet with regard to arthritis. It is certain that a nutritious, well-balanced diet and ideal weight maintenance improves overall health and wellness for everyone. There are a few examples where there is a definite diet connection, such as between high uric acid levels and gout.

There is no scientific evidence, though some specific foods prevent or cause arthritis. Good diet does not prevent arthritis. Unless a person is found to have a particular food allergy which causes their arthritis to flare, there is no proven direct link between a particular food source and arthritis.

 

Misconception #5 – Arthritis consists of only minor aches and pains

Fact: Arthritis consists of much more than just minor aches and pains.

It is another common misconception that arthritis exhibits only minor aches and pains. Television commercials, which claim that a couple of aspirin or another over-the-counter pain reliever takes away the minor aches and pains of arthritis, tend to mislead the public.

Such advertising, along with a lack of knowledge about the disease, expand some people’s unawareness of the more complex forms of arthritis, which require more aggressive forms of treatment.

 

Misconception #6 – “You felt fine yesterday… why so tired today?”

Fact: There is variation in the duration and severity of the symptoms of arthritis.

Since arthritis is a disease characterised by periods of flares and remissions, it is often difficult for the family and friends of an arthritic person to comprehend why they feel so much better or so much worse on any particular day. The inconsistency of arthritis can even lead some people to believe the disease is “all in your head”.

Arthritis is characterised by a mix of good days and bad days. Some days, the joint pain and fatigue is more exacerbated. A balance between rest and activity may be necessary to best manage living with arthritis.

Misconception #7 – “You have arthritis, you can’t….”

Fact: There is much a person with arthritis CAN do.

The limitations that arthritis imposes on an individual can cause people closest to them to become overprotective. Sometimes people do too much to try and help the person with arthritis. The disease does interfere with some physical ability, but certainly the arthritic person should not be viewed as totally dependent and invalid.

A certain amount of help and dependence is likely to be required. It must be remembered though that it is best to maintain as much independence as possible for both physical and emotional reasons.

 

Report compiled by Adebayo Folorunsho-Francis with additional information from Dr. Zashin, author of “Arthritis Without Pain” and About.com Health’s Disease and Condition content.

 

Lessons from the eyes

0

(By Oladipupo Macjob)

lie-eye-movement  Several researches have proven that communication does not only come verbally. As a matter of fact, nonverbal communication, also known as body language, reveals much more about the individual than just mere spoken words. It is not what is said, it is the way it is said. This also applies to the eyes – several nonverbal cues can be picked up, provided you are observant enough. These nonverbal cues tell a whole lot about people and actually reveal the real facts behind what is being probed. Therefore, it’s an important skill everyone, including pharmacists, should acquire. It is useful in all kinds of business transactions and even in domestic matters.

Eye signals are a vital part of being able to read a person’s attitude and thoughts.When people meet for the first time, they make series of quick judgements about others, based on what they see first, before making further judgements from what they hear. A study compared peripheral vision between men and women and it was observed that, at a distance of 18 inches from a woman, about 80 per cent of the men found it hard to describe her necklace except they moved their eyes down. So, at a distance of 18 inches, while maintaining eye contact, a man is not necessarily gazing through a woman’s body. The first look is just for gathering data; just by reflex.

Moral looking time

This concept was developed by Dr Ray Birdwhistell. He believes that a person can observe another’s eyes, face, abdomen, legs and other parts of the body for only so long before tension is created in both observers and observed.

Generally, the eye speaks volumes about what is going on in the mind of an individual. Sometimes one good indicator of deception is that a suspect maintains longer than usual eye contacts. Ability to read concealed emotions in the eyes is an important skill set.

Pupil insight

When someone becomes excited, the pupils can dilate up to four times their original size. Conversely, anger causes the pupils to contract to what is commonly referred to as “snake eyes”.

Eckhard Hess, a onetime H.O.D of the Department of Psychology at the University of Chicago and pioneer of the studies of pupillometry, found that pupil size is affected by one’s general state of arousal. If a woman is attracted to a man, her pupils will be dilated at him.

Research has shown that when pornographic films are shown to men, their pupils dilate to three times their size. Most women’s pupils gave the greatest dilation when looking at pictures of mothers and babies. This is why the best-selling children’s toys almost always have oversized pupils.

Centuries ago, prostitutes put drops of belladonna, a tincture containing atropine into their eyes to dilate their pupils and make themselves appear more desirable.   There are some people however, who suffer from heterochromia i.e have a permanently dilated pupil and they constitute about 1 per cent of the population. So there is a need to get the baseline of the individual, while drawing inferences.

Eyebrow flash

The purpose of this is to draw attention to the face, so that clear signals can be exchanged. The only culture that considers eyebrow flash as impolite with definite sexual connotations is the Japanese culture.

Lowering the eyebrow in humans is a sign of aggression or to show dominance towards others, whereas raising the eyebrows shows submission. A good use of this eyebrow flash in any presentation before an audience does a lot of good to endear an audience to you. So if, as a medical representative or manager doing a clinical presentation, you make use of the eyebrow flash quite often during your presentation, you do not come across as aggressive. This is particularly useful to those whose faces are naturally ‘hard’.

Gaze behaviour

Michael Argyle, a pioneer of social psychology and nonverbal communication skills in Britain, found that when Westerners and Europeans talk, their average gaze time is 61 per cent, consisting of 41 per cent gaze time when talking, 75 per cent when listening and 31 per cent mutual gazing. It’s been found that the amount of eye contact in a typical conversation ranges from 25-100 per cent depending on who’s talking and what culture they are from.

When we talk, we maintain 40-60 per cent eye contact, with an average of 80 per cent eye contact when listening. The notable exceptions to this rule are Japanese and some Asian and South American cultures, where extended eye contact is seen as aggressive or disrespectful. Argyle found out that we often maintain more eye contact when listening than when talking. When the customer is not maintaining an acceptable eye contact with you, especially while you are trying to sell the benefits of your brand or product, there is definitely something to worry about.

To build a good rapport with someone else, your gaze should meet theirs about 60-70 per cent of the time, else it comes across as timidity. When two people meet and make eye contact for the first time, the subordinate person looks away first, but if you maintain gaze with your boss, it shows a clear message of disagreement or aggressiveness.

Men’s peripheral vision is far poorer than that of women. Which is why men sometimes have difficulty seeing things in the refrigerators, cupboards and drawers. Just at a distance of 18 inches from a woman, they can hardly tell what the colour of her shoes is, unless they shift their eyes to look down. Women don’t have this problem. Their peripheral vision extends to at least 45 degrees to each side above and below, which means she can appear to be looking at someone’s face while at the same time, she is inspecting their goods and chattels.

When a woman wants to get the attention of a man in a room, she will meet his gaze, hold it for two to three seconds, then look away and down. This gaze sends him a message of interest and potential submission.When a person’s gaze meets yours for more than two-thirds of the time, it is probably because he or she finds you interesting or appealing, in which case, he will also have dilated pupils; or on the other hand, he’s hostile toward you and could be issued a challenge, in which case, the pupils constrict.

Geography of the face

There are three basic types of gazing:

  1. a) Social gaze: During social encounters, the gazers eyes look in a triangular area on the other persons face between the eyes and the mouth for about 90 per cent of the gaze time. This is the area of the face we look in a non-threatening environment.
  2. b) The intimate gaze: When people approach each other from a distance, they look quickly between the other persons face and lower body to first establish what the gender of the person is and then a second time to determine a level of interest in them. In close encounters, it’s the triangular area between the eyes and the chest, and for the distant gazing, it’s from the eyes to the groin.

A woman’s wider ranging peripheral vision allows her to check out a man’s body from head to toe without getting caught. The male’s tunnel vision is why a man will move his gaze up and down a woman’s body in an obvious way.

c) The Power gaze

This gaze focuses between the front part of the head and the gap between the two eyes. By keeping your gaze directly at this area you keep the screws firmly on the individual. The pressure stays on them provided your gaze does not drop below the level of their eyes. Never use this kind of gaze in friendly or romantic encounters. It works on a person who you want to reprimand. The occasion should determine which kind of gaze we use or adopt, or else, we end up sending wrong signals and may likely be misunderstood.

Extended blinking

A normal relaxed blinking rate is about 6-8 blinks per minute and the eyes are closed for only about one-tenth of a second. People under pressure, for instance, when they are lying, are likely to dramatically increase their blinking rate. Extended blinking rate is an unconscious attempt by the person’s brain to block you from their sight because they have become bored or disinterested or feel they are superior to you. When the eyes dart from side to side, it’s the brains way of searching for an escape route as it were.

Research has shown that, of the information relayed to the brain in visual presentation, 83 per cent comes through the eyes, 11 per cent through the ears and 6 per cent through the other senses. It therefore means that a verbal presentation requires frequent repetition of key points to be effective. Use of visual aids is very effective and saves costs and energy.

The point is this, when doing a power point presentation; your audience follows better when your slides are more visual than when you have too many words written on the slide, except it is a quote. It’s worse, if you have to read almost 90 per centof the content to them while presenting. The question that will be on their mind is, why have they come to listen to you if you would still have to read all the slides to them?

Any opportunity you have to make a presentation before people is such an awesome privilege to influence lives, and you just cannot afford to mess things up. A clinical meeting badly presented is company money wasted. This is one of the areas many pharmaceutical companies are missing it, and it’s the major difference between consumer marketing and Pharma marketing. If lesser attention is paid to the messenger who is to deliver the message, it’s simply an error of judgment.

In our next edition we shall go further in looking at some other nonverbal cues through which we communicate or pick up nonverbal communication. Remember, whether you speak or not, your body does.

 

Divine Assurance for the New Year

3

  In 1943, Abraham Maslow proposed a theory in psychology known as “Maslow’s hierarchy of needs” and represented as a pyramid with five levels of needs. It is a motivational theory that argues that while people aim to meet basic needs, they seek to meet successively higher needs in form of a pyramid.

The five levels of needs, according to the theory, are: physiological needs,   safety needs, social needs, self-esteem needs and self-actualisation needs.

The most fundamental of these needs are physiological needs, which include necessities such as air, food, water, sleep, clothing and shelter. We require physiological needs to stay alive. Once these needs are met, we have need for safety   and then social needs, followed by self-esteem and finally self-actualisation.

Maslow did not consider spiritual needs in his pyramid. But, obviously,   people have spiritual needs, too. At the physiological level, people tend to be closer to God for their needs. However, spiritual needs run throughout the levels of the hierarchy in different ways.

Jesus appreciates the importance of physiological needs. He knows that without   satisfying them, we cannot survive and hence cannot move up the pyramid. This is why He promised to provide them and asked us not to worry about them. He says in Matthew 6:31-33, “Therefore take no thought, saying, What shall we eat? Or, What shall we drink? or, Wherewithal shall we be clothed?…for your heavenly Father knoweth that ye have need of all these things. But seek ye first the kingdom of God, and his righteousness; and all these things shall be added unto you.”

Sometimes, we think there is no way our needs can be satisfied but Jesus says He is the way. He makes a way where there is no way. The first miracle He performed was provision of wine needed for a wedding ceremony in Cana of Galilee. One remarkable thing about that miracle was that, before it was performed, His mother, Mary, had said to the servants, “Whatever He says to you, do it.” I believe that one key that opens divine provision of our needs is this expression: Whatever He tells you to do, do it.

Sometime ago, my cash flow was not good and what occupied my mind was what God wanted me to do to remedy the situation. I was asking for divine   ideas and actions to take. God responded with some ideas that worked. Incidentally, one of the ideas was to give out money for certain purposes. This action even depleted my lean purse – but, eventually, my problem was solved. If God tells you to do something and you fail to do it, it is disobedience.

When you obey and do whatever He tells you to do, He not only provides food, drink, and clothing but opens doors leading to higher levels. His favour, goodness and mercy will follow you.

In order to experience divine provisions, you must believe that your salary or income is not your source of supply. If your focus is centred on your occupational source of income, you have already placed a limit to what God can do for you. You will enjoy abundant life if you believe that God is your Source and Provider. He does not depend on your income or resources.

God is not limited to what you have. He takes whatever you have and multiplies it. He multiplies your income. He even multiplies your time. We all have 24 hours in a day but a believer can achieve a 30-hour output in one day. You may call it efficiency or effectiveness but what I am saying is more than that. I have personally experienced it. He does not need to command the sun to stand still again, as He did to enable Joshua overcome his enemies.

The miracle of multiplying a boy’s lunch of five barley loaves and two small fish to feed 5,000 men (without counting women and children) is one that Jesus keeps doing today, for those who believe. God is not just multiplying, He also creating from nothing.

When Jesus was required to pay temple tax of half a shekel in Capernaum, there was no coin available. He just asked Peter to go the sea, catch the first fish that came up, open its mouth, and get out a shekel. That shekel was used to pay the temple tax for Jesus and Peter. Isn’t that fantastic? How did a shekel get into the mouth of that fish? One shekel was all that was needed for the temple tax. If more than one shekel was needed, Jesus could have provided it.

This is how Jesus provides our needs today. He knows exactly what we need and desires to provide them. This is why He said we should not worry. Sometimes, we want to accumulate what we don’t really need. This is greed and lust. Peter did exactly what his Master told him to do and a miracle happened and a need was met instantly. Whatever He says to you, do it. Miracle happens whenever you do what He asks you to do.

 

Experts task pharmacists on patients’ safety— As Lagos ACPN holds continuing education programme

0

Experts and scholars in the pharmaceutical profession, including Prof. (Pharm.) Azuka Oparah of the University of Benin, have said that in order to provide drug therapy responsibly, pharmacists must take responsibility for identifying, preventing, and resolving drug therapy problems of patients in a consistent manner.

ACPN Lagos
L-R: Pharm. Deji Osinoiki, former National Chairman ACPN and chairman of the event; Pharm. Olumide Akintayo, president, PSN and Pharm. N. A. E. Mohammed, registrar, PCN at the ACPN Continous Education Programme, held in Lagos last December.

 

Prof. Oparah, who is a Fellow of the Pharmaceutical Society of Nigeria (FPSN), made his submission while delivering a keynote address on the topic, “Patient Safety Issue in Nigeria: The Community Pharmacists Perspectives”, at the Continuing Education Conference organised by the Association of Community Pharmacists of Nigeria (ACPN), Lagos State Branch, at NECA House, Alausa Ikeja, Lagos, last December.

The university don stated that no medicine is absolutely safe, noting that every drug or medicine has two inherent qualities of benefits and risks.

“The decision to medicate is based on a balance of probability that the benefits of use outweigh the risks. The harm derivable from drugs varies from one agent to another. It is upon this risk stratification that national and international laws classify medicines into two main groups, namely, over-the-counter (OTC) medicines and prescription only medicines (POM)” Oparah said.

Speaking further, Oparah explained that drugs in the class of prescription-only medicines (POM) do not have high safety margin, unlike the over-the-counter (OTC) drugs, adding that in order to protect public health, decision to use them should not be left in the hands of the general public but a learned intermediary.

“Such medicines are to be dispensed by a registered pharmacist on the prescription of a doctor.Also, the manufacturers of such medicines owe a duty of care to communicate all known and potential inherent risks to the learned intermediary, who in turn, owes a duty of care to convey same information to the consumers,”he urged.

Prof. Oparah also stressed that the goal of pharmaceutical care is to assure the quality of the medication use process through collaborative efforts, adding that the decision to take medications should be based on the balance of probability that the benefits outweigh the risks and that pharmacists owe a professional obligation to guide members of the public to use OTC medicines responsibly.

In his goodwill message at the event, Pharm. Olumide Akintayo, president, Pharmaceutical Society of Nigeria (PSN), commended the Lagos State ACPN for choosing the theme, “Patient Safety Issues in Nigeria”, saying it was inconsonance with the goals of the National Drug Policy in Nigeria.

“What community pharmacists are simply saying is that they want to be in the vanguard of creating an environment whereby Nigerians will consume safe medicines at an affordable cost and accessible at alltimes, even in the remotest part of the country,” he said.

Akintayo also said pharmacists had been working with the National Human Rights Commission (NHRC) in order to come up with a policy that would cover access to medicine as a human right, adding that the time had come for the country to get it right. He also urged community pharmacists and other technical arms of the PSN to keep supporting the NHRC and its mission.

Also, the duo of Registrar, Pharmacist Council of Nigeria, (PCN), Pharm. N.A.E Mohammed and Chairman, Lagos ACPN, Pharm. Aminu Abdulsalam Yinka, maintained that the patient is the major consideration in safety issues in healthcare, adding that what marks out health professionals is their focus on patient safety, not money-making.

Speaking further, Pharm Aminu disclosed that the Continuous Education Conference programme in Lagos has been consistent over the years because of the importance that the Lagos State ACPN places on knowledge and effective service delivery.

“There are new trends even in the management of ailmentsand in order to cope with these, we need to regularly update ourselves, so that we can make positive impacts in the lives of the public. The continuous education programme is a sine qua non in our policy, and in conjunction with the regulatory authority, it is also mandatory”.

Aminu noted that this year’s programme was approved by the Pharmacists Council of Nigeria (PCN) because of the consistency and quality over the years. He said a two–unit credit would be awarded to all pharmacists that attended the programme.

Speaking earlier, chairman of the event, Pharm. Deji Oshinoiki, commended the ACPN, which he described as the window to the pharmacy practice as well as forerunner of the practice, for being consistent in organising the programme every year.

“The world is changing, so also is health care practice; hence the need to consistently update our knowledge in order to meet up with what is going on around the world.And I am very happy that the programme has never failed to live up to expectations since inception”, Oshinoiki intoned.

Other dignitaries at the event include: Prof Anthonia Ogbera, one of the guest lecturers; Pharm. (Mrs) Joke Bakare, managing director, Medplus Pharmacy, also a guest lecturer; Pharm. Gbolagade Iyiola, national secretary (PSN); Pharm. Adeoye Afuye, national secretary (ACPN); Pharm. Madehin Gafar Olanrewaju; Pharm. Tony Oyawole; Pharm. Felix Anieh Felix; Pharm. Akintunde Obembe, among others

 

Smartphone use in nursing practice: evolution or revolution?

0

AA female nurse using smartphone

(By Cheryl D. Parker, PhD, MSN, RNBC, FHIMSS)

Since smartphones were introduced in 2002, a communications revolution has taken place. We talk on our smart phones, we text on them, we take pictures and post them to social networks, we communicate in 140-character “tweets,” and share our thoughts and events on our personal networks. We use Smartphone applications to monitor our exercise, manage our calendars, and practice our deep breathing. For many people, forgetting their smartphone causes instant panic.

In health care, physicians’ smartphone use has grown exponentially. Just 6 years ago, I listened as chief information officers (CIOs) at the largest health care organisations in Texas insisted emphatically that a bring-your-own-device (BYOD) policy would never happen in their facilities. Of course, things don’t always go as planned. According to the Wolters Kluwer Health 2013 Physician Outlook Survey, approximately 80 per cent of physicians now use smart phones in their work.

But in the context of nursing practice, the communications revolution is only now starting to make a direct impact. Most nurses continue to use voice-only phones, multiple pagers, or wearable voice-activated two-way communication devices provided by their employers. While we may use smartphones in our private lives, many of us still use outdated communication devices at work. Or do we?

After visiting health care facilities across the country, I’m convinced nurses are in on the communications revolution. I’ve seen them use their own devices—not those provided by their employers—to text other healthcare team members (including physicians) outside the facility, access reference materials, and perform many other functions on their smartphones that aren’t supported by employer-provided technology.

Is this a problem? For several reasons, increasing use of personal smartphones should raise concern for healthcare facilities. (See Infection prevention for smartphones.)

Legal and regulatory compliance

The foremost concern is legal regulatory compliance. Despite hospital policies forbidding use of personal phones by employees during work hours, 67 per cent of hospitals reported in 2013 that their nurses used personal devices to communicate and support their workflow. This means, in effect, that nurses could be violating federal laws (specifically, the Healthcare Insurance Portability and Accountability Act), hospital security policies, and the American Nurses Association’s Code of Ethics. If they’re sending protected health information (PHI) on their smartphones in a way that can be linked to a specific patient, they’re also violating state nurse practice acts. Sending PHI could lead to loss of employment, financial fines, jail sentences, and loss of one’s nursing license.

To make sure they’re not jeopardizing their jobs, nurses must determine if their communication and workflow habits comply with applicable laws, policies, and procedures.

 Cell phone security

What about security? Don’t most people secure their smart phones? In a word, no. Two of five people surveyed don’t take the most basic smart phone security precautions. Criminal hackers are focusing more attention on smart phones than on other electronic devices, according to cyber security experts.

A 2013 survey asked 1,000 full-time American workers to describe their personal smart phone use in the workplace. Among respondents who chose health care as their employment sector, 88.6 per cent said they used their personal phones for work purposes. Among all respondents, 39 per cent said they don’t password-protect their phones. Potentially more dangerous, 52 per cent used their smart phones on unsecured Wi-Fi networks, such as those at coffee shops. Use of unsecured Wi-Fi is a well-known security vulnerability because it can allow for easy phone data theft.

Do you know if your smartphone’s Bluetooth is set to “discoverable” by other devices, such as your hands-free headset? This is another security layer most people don’t think about. Data on an employer-owned phone usually can be deleted remotely if the phone is lost or stolen. This is sometimes called “wiping” or “bricking,” meaning the device is no longer functional because the operating system, programmes, and data have been rendered inoperable. But it’s rare that data on individually owned devices can be deleted remotely. So even if you never use your smartphone for work, ask yourself if you could delete all those pictures, texts, and emails if you lost your phone. Do you have a backup of your phone’s data just in case you have to delete everything?

 Who owns the phone?

Employers have the greatest control over devices they own and distribute. But even in a BYOD environment, employers can require installation and use of applications that provide the necessary security. Policies and procedures help outline what devices are permitted and specify security requirements to ensure password protection. In many cases, the standard four- to six-digit password is not secure enough; a hacker could crack a password such as 654256 in less than one second.

Policies need to spell out clearly who’s responsible for smartphone-related services, including dealing with problems accessing the facility’s secure network. Employers need to decide which applications are allowed, when updates must be performed to maintain application security, and what happens if the employee leaves the organisation.

In a BYOD environment, wiping the device in case of theft or loss becomes an interesting question. If the device is storing both organisational and personal data, both types will be lost in the wipe. What are the rights of the individual and the organisation in this situation? This is another area where policies and procedures must be made clear to all. If you’re using your personal device at work, find out if your organisation has a BYOD policy and ensure that you’re in compliance.

In the future, certain communication exchanges may become part of the electronic health record (EHR). Such data, including pictures, shouldn’t reside on smartphones no matter who owns them, but instead should be stored on a secure server with audit tracking.

 Future of smartphones in nursing

Facilities considering use of smartphones for clinical staff need to think about clinical communication as part of the patient-care process instead of just replacing current phones and functionality. Nurses need choices in communication methods, including secure, encrypted texting and email. Communication must be put in a clinical context to properly identify the patient, who should be at the heart of the communication exchange. Use of pictures, such as of a patient’s wound, should be part of the available communication methods even if the photos can’t be uploaded to the EHR.

Even more important, just as smartphones give us cognitive support in our personal lives, we need to look for solutions that do the same in the complex work of nursing. Just as personal smartphones remind us that our best friend’s birthday is next Saturday, nurses could use employer-provided smartphones and technology to help them in clinical practice.

If you’re asked for input on your organisation’s next communication solution, consider the issues discussed in this article. It’s not enough that your phone can send texts. Is your phone data secure? Can the phone be disinfected? Will it survive the rough-and-tumble health care environment? What’s the vendor’s vision for the future of its platform, and how will it support nursing practice?

Envision the future of smartphones that can assist us both as nurses and in our private lives. And envision yourself using a smartphone in compliance with laws, policies, and procedures in a way that’s safe and secure.

 

References

Baril AF. Electronic medical record & HIPAA violations. Advance Health Network for Nurses. August 30, 2010. http://nursing.advanceweb.com/continuing-education/ce-articles/electronic-medical-record-hipaa-violations.aspx?CP=2. Accessed June 30, 2014.

Cisco partner firms. BYOD insights 2013: A Cisco partner network study. March 2013. www.structuredweb.com/sw/swchannel/CustomerCenter/documents/8523/22089/Cisco_mCon_BYOD_Insights_2013.pdf. Accessed June 30, 2014.

Mayer A. Smartphones becoming prime target for criminal hackers. CBS News. March 6, 2014. www.cbc.ca/news/technology/smartphones-becoming-prime-target-for-criminal-hackers-1.2561126. Accessed June 30, 2014.

Porter C. Calling all germs. The Wall Street Journal. October 23, 2012. http://online.wsj.com/news/articles/Accessed June 30, 2014.

Spyglass Consulting Group. Healthcare without bounds: Point of care communications for nursing 2014. March 2014. www.spyglass-consulting.com/wp_PCOMM_Nursing_2014.html. Accessed June 30, 2014.

Wolters Kluwer Health 2013 physician outlook survey. Wolters Kluwer Health. (n.d.). www.wolterskluwerhealth.com/News/Documents/White%20Papers/%20Study%20Executive%20Summary.pdf. Accessed June 30, 2014.

Cheryl D. Parker teaches nursing informatics at the Walden University School of Nursing in Minneapolis, Minnesota. She is chief nursing informatics officer for PatientSafe Solutions, based in San Diego, California.

 

Experts lament failings in health sector

0
Dr femi olaleye
Dr Femi Olaleye

A seasoned health care management consultant, Dr Femi Olaleye, has bemoaned the seeming incompetence of the current crop of leaders in the health care industry, citing several unresolved challenges in the sector as a proof.

Olaleye, who was speaking on the topic, “Essentials of Clinical Leadership”, at a workshop organised by Pharmanews Limited in Lagos, recently, critically examined leadership qualities as it affects the Nigerian health care delivery system.

In his words: “The issue of leadership, if it comes to health care in Nigeria is bad, and there is no other way to put it better”.

Acknowledging the possibility of health workers attaining leadership position through professionalism, he said it was imperative for such practitioners to learn and acquire leadership skills in order to be successful.

Citing some failures of the health sector leaders, Olaleye noted that Nigeria, at 54, still has huge deficits of health human resources, professionalism, best practices, job description, job roles and team play under universal leadership and co-ordination of medical doctors.

“Clinical team leadership seems to have taken its flight from Nigeria’s public hospitals, with attendant negative consequences on inter-professional relationship and effective service delivery”, he said.

Olaleye opined that crises in the health sector may never be resolved if the leaders fail to improve their orientation and managerial skills. In order to achieve this, he said, they must learn what clinical leadership is all about and how best to achieve result.

He defined clinical leadership as “a set of tasks to lead improvement in the safety and quality of health care delivery, and the attributes required to successfully carry them out”, adding that while good clinical leadership results in excellent patient experience and outcomes, incompetent leadership leads to low staff morale, higher rates of incidents and poor patients experience.

Olaleye also differentiated between leadership and management, describing leadership as setting direction, influencing others and managing change, while management deals with marshalling and organising resources, as well as maintaining stability and growth of the organisation.

He therefore urged leaders of the health sector to aspire to acquire new tools in solving the multifaceted problems.

In his own contribution, Consultant Psychiatrist, Dr Rotimi Coker, harped on the need for health practitioners to effectively manage their stressful environment, as 75 per cent of management staff consider their jobs highly stressful.

The expert, who noted that most health care professionals cannot change their stressors, however pointed out that while stress can add spice to life, it could also be devastating and deadly. He defined stress as “issues that disturb your mental, emotional, social, financial, spiritual or physical status”, describing it as when pressure is higher than coping resources.

The psychiatrist identified sources of stress to include: environmental, social, organisational, life events and daily hassles to mention but a few. He however counselled the participants to note their key stressors and apply suitable techniques such as physical exercise; slow, deep breathing and relaxation among others.

How government aided proliferation of patent medicine dealers – Sir Chukwumerije

0

Sir Chukwumerije

In this interview with Adebayo Folorunsho-Francis, Sir Anthony Azubuike Chukwumerije, a Fellow of the Pharmaceutical Society of Nigeria (FPSN) and first president of the Pharmaceutical Association of Nigeria Students (PANS), revealed how government encouraged proliferation of patent medicine dealers. He also disclosed the reason pharmacy students went on hunger strike in the 1960s and why he thinks pharmacists are the most suited for public offices. Excerpts:

Tell us a little about your educational background

I gained admission into Government Secondary School, Afikpo (now in Ebonyi State) in 1953 and I went to the Nigerian College of Arts, Science and Technology, Enugu,for my G.C.E. Advanced Level studies in Physics, Chemistry and Biology In 1958. I also attended the Nigerian College of Arts, Science and Technology, Ibadan (Oyo State), for my diploma studies in Pharmacy, and the University of Ife, Ile-Ife (now Obafemi Awolowo University) in Osun State, for a degree in Pharmacy.

 Would you say studying Pharmacy was a good decision for you?

Pharmacy was a wise choice,   even   though   there were occasions when   one   had   one’s   doubts. For example, while at school,   we learnt that despite the   fact   that we entered pharmacy school   with   G.C.E.   A   Level papers in   three   core science subjects, we were,on graduation,to be placed at a grade level in the civil service that was lower than that of other graduates. At that time, we went on hunger strike and the school authorities had to beg us to call off the strike after nearly four days. This, notwithstanding, pharmacy students were still the busiest, the happiest and the most sought after in the campus.

How does the pharmacy profession in your day compare to today’s practice?

Pharmacy practice was characterised by fighting within and fighting without (in the civil service). We contended with low salary grading and unfavourable practice environment. There was no job satisfaction, and all the years spent at school seemed wasted. Many left for Medicine and others for Law. Community pharmacy practice was fully rewarding and the few who were in it prospered financially and in health. Quackery was minimal and proliferation of adulterated and fake drugs was not common.

What about the problem of drug counterfeiting?

Dealers incounterfeit drugs could easily be traced and dealt with;while multinational drug companies who   dared sell prohibited drugs to the open market were easily identified and their parent companies in Europe queried and admonished. There was strict adherence to discounts to pharmacies, hospitals and doctors. Indigenous drug manufacturing was at its incipient stages and only multinational companies imported drugs and medicinal products.

Soon after, drug detailing started and the early pharmacists who were in it had chauffeur-driven flashy cars and enjoyed bountiful allowances. Then the civil war set in and, after it, every person became a drug seller and governments introduced import licences for importation of drugs, even   to moneybags   who   never went   to school. Abuse inevitably set in and remains uncontrollable.

Did you also contend with the issue of multiple registration of premises?

The Supreme Court’s interpretation of “in continuous supervision” of a premises has finally settled that (the   issue of multiple premises for practitioners) and   considerably reduced the take­home income of our   members, while medical practitioners got away with multiple clinics.

As I earlier mentioned, counterfeit, sub-standard and adulterated drugs are still everywhere. When   Chief Akuneme (now late) was the Chief Inspector in Eastern Nigeria, he would trace any drug classified as poison found in any marketplace to its original manufacturer in Europe or anywhere and inquire why such a drug should be found in the shop of a person not licensed to practise as a pharmacist. Any dealer in counterfeit, sub-standard or adulterated drug was promptly prosecuted.

Some state governments themselves encouraged sale of drugs in open markets by issuing drug importation licences to unqualified persons. Pharmaceutical inspectors were few and could not cope with the problem. Schools of pharmacy were few and only a few pharmacists could be produced. Consequently, community pharmacists already restricted by law to one premises each,could not cope with the expanding population, and colluding governments seized the opportunity to proliferate patent and proprietary medicine stores.

Predictably, in a very short time, the patent medicine dealers outnumbered qualified pharmacists and having saturated the towns, they invaded the open markets, formed very strong unions, and overwhelmed the few fearless pharmacists who wanted to do honest business. The situation has persisted even though the late Director-General of NAFDAC, Dora Akunyili,   dealt severe blows on counterfeiters, open market drug dealers and importers of fake and sub-standard drugs.

What is your view about pharmacists in politics?

I have always advocated that pharmacists should be in politics. We are the only health professionals properly trained to handle men, money and materials. Remember that pharmacy is a profession, a science and a business. Tell me of any business that is more complex than politics and government? If pharmacists are in government, they will correctly interpret the pharmaceutical component of any health bill to their colleagues and be in a position to challenge assaults on pharmacists in any area of practice.

How best do you think the issue of fake drugs and counterfeit medicines can be curbed?

I have earlier suggested that to curb fake drugs and counterfeit medicines, a competent and incorrupt pharmacist should head NAFDAC. Some state directors of pharmacy are also corrupt and issue patent and proprietary medicine licences recklessly; andthey hardly go oninspection nor have a strong inspectorate division.

In our time, part-time inspectors were appointed from practitioners to complement the scarcity in government. Even though governments in Nigeria pay lip service to local manufacturing, I have   not   seen any incentive to local manufacturers of anything. All sorts of things are imported freely into this country; and these include drugs.

To what extent did you participate in pharmaceutical activities?

I was the first president of the Pharmaceutical Association of Nigeria Students (PANS). We started fighting for pharmacy while at the university and I remember being called to the office of the then Vice Chancellor, the Late Prof. Oluwasanmi, to be persuaded to ask pharmacy students to call off their strike and go back to the classroom.

At the end of the Nigerian civil war, I found myself in Enugu.   I enrolled with   the   Enugu   State branch of the PSN, became its Assistant Secretary, then   Secretary, then Assistant Chairman and finally, Chairman. I was member of council for several years and served in various committees both at the state and national levels. This culminated in my award of the Fellowship (FPSN) in 1985.

What is your impression about the annual PSN national conferences?

The annual PSN conference was instituted in our time and pharmacists generally loved it. I remember that as a younger man, I never   missed any PSN or FIP conferences but age has many limitations including less travelling and limited resources. These conferences afford opportunities for   interaction, fellowship, updates in scientific advances, getting to know places and asking questions on confusing issues. Branches and more affluent members should occasionally sponsor older colleagues to some of these conferences.

 Should an active pharmacist be made to retire?

My answer is yes ­ when he can   no longer   understand advances in the profession and would therefore not counsel properly on the correct and safe use of drugs. In my opinion, all professionals should retire at the age of 80 and like the psalmist, number their days to apply their hearts unto wisdom.

What is your advice to young pharmacists?

Young pharmacists should learn to appreciate their profession and do whatever they can in their practice area to adhere to good and ethical practice. The present acquisitive proclivity of the youth is condemnable. Wealth comes through hard work and faith in God whose wish is that we should prosper and be in health, even as our souls prosper. If we all practise ethically and not abet quacks and counterfeiters, no pharmacist has business with poverty.

Why Seagreen launched Gvither Plus and Klovinal – Product manager

0

In this exclusive chat with Temitope Obayendo, a product manager with Seagreen Pharmaceuticals Limited, Pharm. Abiola Akinwunmi, explains the company’s vision for the health care needs of Nigerians and why it recently launched two key products into the Nigerian market. Excerpts:

Could you tell us a bit about Seagreen Pharmaceuticals Ltd?                

Seagreen is a fully indigenous pharmaceutical company incorporated in Nigeria. The company commenced operations in 2010. We are a company wholly committed to enhancing the health and wellness status of the Nigerian society. We see a Nigeria where every individual has access to basic essential medicines regardless of their socio-economic status.

Seagreen Pharmaceuticals Limited specialises in manufacturer’s representation, maintenance of scientific offices, importation, distribution, sales and marketing of pharmaceutical products. Our product portfolio includes drugs for management of tropical diseases, anti-infectives, drugs for management of chronic diseases, paediatric health, obstetrics and gynaecology and daily healthy living products.

We continuously scan the health care landscape to come up with products that can deliver exceptional value to health professionals and patients alike, in terms of quality, efficacy and relevance to the health care burden of the society. We specially focus on key challenges in the management of common tropical diseases and essential medicines for women and children’s health needs. Recently, we launched two products to tackle highly prevalent conditions in Nigeria – Gvither Plus, for malaria and Klovinal, for female genital tract infections.

 Could you further explain why you decided to produce Gvither Plus?

The endemicity of malaria in Nigeria, coupled with the high incidence of treatment failures, prompted our search for a solution. Seagreen consequently collaborated with a leading company in the antimalarial therapy field in Africa, Bliss GVS, to avail the society of an efficacious antimalarial product. Bliss GVS has evolved substantial expertise in the antimalarial market in Africa, being the company to pioneer the 80/480 Artemether-Lumefantrine formulation and also Dihydroartemisinin-Piperaquine combination. The company’s antimalararial brands are well known and trusted in over 40 African countries. Gvither Plus is a uniquely cost-effective combination of Artemether and Lumefantrine. Currently, Artemisinin-based combination therapies are the mainstay of malaria treatment and Artemether-Lumefantrine is a well-tolerated and effective ACT.

 It is commonplace for an individual that is down with malaria to use three to four brands before getting well. What is responsible for this?

The need to repeat courses of antimalarial drugs could result from recurrence following treatment. Recurrence of malaria has been attributed to repeat infections, relapsing malaria and recrudescence. Recrudescence is caused by failure of a course of antimalarial treatment and it accounts for majority of cases of recurrence.

The WHO guidelines for malaria treatment notes that treatment failures could result from drug resistance, poor adherence and inadequate exposure to the administered agent. Here, we talk about low quality substitute drugs that, in themselves, promote drug resistance, sub-optimal dosing, and lack of dosing consistency and even outright use of the wrong drugs.

Treatment failures can be minimised by careful selection of antimalarial brands to guarantee quality and efficacy. Brand selection must take bioequivalence into cognisance. Not all substitute brands will achieve the same drug target concentrations as brands that have been tested and proven over the years.

Repeat infections can be reduced by eliminating or minimising exposures to the disease vector, mosquito bites. Proper hygiene and environmental sanitation go a long way to reducing breeding of mosquitoes. Use of insecticides and insecticide treated bed-nets is also a viable means of controlling malaria spread.

Self-diagnosis of malaria by patients is also rampant. Misdiagnosis is as such common, since symptoms of malaria may mimic symptoms of other common ailments such as influenza and typhoid fever. Rapid malaria diagnostic kits are now available to reduce misdiagnosis.

 What are the properties inherent in Gvither Plus which make it unique compared to other antimalarial drugs?

Gvither Plus represents a solution to antimalarial treatment failure. The brands positive attributes include the manufacturer’s track record and competence, assured quality and convenience of administration.

The brand is manufactured by Bliss GVS, a company that has a track record as a leader in antimalarial therapy across Africa. The company manufactures the constituent drug molecules of Artemether and Lumefantrine; this eliminates inter-batch variability so the issues of bioequivalence and quality assurance are addressed.

Gvither plus also promotes dosing compliance. It is formulated as 80/480 tablets for adults. That means just a single tablet is required for each dose. This reduces the pill burden on the patient, provides convenience and promotes compliance.

Treatment failure in children is also common. Here lack of dosing accuracy and consistency plays a major role. The paediatric formulation of Gvither Plus is presented as pleasantly flavoured dispersible tablets. Children find this more palatable and so adherence is improved. Dosing variation and inaccuracy is usually due to human factors introduced by carers that administer the drug, Gvither plus dispersible eliminates this risk because each dose has been carefully measured into a tablet. No measurement is therefore needed on the part of the patient’s carer.

 WHO’s prequalification is gaining credence in the country, and the continuity of this trend may spell doom for pharma manufacturers without the qualification. Is there any plan to get the qualification for your brands?         

Our mission at Seagreen is closely aligned with the WHO’s purpose for prequalification – provision of quality-assured priority medicines. With Seagreen, the goal is to make available good quality pharmacotherapy options for the management of prevalent healthcare challenges in the country. Hence the company adopted a proactive approach to quality right from inception. This has ensured that Seagreen’s activities would not be significantly affected by the prequalification requirements.

We maintain a stringent prequalification and selection process for our manufacturers. Our main manufacturer, Bliss GVS, operates a Total Quality Management (TQM) system that has been validated and accredited by WHO GMP, EU GMP, PIC/S, ISO and NAFDAC.

 In this age of counterfeiting, how do you ensure quality for your customers?

At Seagreen, we hold quality close to our hearts. Apart from this, we have invested in the MAS. Gvither Plus comes with the scratch cards that enable verification of the authenticity of each product pack by the end user. We also invest in other quality monitoring and enhancement activities, including distribution channel and market surveillance.

 Klovinal is another new product from Seagreen Pharma. Could you tell us more about it?

Research has it that, annually, up to 40 per cent of women would suffer episodes of non-sexually transmitted urogenital infections, leading to vaginitis; and over a million and half Nigerian women have recurrent fungal forms of vaginitis annually. These require at least four treatment courses annually.

Infective vaginitis is characterised by abnormal malodorous discharge, itch, burning sensation and dyspareunia. Mixed infections are common. Recurrence is a major challenge to the pharmacotherapy of vaginitis and recurrent vaginitis is a risk factor for sexually transmitted infections including HIV.

Seagreen, being a customer responsive company decided to respond to the yearnings of the health care industry for a solution that can provide sustained cure against vaginitis. This heralded the launch of Klovinal.

Klovinal is a brand of polyactive pessaries introduced by Seagreen in the course of the company’s last business year. It is specially designed and formulated for the management of vaginitis due to bacterial, fungal, protozoal organisms. Klovinal has a spectrum of antimicrobial activity that covers the three most prevalent forms of vaginitis, which are bacteria vaginosis, vaginal candidiasis and trichomoniasis. It is therefore suitable for empirical or syndromic management of vaginitis including mixed infections.

 What elements distinguish Klovinal from competitive brands?

Klovinal is, indeed, a veritably unique product in its category. It represents a whole paradigm shift in the management of vaginitis. Moving from merely eradicating pathogenic species to a system where microbiological cure is augmented by re-establishing the dominance of the healthy normal flora.

Klovinal is different from other agents useful in the management of vaginitis by the following factors: Firstly is its unique composition. Klovinal consists of three active agents – Metronidazole, Clotrimazole and Lactobacillus spores co-formulated as pessaries. The first two actives confer efficacy against the common forms of vaginitis, while Lactobacillus is included as a probiotic. Probiotics, according to the WHO, are live microorganisms which are administered in adequate amounts for health benefits in the human host system. So we purposefully use a species of microorganism to inhibit other pathogenic species.

The essence of the combination is to achieve the dual purpose of achieving microbiological cure and restoring the dominance of the normal healthy vaginal flora with the same agent. The outcome is efficacy against mixed infection and minimisation of the risk of recurrence. This is the first agent available in Nigeria to achieve this.

Secondly, Klovinal is manufactured with outstanding attention to quality in the pessary laboratories of Bliss GVS. That manufacturing facility is WHO GMP compliant, EU GMP compliant, ISO14001 and PIC/S.

Thirdly, Klovinal is produced using a new and innovative formulation technique, termed, SMEDDS – Self Micro Emulsifying Drug Delivery System. SMEDDS guarantees that the pessary will melt rapidly at body temperature and uniformly coat the affected surface. So, with Klovinal, you are sure that the pessary releases the active drug to the site where it is required. Women will not wake up to find administered pessaries falling off wholly or partially without having elicited any effects.

 What is your vision for these products in the next five years?

I sum that up as “sustained relevance”. Health care science and practice are dynamic. In five years, it is our desire that Seagreen attains greater relevance in the health care system; and we are vigorously pursuing this. We are also positive that the products would have attained full acceptance as veritable health care solutions and, barring any major evolutions in science and knowledge, that the health care community would find them dependable allies in the management of the disease conditions.

 

The National Health Act and the road ahead

0

 The year 2014 ended with the signing of the harmonised National Health Bill by President Goodluck Jonathan. The Bill, which is now an Act of Parliament, is designed to provide a framework for the regulation, development and management of a National Health System and set standards for rendering health service in the country. Among other things, it provides a comprehensive integration of the functions of the different sectors of health care in Nigeria and provides a description of “The National Health System”.

The Act, which was long in coming, and the processes heralding the emergence of the harmonised version, which is believed to have been signed by the president, reflect the nature of the peculiar challenges facing the Nigerian health care industry. The sheer magnitude of the inter-professional rivalry that exists in the Nigerian health care sector was unveiled in the events leading to the presidential assent.

It is particularly notable that, at the news of the signing, President of the Pharmaceutical Society of Nigeria, Pharm. Olumide Akintayo, in his congratulatory remarks, expressed some reservations, particularly of his hope that the landmark document was not doctored after the harmonised version had been passed at the National Assembly. Prior to the harmonisation, the PSN and other associations had fought hard to ensure that specific clauses that favoured only medical doctors in the operation of the health care system be removed. Though the harmonised copy passed by the National Assembly reflects the success of their efforts, we are yet to confirm if it was the same one endorsed by the President.

In a statement signed by its President, the PSN said: “the harmonised version of the National Health Bill signifies the first time the borders of restriction in health care were opened as major Health professional associations and trade unions are represented in key structures of the new Health Act”. The Act, among other things, makes it a legal statute that 1 per cent of the consolidated revenue of the Federal Republic of Nigeria be dedicated to the funding of Primary Health Care. Though this represents a progressive effort in the right direction, it still does not reflect the realities of the Nigerian challenge. Considering that diseases like malaria account for 60 per cent of outpatient hospital visits in Nigeria, Primary Health Care in Nigeria needs greater attention – one that is embedded in a health insurance system that is adequately funded and managed.

At present, going by the 2013 and 2014 budgets, less than 6 per cent budgetary allocations were made to the health care sector, as against the agreed on 15 per cent in the Abuja declaration by African Heads of States in 2001.It is expected that the funding in 2015 would be even far less, considering the dramatically reduced government earnings, as a result of the global fall in oil prices. Our concern is that, given the level of bickering among health care professionals, the shrinking oil revenues and the present low level of health care funding, there are very tough times ahead. Hence, in as much as we must congratulate ourselves that we now have the Health Care Act, it must be emphasised that the journey is just beginning.

The next vital step is to design a pragmatic implementation system that is focused on the national health insurance structure – one that seeks to protect the lives of Nigerians in the days ahead, guaranteeing access to basic care, making the most of the 1 per cent of consolidated revenue commitment enshrined in the Health Act, while we ask for more.To achieve this, the Federal Government must, once and for all, take up the serious challenge of resolving the inter-professional bickering in the Nigerian health care sector, as this management challenge alone contributes a major bulwark hindering efficiency in the sector.

 

Commercial transactions 1: When is there a contract?

2

Legal Angle

While reading the daily newspaper, Mrs Uche comes across an advert for Multivitamin Blood Tonic. She is informed that the product is available at Allen Pharmacy and immediately decides to purchase one when she goes shopping later in the day. On getting to the pharmacy, she sees the sales girl, Stella, who is busy attending to other customers. Mrs Uche picks up a shopping basket and proceeds to select the only bottle of Multivitamin Blood Tonic on the shelf, along with some baby food and household products.

Meanwhile, Stella receives a phone call. It is Madam Tinubu, her regular customer. Tinubu calls to enquire about the blood tonic. Stella confirms that there is one bottle left and promises to keep it for her. Fortunately, the price of the blood tonic can be deducted from a refund that Madam Tinubu was meant to have collected from the pharmacy earlier. Tinubu is happy about this and promises to pass by in the morning to pick up the blood tonic and the balance of her refund.

By the end of the call, Mrs Uche gets to the counter and offloads the contents of the shopping basket with the intention to pay. A serious argument erupts between the two ladies. Stella tries to explain that she has already sold the blood tonic to her regular customer. Mrs Uche, on the other hand, refuses to give up the product, having responded to an advert, driven all the way to the pharmacy and picked up the blood tonic from the shelf.

The question is, who has the legal right to this product?

In law, every business transaction is premised on a contract. A contract is defined as an agreement between two parties which is enforceable. For a contract to be valid there must have been an offer by one party and then an acceptance by the other. Commercial transactions would be problematic if there were no principles governing the conduct of business. The law of contract covers every field of human endeavour.

The scenario above raises some legal questions:

  1. Are the elements of a contract present to make the transaction valid?
  2. What constitutes an offer?
  3. What distinguishes an offer from an invitation to treat?
  4. At what point is the agreement for sale reached?

The foremost authority on Nigerian Law of Contract, Professor Sagay, defines an offer as “a promise made by one party with the intention that it shall become binding on the party making it, as it is accepted by the party to whom it is addressed.” An offer must be precise, leaving no room for speculation.

The offer may be expressly communicated or implied by action. Everyday in life, we engage in activities that constitute the making of offers: When we call for a newspaper from a vendor; when we get into a bus or taxi; when we drive into a petrol station to refuel or when we place an order for food at a restaurant. Each of these actions constitutes an offer to do business with another party.

However, for an offer to be capable of binding the person making it, the offer must be clear and final. If the act is a preliminary step taken towards making the actual offer, it is termed in law, an invitation to treat. In the classic case, Carlill v. Carbolic Smoke Ball Co., the judgement held that when someone offers to negotiate, or issues advertisements that they have got a stock of books to sell (for instance), “there is no offer to be bound by any contract. Such advertisements are offers to negotiate – offers to receive offers.”

In the case at Allen Pharmacy, it is necessary to pinpoint exactly when a valid offer was made in the transaction. We have seen that a newspaper advertisement was published. It may be the view of some that such an advert constitutes an offer for sale of the specific product. Nevertheless, the law is very clear on this issue. The publication of the advert is merely an invitation to potential buyers to come and make offers for purchase. The advertiser reserves the right to reject offers from members of the public who respond to the advertisement.

In this case also, goods were displayed in the shop for the purpose of sale to buyers. It could be argued that the display of goods, in this manner, is an offer for sale which could be accepted, culminating in a valid transaction. On the contrary, in the case of Pharmaceutical Society of Great Britain v. Boots Cash Chemists, it was held that “goods are merely displayed to enable customers to choose what they want and that the contract is not completed until the shopkeeper or someone on his behalf accepts the offer after the customer has indicated the articles he needs.”

It therefore means that the act of selecting a product from the shelf and presenting at the counter is itself the offer that is made. In a shop situation, it is the buyer that makes the offer and the seller that decides whether or not to accept.

In view of this, it was the act of the phone call from Madam Tinubu that constituted a valid offer for purchase. This offer was accepted, resulting in a contract. In conclusion, even though Mrs Uche had received an advertisement; gone to great lengths to make the purchase and actually picked up the product from the shelf, she had not made an offer at the time the phone call came through, leading to the sale. In essence, the blood tonic now belongs to Madam Tinubu who had made a valid purchase over the phone.

 

Principles and cases are drawn from Sagay: Nigerian Law of Contract

Now that ACTs appear to be failing

1
Nelson Okwonna
Pharm. Nelson Okwonna

 

It is no longer news, at least to general practice doctors and community pharmacists that our cherished Artemisinin-based Combination Therapies (ACTs) appear to have begun to fail. Though no one has produced a clinical trial documenting the scale and nature of this development in Nigeria, products sourced from leading proprietary and generic brands have been reported by some health care providers to be ineffective in achieving total clearance of the malaria parasite from the bloodstream as they once did. These observations are in volumes too numerous to be completely discounted.

There are many possible reasons for these observations. The first culprit could be poor diagnosis by the clinician. Next are adulteration and the use of mono therapy; and then the one we fear the most – resistance by the protozoa.

Most of our antimalarial medications are sourced from India and China and if one should go by the recent USFDA’s concerns about the quality of medications from these two countries, we might have a lot to be worried about. A notable pharmaceutical company in India, for example, was fined $500 Million dollars by the US FDA in 2013 for seven felony counts related to data fabrication about the safety of the company’s products over the prior decade.

The question is, if the United States could experience such massive scale adulteration by a renowned company, what could be the case for Nigeria, where we are yet to publicly indict any foreign pharmaceutical company? However, we believe that NAFDAC is doing a lot to protect the interests of Nigerians by ensuring consistency in the quality of antimalarial medications in the market.

That said, let’s assume that this is not a case of adulteration but rather, of resistance, which could as well have been caused by adulteration. Let us now evaluate a scenario where the malaria parasite is developing resistance to our therapy.

 In the event of resistance to ACTs

At present, malaria accounts for more deaths and morbidity in Nigeria than in any other country in the world. At least, a whopping 300,000 individuals die annually from malaria in Nigeria. That is about 34 individuals per hour.

Each year, Nigeria experiences more than a 100 million malaria episodes. What this means is that if, for any reason, we fail to not have a cure for malaria, in one year alone, we would be facing an epidemic of monumental proportions. It is therefore right that we endeavour to evaluate scenarios like this so that we can, at least, prepare. It should be borne in mind that there are countries where ACTs have been proven to have failed.

One important thing to note is that, unlike Ebola, we could be facing this alone. Again, if our experience with Ebola and available therapies are anything to go by, the picture is definitely not an exciting one; hence my decision not to shy away from this article, regardless of how gloomy things may appear.

As health care practitioners, our job includes preparing for such public health emergencies and from our training, the following are obvious indicators we could use to evaluate our preparedness for such a day:

  1. The presence of a long term strategic commitment
  2. Institutional mandate
  3. Ongoing research and development projects
  4. Public–private ownership of the development challenge

Essentially, we need to ask ourselves if there is a long term strategic commitment by anyone, public or private, in preparing for a day like this. Is there an institution whose mandate includes harbouring and managing such a commitment? Are there sufficient will and resources deployed in the form of research and development projects to reflect such commitments? If there are, do we have sufficient local engagement of the stakeholders – both private and public – in ensuring the feasibility of such endeavours?

Presence of a long term strategic commitment

A study of the Ebola scenario offers some interesting highlights, one of which is that there was a long term strategy for the virus disease. Somebody was worrying about what could happen and was doing something about it. ZMapp, for example, represented a wonderful demonstration of the power of effective partnerships between public research organisations and the private industry. For such partnerships to occur, there must have been strategic commitment.

At present, malaria receives massive funding from a wide diversity of donors. In 2012 alone, funding for malaria control peaked at US$ 2.5billion, representing more than a fivefold increase since 2004, when funding was less than US$ 400 million. At the center of these interventions, specifically for drug treatments, are the Artemisinin-based Combination Therapies (ACTs). ACTs are recommended as the first-line treatment of malaria caused by P. falciparum, the most dangerous of the Plasmodium parasites that infect humans. By 2012, 79 countries and territories had adopted ACTs as first-line treatmentfor P. falciparum malaria.

According to the 2013 WHO World Malaria Report, parasite resistance to artemisinins has now been detected in four countries of the Greater Mekong sub region: Cambodia, Myanmar, Thailand and Viet Nam. In Cambodia’s Pailin province, resistance has been found to both of the components of multiple ACTs; therefore, special provisions for directly observed therapy using a non artemisinin-based combination (atovaquone+proguanil) have been introduced.

One could say with confidence that there is a commitment to research and development of new antimalarials, but if we are to judge by recent occurrences, such commitments have not yielded a product yet.

Institutional mandates

Still on the Ebola scenario. A study of the efforts made by the US government to prepare for an Ebola Virus Disease situation shows a strong degree of long–term cohesive thrust between different organisations that include the National Institute of Health (NIH), Centres for Disease Control and Prevention (CDC), the United States Army Medical Research Institute of Infectious Diseases (USMRIID), the Canadian government and a host of private pharmaceutical firms.Apparently, each member of the partnering group had been preparing for a time like this and the outbreak was simply an opportunity to evaluate their degree of preparedness.

One could point out that the United States, in particular, had reasons to take the Ebola Virus Disease seriously – considering that there are no known cures for EVD and that Ebola virus constitutes a potential biological weapon. That said, should malaria not be of more concern to Nigeria at least – considering that we bear the largest global burden of the disease?

Going by the volume of funding dedicated to malaria control and the plethora of organisations involved in its disbursement, one could say that “yes, there is a long term strategic commitment. Institutions like Global Fund, World Bank, WHO, National Malaria Control Programme and the Ministry of Health, are the ones leading such interventions in Nigeria.

Ongoing research and development projects

This is one area that I am bit bothered about – not necessarily about the volume of the interventions but in their ownership. Preliminary investigations suggest that there is no ownership, at least in Nigeria, of the much needed research and development endeavours required to prepare for this eventuality – the failure of ACTs, a scenario that is quite predictable.

We all know that, in no distant time, we are going to have increased resistance to ACTs and that Nigeria bears the world’s largest global burden; yet it appears there are insufficient coordinated efforts in preparation for this eventuality. Some of the events seen in the management of the Ebola outbreak suggest that in situations of national emergencies like the one seen with the Ebola Virus Disease, it is possible that seemingly available therapies can be withheld on various grounds.

Ownership is very important. Yes, there are ongoing research and development efforts in finding malaria therapies which, by the way, are not as many as the level of R and D investment in HIV although malaria kills more people than HIV in Nigeria. The issue is that I do not think Nigeria owns these efforts; if it does, it would show in the level of funding dedicated to it.

The National Institute for Pharmaceutical Research and Development (NIPRD), in my opinion, should be leading such an effort. I know they are working on some antimalarial projects, yet the level of funding dedicated to such ventures is abysmal by any standard. Considering the magnitude of the scenario, it should be a national emergency and a malaria research and development tax could be justified if our government believes the problem is insufficiency of resources.

Public-Private ownership of the development challenge

As mentioned earlier, the Nigerian government, through appropriate parastatals, should be engaging other public and private organisations to ensure effectiveness and efficiency. These organisations could be national or international. The private sector, because of their profit motive, bring a certain level of efficiency in their operations and their partnerships as shown also with the USA management of the Ebola scenario are critical in the timely delivery of intervention.

In the Nigeria scenario, government intervention could provide the impetus for private pharmaceutical firms to invest some resources to finding new antimalarial medication.

 Heading home for answers

One area I believe we should look closely at is combination therapies – that is, of combining our local indigenous herbs/extracts with known existing therapies. The ACTs were born in like fashion.

 

Neros CEO launches ‘Entrepreneurial Spirits’

1

Managing director/CEO, Neros Pharmaceuticals Limited, Chief Poly I. Emenike, has launched a new book, “Entrepreneurial Spirits”.

Neros Entreprenuer
L-R: Chief Poly I. Emenike, managing director/CEO, Neros Pharmaceuticals Limited and author of the book, ‘Enterpreneurial Spirits’; Mr Emeka Onwuka, former MD/CEO, Diamond Bank Plc and chairman of the occasion; and Prof. Pat Utomi, keynote speaker, during the book launch, held at the Nigerian Institute of International Affairs, Victoria Island, Lagos, recently

Published by Napoleon Hill Foundation, USA, the book is aimed at propagating the teachings of Dr Napoleon Hill, reputed to have inspired many people the world over to achieve financial success,

The memorable book launch, held at the Nigerian Institute of International Affairs, Victoria Island, Lagos, and chaired by Mr Emeka Onwuka, former MD/CEO, Diamond Bank Plc, was graced by distinguished Nigerians, among whom were: Prof. Pat Utomi, Prof. Ben Oghojafor, Chief Olubukunola Okunowo and Dr Helen Ekwueme, wife of former vice president, Dr Alex Ekwueme.

Speaking at the occasion, the author, Chief Emenike, said the book represented his humble contribution towards the expansion of the frontiers of knowledge through writing, adding that ‘Entrepreneurial Spirits’ is the story of how he climbed from the very bottom to the pinnacle of the success ladder. He added that, in the book, he directly acknowledges the far-reaching influence which the writings of Dr Napoleon Hill had had on him in his quest to achieve success in life.

The book, Chief Emenike further said, is “therefore a lucid exposition of the fact that Dr Hill’s success principles can work for people in Nigeria, nay, Africa – just in the same manner as it has continued to work for people in Europe, the Americas and, indeed, the world over.”

The Neros boss also explained that the book was written essentially to teach Nigerians how to employ the power of the mind to their greatest benefit, and to also show how to develop and maintain a positive mental attitude at all times in order to achieve the success they desire in life. He said the book also serves to localise the teachings of Dr Napoleon Hill, since they have universal applications.

Chief Emenike urged other eminent Nigerian leaders in various sectors to document their experiences in writing for posterity, noting that knowledge gained from reading the writings of present day leaders would be useful to the young ones when they assume leadership positions.

Professor Utomi, who was the keynote speaker at the occasion, said Chief Emenike represented a special breed to showcase to the next generation, adding that the author was an example of the saying that ‘if you can dream it, you can make it happen.’

Prof. Utomi, who bemoaned the current obsession with materialism in the country, noted that society is not built by the size of a man’s car or how much is in his bank account, but by people who think. He disclosed that Chief Emenike has continued to read as he builds businesses because he knows that to build is to know, adding that what the Neros boss has done by writing ‘Entrepreneurial Spirits’ is to tell the present and coming generations that it can be done. He stated further that, for the generations to learn about how to climb the ladder of success, they have to read, insisting that motivating them to read should be the concern of all.

Earlier in his opening remarks, chairman of the occasion, Mr Onwuka, urged Nigerians to read the book because it would help change their lives. He added that the book is a must read for anyone aspiring to be successful.

Also at the occasion were Pharm. (Sir) Ifeanyi Atueyi, MD, Pharmanews Limited; Pharm. (Sir) Nnamdi Obi, MD/CEO, Embassy Pharmaceuticals and Chemicals Limited; Dr Obiora Chukwuka, chairman, Greenlife Pharmaceuticals; and Mr Emma Umenwa, MD, Geneith Pharmaceuticals, amongst others.

 

Becoming successful through self-actualisation drive

2
 Dr Lolu Ojo
Dr Lolu Ojo

 

 

 

 

 

 

Self-actualisation is a term that was first used by Kurt Goldstein in 1939 to describe the ‘tendency to actualise, as much as possible, the (organism’s) individual capacities’ in the world. Abraham Maslow made the term more popular when he developed a hierarchical theory of human motivation in his book, Motivation and Personality (1954). Maslow defined self-actualisation as ‘the desire for self-fulfilment, namely, the tendency for him (the individual) to become actualised in what he is potentially…to become everything one is capable of becoming’. A simple textbook definition is ‘the full realisation of one’s potential’.

The purpose of this piece is not to discuss the theory and details of human motivation as expounded by Abraham Maslow and other renowned scholars but to briefly examine the route that pharmacists (and in fact, all young Nigerians) can take to self-actualisation. However, we will be relying on the writings of Abraham Maslow and other motivational personalities like Prof. Fola Tayo (Designed for Success, Engineered for Accomplishment, 2013) to chart the way forward.

 

Essence of education

According to Maslow, ‘What a man can be, he must be’. Simply put, if you are capable of scoring 90 per cent in an examination, you should not be satisfied with 70 per cent mark! Education is best defined as ‘the training of mind and character’. As a pharmacist, your mind and character have been trained and prepared to take on the world before you and be the best you can be. You are expected to make the full use (exploitation) of your talents, capacities and potentialities – your environment of operation notwithstanding.

Maslow also told us that ‘the story of the human race is the story of men and women selling themselves short’. With experience, we are almost giving credence to this assertion such that it can be said that the story of pharmacists in Nigeria is the story of men and women selling themselves short! We are challenged in all the areas of practice and we are desperately in need of self-actualisers to serve as role models.

A self-actualiser is a person living creatively and fully using his or her potentials. I will urge all to read more about the 13 characteristics of self-actualisers as written down by Abraham Maslow. This knowledge will help you to stay above your environment.

 

Excellence despite environment

The time is now to stop talking about the limitation of our environment. The attention should now be focused on the individuals and his or her desire to be self-actualised.

According to Abraham Maslow, ‘what is necessary to change a person is to change his awareness of himself’. Since you left school, have you taken a self-examination about who you are and what you have achieved so far? What is stopping you from getting to highest point of the ‘life ladder’, i.e. a higher purpose of human existence?? This self-examination includes answering several questions about yourself and your life journey:

  1. What do you want in life?
  2. If you do not GO after what you want or desire, you will NEVER have it.
  3. If you do not ASK, the answer will always sound like a NO.
  4. If you do not step FORWARD, you will ALWAYS be in the same place.
  5. If you REMAIN in the same place, you will NEVER SEE what lies ahead of you.
  6. If you DO NOT KNOW what lies ahead of you, you will never ASPIRE.
  7. Do you really know yourself?
  8. Who are you (talents, competencies, skills, knowledge, contacts, strengths, weaknesses, aspirations, etc.)?
  9. Why are you here (or what are you doing here): in the profession, work, societies, church/mosques, etc.?
  10. What is so special about me that I am chosen to perform this task? Are others not available?
  11. What is your destination?
  12. What can you make of your stay here?
  13. Do you have a plan for success?
  14. Where are you now? A situation analysis: defining life’s journey, successes, failures and opportunities.
  15. Where do you want to be? Statement of intent describing the expected output of a plan. Mission, goals, objectives, targets.
  16. How will you get there? Implementation strategy, activities or tasks, etc.
  17. How will you that you have arrived? Measurement, discipline, monitoring and evaluation.
  18. A plan is your vision embodied. Seeing what others are not seeing and communicating between the present and the future. It is an evidence of hope, an expression of aspiration which prepares the planner for a journey into an unseen reality. It is an essential ingredient of success without which self-actualisation may be impossible to attain.
  19. Are you aware of the Do’s and Don’ts?
  20. Never undertake any task that was not planned (Failure is built in already)
  21. Never take NO for an answer.
  22. Do not underestimate or overestimate yourself.
  23. Always expect accomplishment and success.
  24. Do not enter into the train of procrastination.
  25. Live everyday conscious of who you are.
  26. Time is a precious gift that can never be regained when lost. Run away from time devourers.
  27. Don’t make friends with ‘planless’ people.
  28. Be focussed and remain diligent even in adversity.
  29. Document all your activities, thoughts and plans

Expanding your horizon

We may not be able to exhaust the list of things to know or to be done in a single piece. What is important is that you change the awareness of yourself and this could lead to a permanent change in your life. We will give more attention to planning in this column in the nearest future.

There is something you should always remember: ‘If the only tool that you have is a hammer, you tend to see every problem as a nail’ (Abraham Maslow). It is therefore important for you to constantly update your knowledge base, developing skills and competencies and stay above your environment. Surely and steadily, you will get there.

HealthPlus to open 48 branches in 2015

1

 – As JNC International boss canvasses harmony in health sector

Managing Director and Chief Executive Officer of the HealthPlus Group, Pharm. Bukky George, has announced that the company, rated as the fastest growing pharmacy chain in West Africa, would add 48 new branches to the existing ones in 2015.

HealthPlus
L-R: Pharm. Bolanle Adekoya, head of pharmacy department, Lagos University Teaching Hospital (LUTH); Pharm. Lekan Asuni, managing director of GlaxoSmithKline; Pharm. Bukky George, MD/CEO of HealthPlus Group; Pharm. Lolu Ojo, former chairman, National Association of Industrial Pharmacists (NAIP); and Pharm. Clare Omatseye, founder and Managing Director of JNC International Nigeria Limited.

 Speaking at the 7th annual thanksgiving dinner and awards ceremony which coincided with the company’s 15th anniversary, held at the Civic Centre, Victoria Island, Lagos on 15 December, 2014, the pharmacist remarked that she was happy that HealthPlus, Nigeria’s first integrative pharmacy store, had become the pride of Pharmacy.

“15 years is a major milestone for us,” Pharm. George recalled. “I still remember how we started from the 18 square-metre room in Ikeja, GRA, with three staff. We ensured that there was a pharmacist always on duty. We never paid lip service and, in 2011, we opened our first branch outside Lagos in Abuja. Today, with 40 branches nationwide, HealthPlus has become the pride of Pharmacy and the beauty industry.”

While crediting the success of the chain to her ‘people’ (the staff), the pharmacist said she was proud that HealthPlus was no longer about herself alone, adding that with the company’s current growth rate, past successes would seem insignificant in comparison with future prospects.

“We have a target to start 48 new branches next year [2015]. That is, 12 branches every quarter. It is going to be a challenge but it is achievable as we trust God for everything. It might also interest you to know that we have finally signed an agreement with International Financial Corporation (IFC),” she disclosed.

Lamenting the incessant conflicts besetting the health care sector, George said the time had come for health practitioners to stop fighting each other and work in the best interest of the patient.

She added: “On our part, we will continue to contribute our own quota. Just yesterday, we opened a new branch at Magboro along Lagos-Ibadan expressway. From next year, we will also target areas like Akowonjo, Tejuosho, Agege and several others.”

While delivering the keynote address for the occasion, Pharm. Clare Omatseye, founder and Managing Director of JNC International Nigeria Limited, disclosed that she almost screamed when she heard that HealthPlus was planning to open 48 additional branches in just one year.

“But knowing Bukky for who she is, a woman full of passion and vision, I believe she can achieve it,” she enthused.

The seasoned pharmacist with years of pharmaceutical, public health and medical device experience, recounted the sad event of an asthmatic young man who relapsed while driving along the Lagos-Ibadan expressway.

“All efforts made to get a quality patent medicine store, let alone a pharmacy, proved abortive. In the end, the young man died. Today I am happy somebody like Bukky George has taken care of that problem by opening a HealthPlus branch along the express,” she noted.

Omatseye also called on healthcare practitioners to put their differences aside and work in the collective interest of the patient. According to her, hospitals and doctors cannot make everything happen by themselves. What makes things happen is harmonisation, if the health sector is ever to break free from its vicious cycle.

“We cannot continue to do the same thing in the same way, day in, day out. We need to start creating new frontiers,” she said.

Also at the event were Pharm. Bolanle Adekoya, head of pharmacy department, Lagos University Teaching Hospital (LUTH); Pharm. Ike Onyechi, managing director of Alpha Pharmacy; Pharm. Lekan Asuni, managing director of GlaxoSmithKline; Pharm. Femi Soremekun, chairman of Biofem Pharmaceuticals; and Dr Lolu Ojo, former chairman of National Association of Industrial Pharmacists (NAIP).

Commenting on the thanksgiving dinner and award ceremony, Dr Lolu Ojo described it as laudable.

“Bukky is somebody one can describe as the best of the best. I think she has succeeded in bringing what we (pharmacists) dream about to reality,” he remarked.

On whether the HealthPlus boss could achieve the target of 48 new branches, the immediate past NAIP chairman was optimistic, citing Pharm. George past records.

“Although it is a very big and expansive ambition, she has the commitment to do it. Just as she vowed to increase HealthPlus Pharmacy from 17 to 40 branches in the past, this won’t be an exception. Don’t forget she just signed an agreement with the IFC,” he said.

Corroborating Dr Lolu Ojo’s view was Pharm. Chukwuemeka Obi, operations manager of PharmacyPlus Nigeria Limited, who said Bukky George had succeeded in revolutionising retail pharmacy in the country.

Obi disclosed that he knew the enterprising pharmacist way back when she left GSK and pitched tent with London’s popular pharmacy – John Bell and Croyden – to learn the ropes of managing a retail chain. He described her as a focussed pharmacist and go-getter.

Towards the end of the programme, some of the company’s staff were given awards and special recognition for their commitment over the years. They included Adebimpe Odesanya (2014 Outstanding Manager), Sandy Augustina (2014 Outstanding CasaBella Beauty Manager) and Sola Subair (Long Service Award).

HealthPlus was incorporated in 1996 four years after Pharm. Bukky George graduated from the School of Pharmacy, University of Lagos as the best student of the college. It officially started operations in May 1999 and CasaBella Beauty, a retail beauty business, was incorporated into the chain soon after.